US20020042564A1 - Devices for creating collateral channels in the lungs - Google Patents

Devices for creating collateral channels in the lungs Download PDF

Info

Publication number
US20020042564A1
US20020042564A1 US09908087 US90808701A US2002042564A1 US 20020042564 A1 US20020042564 A1 US 20020042564A1 US 09908087 US09908087 US 09908087 US 90808701 A US90808701 A US 90808701A US 2002042564 A1 US2002042564 A1 US 2002042564A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
conduit
method
airway
step
device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09908087
Inventor
Joel Cooper
Bryan Loomas
Don Tanaka
Michael Laufer
David Thompson
Gary Kaplan
Dave Haugaard
Glendon French
Ed Roschak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laufer Michael D
Broncus Tech Inc
Original Assignee
Broncus Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1477Needle-like probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/12Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/92Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B17/0644Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1442Probes having pivoting end effectors, e.g. forceps
    • A61B18/1445Probes having pivoting end effectors, e.g. forceps at the distal end of a shaft, e.g. forceps or scissors at the end of a rigid rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/1815Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00106Sensing or detecting at the treatment site ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00809Lung operations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1135End-to-side connections, e.g. T- or Y-connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1139Side-to-side connections, e.g. shunt or X-connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22065Functions of balloons
    • A61B2017/22067Blocking; Occlusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22072Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
    • A61B2017/22074Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other the instrument being only slidable in a channel, e.g. advancing optical fibre through a channel
    • A61B2017/22077Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other the instrument being only slidable in a channel, e.g. advancing optical fibre through a channel with a part piercing the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • A61B17/3423Access ports, e.g. toroid shape introducers for instruments or hands
    • A61B2017/3425Access ports, e.g. toroid shape introducers for instruments or hands for internal organs, e.g. heart ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B2017/348Means for supporting the trocar against the body or retaining the trocar inside the body
    • A61B2017/3482Means for supporting the trocar against the body or retaining the trocar inside the body inside
    • A61B2017/3484Anchoring means, e.g. spreading-out umbrella-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00029Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00273Anchoring means for temporary attachment of a device to tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00273Anchoring means for temporary attachment of a device to tissue
    • A61B2018/00279Anchoring means for temporary attachment of a device to tissue deployable
    • A61B2018/00285Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00541Lung or bronchi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1425Needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1435Spiral
    • A61B2018/1437Spiral whereby the windings of the spiral touch each other such as to create a continuous surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1475Electrodes retractable in or deployable from a housing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1497Electrodes covering only part of the probe circumference
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/08Accessories or related features not otherwise provided for
    • A61B2090/0801Prevention of accidental cutting or pricking
    • A61B2090/08021Prevention of accidental cutting or pricking of the patient or his organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • A61B2090/3782Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937Visible markers
    • A61B2090/395Visible markers with marking agent for marking skin or other tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4887Locating particular structures in or on the body
    • A61B5/489Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/06Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/44Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
    • A61B8/4444Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
    • A61B8/445Details of catheter construction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/20Epiglottis; Larynxes; Tracheae combined with larynxes or for use therewith
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/856Single tubular stent with a side portal passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/043Bronchi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8483Barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0066Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0058X-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0076Quadric-shaped ellipsoidal or ovoid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0078Quadric-shaped hyperboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0091Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0078Ultrasound therapy with multiple treatment transducers

Abstract

The devices and methods disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices and methods produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The devices and methods also disclose locating and selecting a site for creation of a collateral opening.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application Ser. No. 60/147,528 filed Aug. 5, 1999, and U.S. Provisional Application Ser. No. 60/176,141 filed Jan. 14, 2000 and U.S. patent application Ser. No. 09/633,651 filed Aug. 7, 2000.[0001]
  • FIELD OF THE INVENTION
  • The invention is directed to methods and devices to altering gaseous flow within a lung to improve the expiration cycle of an individual, particularly individuals having Chronic Obstructive Pulmonary Disease (COPD). More particularly, methods and devices are disclosed to produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. [0002]
  • BACKGROUND OF THE INVENTION
  • The term “Chronic Obstructive Pulmonary Disease” (COPD) is generally used to describe the disorders of emphysema and chronic bronchitis. Previously, COPD was also known as Chronic Obstructive Lung Disease (COLD), Chronic Airflow Obstruction (CAO), or Chronic Airflow Limitation (CAL). Some also consider certain types of asthma to fall under the definition of COPD. Emphysema is characterized by an enlargement of air spaces inside the lung. Hence, Emphysema is an anatomic definition and it can only be presumed in a living patient. Chronic bronchitis is characterized by excessive mucus production in the bronchial tree. Chronic bronchitis is a clinical definition and denotes those individuals who meet criteria defining the disease. It is not uncommon for an individual to suffer from both disorders. [0003]
  • In 1995, the American Lung Association (ALA) estimated that between 15-16 million Americans suffered from COPD. The ALA estimated that COPD was the fourth-ranking cause of death in the U.S. The ALA estimates that the rates of emphysema is 7.6 per thousand population, and the rate for chronic bronchitis is 55.7 per thousand population. [0004]
  • Those inflicted with COPD face disabilities due to the limited pulmonary functions. Usually, individuals afflicted by COPD also face loss in muscle strength and an inability to perform common daily activities. Often, those patients desiring treatment for COPD seek a physician at a point where the disease is advanced. Since the damage to the lungs is irreversible, there is little hope of recovery. Most times, the physician cannot reverse the effects of the disease but can only offer treatment and advice to halt the progression of the disease. [0005]
  • To understand the detrimental effects of COPD, the workings of the lungs requires a cursory discussion. The primary function of the lungs is to permit the exchange of two gasses by removing carbon dioxide from venous blood and replacing it with oxygen. Thus, to facilitate this exchange, the lungs provide a blood gas interface. The oxygen and carbon dioxide move between the gas (air) and blood by diffusion. This diffusion is possible since the blood is delivered to one side of the blood-gas interface via small blood vessels (capillaries). The capillaries are wrapped around numerous air sacs called alveoli which function as the blood-gas interface. A typical human lung contains about 300 million alveoli. [0006]
  • The air is brought to the other side of this blood-gas interface by a natural respiratory airway, hereafter referred to as a natural airway or airway, consisting of branching tubes which become narrower, shorter, and more numerous as they penetrate deeper into the lung. Specifically, the airway begins with the trachea which branches into the left and right bronchi which divide into lobar, then segmental bronchi. Ultimately, the branching continues down to the terminal bronchioles which lead to the alveoli. Plates of cartilage may be found as part of the walls throughout most of the airway from the trachea to the bronchi. The cartilage plates become less prevalent as the airways branch. Eventually, in the last generations of the bronchi, the cartilage plates are found only at the branching points. The bronchi and bronchioles may be distinguished as the bronchi lie proximal to the last plate of cartilage found along the airway, while the bronchiole lies distal to the last plate of cartilage. The bronchioles are the smallest airways that do not contain alveoli. The function of the bronchi and bronchioles is to provide conducting air ways that lead inspired air to the gas-blood interface. However, these conducting airways do not take part in gas exchange because they do not contain alveoli. Rather, the gas exchange takes place in the alveoli which are found in the distal most end of the airways. [0007]
  • The mechanics of breathing include the lungs, the rib cage, the diaphragm and abdominal wall. During inspiration, inspiratory muscles contract increasing the volume of the chest cavity. As a result of the expansion of the chest cavity, the pleural pressure, the pressure within the chest cavity, becomes sub-atmospheric with respect to the pressure at the airway openings. Consequently, air flows into the lungs causing the lungs to expand. During unforced expiration, the expiratory muscles relax and the lungs begin to recoil and reduce in size. The lungs recoil because they contain elastic fibers that allow for expansion, as the lungs inflate, and relaxation, as the lungs deflate, with each breath. This characteristic is called elastic recoil. The recoil of the lungs causes alveolar pressure to exceed the pressure at airway openings causing air to flow out of the lungs and deflate the lungs. If the lungs' ability to recoil is damaged, the lungs cannot contract and reduce in size from their inflated state. As a result, the lungs cannot evacuate all of the inspired air. [0008]
  • Emphysema is characterized by irreversible damage to the alveolar walls. The air spaces distal to the terminal bronchiole become enlarged with destruction of their walls which deteriorate due to a biochemical breakdown. As discussed above, the lung is elastic, primarily due to elastic fibers and tissues called elastin found in the airways and air sacs. If these fibers and tissues become weak the elastic recoil ability of the lungs decreases. The loss of elastic recoil contributes to more air to entering the air sacs than can exit preventing the lungs from reducing in size from their inflated state. Also, the biochemical breakdown of the walls of the alveolar walls causes a loss of radial support for airways which results in a narrowing of the airways on expiration. [0009]
  • Chronic bronchitis is characterized by excessive mucus production in the bronchial tree. Usually there is a general increase in bulk (hypertrophy) of the large bronchi and chronic inflammatory changes in the small airways. Excessive amounts of mucus are found in the airways and semisolid plugs of this mucus may occlude some small bronchi. Also, the small airways are usually narrowed and show inflammatory changes. [0010]
  • In COPD, a reduction in airflow arises as a result of 1) partial airway occlusion by excess secretions, 2) airway narrowing secondary to smooth muscle contraction, bronchial wall edema and inflation of the airways, and 3) reduction in both lung elasticity and tethering forces exerted on the airways which maintain patency of the lumen. As a result of the COPD, the airways close prematurely at an abnormally high lung volume. As mentioned above, in an emphysematous lung there is a decrease of lung parenchyma as there are larger and fewer air sacs. Thus, there is a decrease in the amount of parenchymal tissue which radially supports the airways. This loss of radial traction allows the airway to collapse more easily. As lung recoil decreases and airway closure occur at higher lung volumes, the residual volume of gas in the lung increases. Consequently, this increased residual gas volume interferes with the ability of the lung to draw in additional gas during inspiration. As a result, a person with advanced COPD can only take short shallow breaths. [0011]
  • One aspect of an emphysematous lung is that the flow of air between neighboring air sacs, known as collateral ventilation, is much more prevalent as compared to a normal lung. Yet, while the resistance to collateral ventilation may be decreased in an emphysematous lung the decreased resistance does not assist the patient in breathing due to the inability of the gasses to enter and exit the lungs as a whole. [0012]
  • Currently, although there is no cure for COPD, treatment includes bronchodilator drugs, and lung reduction surgery. The bronchodilator drugs relax and widen the air passages thereby reducing the residual volume and increasing gas flow permitting more oxygen to enter the lungs. Yet, bronchodilator drugs are only effective for a short period of time and require repeated application. Moreover, the bronchodilator drugs are only effective in a certain percentage of the population of those diagnosed with COPD. In some cases, patients suffering from COPD are given supplemental oxygen to assist in breathing. Unfortunately, aside from the impracticalities of needing to maintain and transport a source of oxygen for everyday activities, the oxygen is only partially functional and does not eliminate the effects of the COPD. Moreover, patients requiring a supplemental source of oxygen are usually never able to return to functioning without the oxygen. [0013]
  • Lung volume reduction surgery is a procedure which removes portions of the lung that are over-inflated. The improvement to the patient occurs as a portion of the lung that remains has relatively better elastic recoil which allows for reduced airway obstruction. The reduced lung volume also improves the efficiency of the respiratory muscles. However, lung reduction surgery is an extremely traumatic procedure which involves opening the chest and thoracic cavity to remove a portion of the lung. As such, the procedure involves an extended recovery period. Hence, the long term benefits of this surgery are still being evaluated. In any case, it is thought that lung reduction surgery is sought in those cases of emphysema where only a portion of the lung is emphysematous as opposed to the case where the entire lung is emphysematous. In cases where the lung is only partially emphysematous, removal of a portion of emphysematous lung increases the cavity area in which the non-diseased parenchyma may expand and contract. If the entire lung were emphysematous, the parenchyma is less elastic and cannot expand to take advantage of an increased area within the lung cavity. [0014]
  • Both bronchodilator drugs and lung reduction surgery fail to capitalize on the increased collateral ventilation taking place in the diseased lung. There remains a need for a medical procedure that can alleviate some of the problems caused by COPD. There is also a need for a medical procedure that alleviates some of the problems caused by COPD irrespective of whether a portion of the lung, or the entire lung is emphysematous. The production and maintenance of collateral openings through an airway wall which allows expired air to pass directly out of the lung tissue responsible for gas exchange. These collateral openings ultimately decompress hyper inflated lungs and/or facilitate an exchange of oxygen into the blood. [0015]
  • SUMMARY OF THE INVENTION
  • This invention relates to devices and methods for altering gaseous flow in a diseased lung. In particular, the inventive method includes the act of improving gaseous flow within a diseased lung by the step of altering the gaseous flow within the lung. A variation of the inventive method includes the act of selecting a site for collateral ventilation of the diseased lung and creating at least one collateral channel at the site. The term “channel” is intended to include an opening, cut, slit, tear, puncture, or any other conceivable artificially created opening. A further aspect of the invention is to locate a site within a portion of a natural airway of the respiratory system of the patient having the diseased lung. The portion of the natural airway selected for the creation of the collateral channels may be, for example, the bronchi, the upper lobe, the middle lobe, the lower lobe, segmental bronchi and the bronchioles. [0016]
  • A variation of the invention includes selecting a site for creating a collateral channel by visually examining areas of collateral ventilation. One variation includes visually examining the lung with a fiber optic line. Another example includes the use of non-invasive imaging such as x-ray, ultrasound, Doppler, acoustic, MRI, PET computed tomography (CT) scans or other imaging. The invention further includes methods and devices for determining the degree of collateral ventilation by forcing gas through an airway and into air sacs, reducing pressure in the airway, and determining the reduction in diameter of the airway resulting from the reduction in pressure. The invention further includes methods and devices for determining the degree of collateral ventilation by forcing a volume of gas within the lung near to the airway and measuring pressure, flow, or the return volume of gas within the airway. The invention also includes methods and devices for occluding a section the airway and determining the degree of collateral ventilation between the occluded section of the airway and the air sacs. [0017]
  • An important, but not necessarily critical, portion of the invention is the step of avoiding blood vessels or determining the location of blood vessels to avoid them. It is typically important to avoid intrapulmonary blood vessels during the creation of the collateral channels to prevent those vessels from rupturing. Thus, it is preferable to avoid intrapulmonary or bronchial blood vessels during the creation of the collateral channels. Such avoidance may be accomplished, for example by the use of non-invasive imaging such as radiography, computed tomography (CT) imaging, ultrasound imaging, Doppler imaging, acoustical detection of blood vessels, pulse oxymetry technology, or thermal detection or locating. The avoidance may also be accomplished using Doppler effect, for example transmission of a signal which travels through tissue and other bodily fluids and is reflected by changes in density that exist between different body tissue/fluids. If the signal is reflected from tissue/fluid that is moving relative to the sensor, then the reflected signal is phase shifted from the original signal thereby allowing for detection. The invention includes devices having at least one sensor for the above described imaging methods. In variations of the invention having multiple sensors, the sensors may be arranged in a linear pattern or in an array pattern. Also, the invention may have a mark to serve as a reference point while the device is remotely viewed. [0018]
  • The invention may include adding an agent to the lungs for improving the imaging. For example, a gas may be inserted into the lungs to provide contrast to identify hyperinflation of the lungs during an x-ray or other non-invasive imaging. For example, [0019] 133Xe (Xenon 133) may be used as the agent. Also, a contrast agent may help in identifying blood vessels during CT scans. Another example includes inserting a fluid in the lungs to couple an ultrasound sensor to the wall of an airway.
  • Another variation of the act of looking for blood vessels includes insertion of a probe into a wall of the natural airway for the detection of a blood vessel. Such a probe may, for example, detect the presence of a blood vessel upon encountering blood such as when the probe is inserted into a vessel. The probe may also use ultrasonic detection to determine the location of a vessel. For example, ultrasound may be used to determine changes in composition of the tissue beyond the airway wall for determination of the location of a vessel. A probe may, for example, use low frequency radio energy to induce heat at a point and determine the presence of a vessel by measuring a change in temperature due to the conduction of heat by the blood flowing within the vessel. Another variation is that the probe could detect changes in impedance given a pre-arranged discharge of current through the bloodstream. It is also contemplated that the probe is used, for example, purposely to find the blood vessel, so that an alternative site may be selected at a safe distance from the vessel. [0020]
  • Another variation of the invention is via the delamination of the blood vessel and the wall of an airway. This delamination may occur in many ways. For instance, the airway may be expanded until the vessel separates from the wall of the airway. Or, a vacuum may be applied within the interior of the airway using, for example, two occlusive balloons or the like to isolate a portion of the airway and apply a vacuum. The vacuum between the balloons constricts the diameter of the airway by collapsing the walls of the airway until the exterior walls separate from any blood vessel. [0021]
  • The invention may also include providing a remotely detectable signal to indicate the presence or absence of any blood vessels at the target site. The invention also includes methods and devices for marking a desired site for the creation of a collateral channel. [0022]
  • The invention also includes the act of creating one or more collateral channels within the respiratory system of the individual. The collateral channels may have a cross sectional area anywhere between 0.196 mm[0023] 2 to 254 mm2. Any subset of narrower ranges is also contemplated. The collateral channels may also extend anywhere from immediately beyond the epithelial layer of the natural airway to 10 cm or more beyond the epithelial layer. The channel or channels should be created such that the total area of the channel(s) created is sufficient to adequately decompress a hyperinflated lung. The channel may be, for example, in the shape of a hole, slit, skive, or cut flap. The channel may be formed by the removal of any portion of the airway wall; e.g., a circumferential or arc-shaped ring of material may be removed to form the channel. Such an excised periphery may be for example, perpendicular or at angled with respect to the axis of the airway.
  • Another variation of the invention involves creation of a collateral channel by creating an incision in a natural airway and using a blunt member to push the vessel away from the path of a collateral channel. Another variation of forming the collateral channel is, for example, by use of a mechanical process such as dilation, cutting, piercing, or bursting. For example, a balloon may be used to expand an incision made in the natural airway or the natural airway itself until a collateral channel is opened. Or, a mechanical cutter or piercing tool could be used to open and create the collateral channel. Another variation for creating a collateral channel includes making an incision in the natural airway and placing the wall of the airway in tension, then advancing a blunt instrument into the incision. [0024]
  • Also, it is anticipated that along with any method of creating a collateral channel any loose material or waste generated by the creation of the collateral channel is optionally removed from the airway. [0025]
  • Another variation for creating the collateral channel is the creation of the airway using electric energy, for example radio frequency. Or, for example, ultrasonic energy, a laser, microwave energy, chemicals, or cryo-ablative energy may be used to form a collateral channel as well. A feature of these methods often includes creation of a hemostasis in the event that any blood vessel is punctured. For example, use of RF energy provides a hemostasis given a puncture of a vessel by using heat to seal the vessel. Similarly, an ultrasonic scalpel also provides an area of hemostasis in case the vessel is punctured. It is understood that any combination of different methods may be used for forming a single or multiple collateral channels. A variation of the invention includes a limiter for limiting the depth of a collateral channel. [0026]
  • A variation of the inventive device includes a device that detects motion within tissue using Doppler measurements. The device may include a flexible member having a transducer assembly that is adapted to generate a source signal and receive a reflected signal. The inventive device may also comprise a hole-making assembly that is adapted to making collateral channels within tissue. The transducer assembly may include an acoustic lens which enables the transmission and detection of a signal over a tip of the device. The hole-making assembly may be an RF device and use portions of the tip of the device as RF electrodes, or the hole-making assembly may use ultrasound energy to make the hole. [0027]
  • Another variation of the invention includes the act of inserting an implant or conduit within a collateral channel to maintain the patency of the channel over time during the expiration cycle of the lung. A conduit could, for example, have distal and proximal ends with a wall defining a lumen extending between the ends. The conduit could have, for example, a porous wall permitting the exchange of gasses through the wall. The conduit may, for example, be comprised of a material such as elastomers, polymers, metals, metal alloys, shape memory alloys, shape memory polymers, or any combination thereof. A variation of the invention includes an expandable conduit, either one that is self-expanding, or one that expands in diameter in relation to any applied radial, or axial force. For example, the conduit may be expanded into an opening of the natural airway upon the inflation of a balloon. A variation of the conduit may include the use of flanges or anchors to facilitate placement of the device within an airway. Another variation of the conduit includes placing a one-way valve within the conduit. Another variation includes using a self cleaning mechanism within the conduit to clear accumulating debris. [0028]
  • The inventive conduit may be, for example, removable or permanent. Also, another variation of the device includes a means for inserting the conduit within a collateral channel. The conduit may be constructed to allow for passage of gasses through its wall, for example, the conduit may have a wall consisting of a braid. A variation of the conduit may be located through an opening in a wall of an airway and engage both an inside and outside of the wall. Another variation of the conduit includes a distal end having a porous member and a proximal end having a grommet member which engages an opening in a wall of the natural airway. Yet another variation of the implant, for example, comprises an expandable conduit-like apparatus which could bridge an opening within a wall of a natural airway. Another variation includes the conduit-like apparatus having a cutting portion exterior to the device wherein expansion of the device pierces the wall of the natural airway and creates a collateral channel. [0029]
  • An aspect of the invention is that conduits of varying cross-sectional areas may be placed in various sections of the lung to optimize the effect of the collateral channels. [0030]
  • Another variation of the invention includes the application of a cyanoacrylate, fibrin or other bio-compatible adhesive to maintain the patency of a collateral channel. The adhesive may be used with or without the conduit described above. For example, the adhesive may be deposited within the collateral channel to maintain patency of the channel or to create a cast implant of the channel. The inventive act further includes the act of delivering medications such as steroids which have been shown to inhibit the healing process, bronchodilators, or other such drugs which aid in breathing, fighting infection, or recovery from the procedure. The steroids inhibit inflammation and then promote the stabilization of the created channel. [0031]
  • Another variation of the inventive process includes promoting the flow of gasses through under-utilized parenchymal inter-conduits, or bypassing restricted airways. It is also contemplated that the gaseous flow may be altered by, for example, making separate inspiratory and expiratory paths. Also, relieving pressure on the external wall of a natural airway may be accomplished to assist the natural airway by maintaining patency during the expiration cycle of the lung. Yet another variation includes creating collateral channels parallel to existing airflow paths, or the existing airflow paths may be increased in cross-sectional area. [0032]
  • The invention further includes a device for altering gaseous flow in a diseased lung comprising a locator for locating a site for collateral ventilation of the lung, and optionally, a creating means for opening at least one collateral channel at the site. It is contemplated that the device includes a means for locating a blood vessel as described above. Also, as stated above, the device may use a mechanical, electrical, laser, ultrasonic, microwave, or chemical process for creating a collateral channel. Another variation of the device includes a means for coagulating blood upon the entry of the device into a blood vessel. Yet another variation of the device includes the means for locating and the means for creating are the same. The device may further include a means for simultaneously creating a plurality of collateral channels. [0033]
  • Another variation of the implant includes conduits constructed from materials that oppose the constriction of the natural airway over time during the expiration cycle of the lung. Yet another variation of the implant includes a device which expands as the pressure in the lung decreases during the expiration cycle. [0034]
  • The invention further includes a modified respiratory airway having an artificially created channel allowing gaseous communication between an exterior of the airway and an interior of the airway. [0035]
  • The invention may include an endoscope or a bronchoscope configured to select sites and create collateral channels at those sites. An endoscope or a bronchoscope may also be configured to deploy conduits within the collateral channels. Another variation of the invention includes sizing the device to fit within the working channel of a bronchoscope. [0036]
  • The invention also includes methods for evaluating an individual having a diseased lung for a procedure to create collateral channels within an airway of the individual. The invention further includes the method of determining the effectiveness of the procedure. [0037]
  • The invention further includes the act teaching any of the methods described above. [0038]
  • The invention further includes the method of sterilizing any of the devices or kits described above.[0039]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. [0040] 1A-1C illustrates various states of the natural airways and the blood-gas interface.
  • FIGS. [0041] 1D-1G illustrate devices and methods for determining the degree of collateral ventilation within a lung.
  • FIG. 2A illustrates a natural airway with a collateral channel in relation to a blood vessel. [0042]
  • FIGS. [0043] 2B-2K illustrate methods of avoiding blood vessel prior to the creation of a collateral channel.
  • FIGS. [0044] 2B-2E illustrate various methods for delaminating an airway from a blood vessel.
  • FIG. 2F illustrates the use of a probe to determine a site for creating a collateral channel. [0045]
  • FIGS. [0046] 2G-2K illustrate the use of sensors to determine a site for creating a collateral channel.
  • FIGS. [0047] 3A-3I illustrate methods of and devices for creating a collateral opening within a natural airway.
  • FIGS. [0048] 3J-3K illustrate a method of folding epithelial tissue through a collateral channel.
  • FIG. 4 illustrates a device and method for simultaneously creating numerous collateral channels or deployment of numerous probes. [0049]
  • FIGS. [0050] 5A-5V illustrate various configuration of implantable conduits.
  • FIGS. [0051] 6A-6D illustrate devices for detecting blood vessels within tissue.
  • FIGS. [0052] 6E-6O illustrates various devices for detecting blood vessels within tissue where the devices also include hole-making assemblies.
  • FIGS. [0053] 6P-6V illustrate various electrode configurations for the hole-making assemblies of the device.
  • FIGS. [0054] 7A-7B illustrate devices and methods for creating a collateral channel with a device having a hole-making assembly and also preserving the tissue surrounding the collateral channel.
  • FIGS. [0055] 7C-7D illustrate additional electrode configurations for use with a device of the present invention where the structure of the electrodes limits the possible depth of a collateral channel formed by the electrode.
  • FIGS. [0056] 8A-8U illustrate variations of conduits of the present invention.
  • FIGS. [0057] 9A-9I illustrate variations of methods and devices for deployment of conduits of the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Prior to considering the invention, simplified illustrations of various states of a natural airway and a blood gas interface found at a distal end of those airways are provided in FIGS. [0058] 1A-1C. FIG. 1A shows a natural airway 100 which eventually branches to a blood gas interface 102. FIG. 1B illustrates an airway 100 and blood gas interface 102 in an individual having COPD. The obstructions 104 impair the passage of gas between the airways 100 and the interface 102. FIG. 1C illustrates a portion of an emphysematous lung where the blood gas interface 102 expands due to the loss of the interface walls 106 which have deteriorated due to a bio-chemical breakdown of the walls 106. Also depicted is a constriction 108 of the airway 100. It is generally understood that there is usually a combination of the phenomena depicted in FIGS. 1A-1C. More usually, the states of the lung depicted in FIGS. 1B and 1C are often found in the same lung.
  • The following illustrations are examples of the invention described herein. It is contemplated that combinations of aspects of specific embodiments or combinations of the specific embodiments themselves are within the scope of this disclosure. [0059]
  • As will be explained in greater detail below, central to this invention in all of its aspects is the production and maintenance of collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue and into the airways to ultimately facilitate exchange of oxygen into the blood and/or decompress hyper inflated lungs. The term ‘lung tissue’ is intended to include the tissue involved with gas exchange, including but not limited to, gas exchange membranes, alveolar walls, parenchyma and/or other such tissue. To accomplish the exchange of oxygen, the collateral channels allow fluid communication between an airway and lung tissue. Therefore, gaseous flow is improved within the lung by altering or redirecting the gaseous flow within the lung, or entirely within the lung. FIG. 1D illustrate a schematic of a lung [0060] 118 to demonstrate a principle of the invention described herein. As shown, a collateral channel 112 places lung tissue 116 in fluid communication with airways 100 allowing expired air to directly pass out of the airways 100. As shown, constricted airways 108 may ordinarily prevent air from exiting the lung tissue 116. In the example illustrated in FIG. 1D, conduits 200 may be placed in the collateral channels 112 to assist in maintaining the patency of the collateral channels 112. Therefore, it is not necessary to pierce the pleura to improve gaseous flow within the lungs. While the invention is not limited to the number of collateral channels which may be created, it is preferable that 1 or 2 channels are placed per lobe of the lung. For example, the preferred number of channels is 2-12 channels per individual patient.
  • Accordingly, since the invention is used to improve the function of the lungs, a variation of the inventive device may include an endoscope or a bronchoscope configured to locate a site for creating a collateral channel and create the collateral channel. Another variation includes sizing the inventive device to fit within a working channel of an endoscope or a bronchoscope. For the sake of brevity, hereafter, any reference made to an endoscope includes the term bronchoscope. [0061]
  • The invention includes assessing the degree of the collateral ventilation taking place in an area of a lung to select a site for creation of a collateral channel. The invention may include locating a site for creation of a collateral channel by visually examining an airway for dynamic collapse. One method of visual examination includes the use of a fiber optic line or camera which may be advanced into the lungs and through the airways. Other variations of visually examining the lung to determine the location of a site for the creation of the collateral channel using non-invasive imaging, including but not limited toradiography, computer tomography, ultrasound, Doppler, and acoustic imaging. Such imaging methods may also be used to determine the amount of collateral channels to be created. [0062]
  • Also contemplated in the invention is the addition of various agents to assist during imaging of the airways or lungs. One example includes the use of a non-harmful gas, such as Xenon, to enhance the visibility of hyperinflated portions of the lung during radiological imaging. Another example includes the use of inserting a fluid in the lungs to provide an improved sound transmission medium between the device and the tissue in variations of the invention using ultrasound, acoustic, or other imaging. [0063]
  • Another variation of the invention includes methods and devices for triggering a collapse of the airway to determine the degree of collateral ventilation in the lung. One example includes forcing a fluid, such as a gas, air, oxygen, etc., through the airway and into the air sacs. Next, to assess the patency of the airway, the pressure is reduced in the airway. One example of how pressure is reduced in the airway includes evacuating the air in a direction opposite to the air sacs. Constriction of the airway given a drop in pressure may be an indication of collateral ventilation of the lung in that region. [0064]
  • FIG. 1E, illustrates a method and device [0065] 212 for causing collapse of the airway wall 100. The device 212 includes a fluid delivery member 214 located at a distal end of the device 212. The fluid delivery member 214 is configured to deliver a volume of fluid through the airway 100 and into an air sac (not shown). The device 212 may also comprise a probe 216 configured to collect data within the lung. The probe 216 may also simply consist of a channel that transmits signals outside of the lung. Moreover, the fluid delivery member 214 and the probe 216 may not be separate channels. Also, the device 212 may, but does not necessarily, have an occlusion member 218 designed to isolate a section of the airway 100 between the occlusion member 218 and the air sacs (not shown). The occlusion member 218, which forms a seal against the airway 100 walls, may provide a partially closed system allowing a more effective search for collateral ventilation between the air sacs (not shown.) The device delivers a burst of fluid, through the fluid delivery member 214 and subsequently uses the probe 216 to measure characteristics such as pressure, flow, or return volume to determine the degree of collateral ventilation. The term fluid is intended to include, air or a gas, such as oxygen, etc. For example, if the air sacs are diseased (as shown in FIG. 1C), the forced fluid will escape/disperse through another air sac due to the collateral ventilation of the air sacs. As a result, the probe 216 may fail to record any increase in pressure, volume, flow, or any other characteristic of the fluid at the site. Another variation of the invention includes using the fluid delivery member 214 to add or remove fluid distally to the occluded segment and using the probe 216 to monitor flow or pressure changes in the area. For example, if after adding/removing fluid the pressure in the occluded segment fails to build/drop, the assumption may be made that the gas is being collaterally vented through diseased air sacs.
  • FIG. 1F illustrates another variation of the invention. In this example, the device [0066] 220 comprises a separated probe 216 and gas delivery member 214. In this variation, the fluid delivery member 214 is configured to pass through a wall of the airway 100 so that fluid may be directly forced into, or pulled out of an air sac 102.
  • FIG. 1G illustrates yet another variation of the invention. In this variation, the device [0067] 222 may have at least one fluid exchange passageway 224. The device 222 may force fluid into the airway 100 via the passageway 224. Then, fluid can be pulled out via the passageway 224, thus decreasing pressure distally to the device 222. The decrease in pressure permits fluid to flow out of the airway 100 and away from the air sac (not shown). In this case, if the air sacs surrounding the airway 100 are diseased and collateral ventilation is taking place, then the airway 100 may collapse. A variation of the invention may include an expandable member 218, such as a balloon, to create a seal against the airway 100 walls. Forming a seal may provide a partially closed system to search for collateral ventilation between air sacs (not shown.) As described above, observation of a collapsing airway 100 may indicate a desired site for creation of a collateral channel.
  • FIG. 2A illustrates a blood vessel [0068] 110 on an outer wall of an airway 100. In this figure, the collateral channel 112 created using this invention is located away from the vessel wall 110. Such a positioning of the collateral channel 112 eliminates the risk of rupturing the vessel 110 during formation of the collateral channel 112. As mentioned above, the term channel is intended to include an opening, cut, slit, tear, puncture, or any other conceivable artificially created opening.
  • Of course, it is not the case that blood vessels are necessarily as conveniently located as is seen in FIG. 2A. Consequently, it may be desirable to move the vessels or to avoid them. FIG. 2B illustrates a first way of moving the nearby vessel. FIG. 2B shows the inflation of the airway [0069] 100 using a balloon 204 provided on a delivery device 202. As shown in FIG. 2C, upon deflation of the balloon 204, the airway 100 and the vessel 110 become delaminated thereby moving the vessel from the region just outside the exterior of the airway. Subsequent creation of a collateral channel using the inventive procedures will be less likely to hit the vessel.
  • FIG. 2D demonstrates another device [0070] 206 and method for delaminating an airway 100 from a vessel 110. In this variation, the two balloons (204 & 205) occlude the airway 100. As shown in FIG. 2E, upon application of a vacuum, the vessel 110 and the airway 100 delaminate as the airway 100 separates from the vessel 110. It may be desirable to make a channel while the airway is contracted as shown in FIG. 2E.
  • FIG. 2F illustrates the insertion of a probe [0071] 210 into a wall of the airway 100. Although, the probe 210 is illustrated to be a singular probe, the delivery device 208 may be adapted to have multiple probes. As described above, the probe 210 may detect the presence of blood such as when the probe is inserted into a vessel. For example, the probe 210 could be configured to puncture a wall of the airway 100, and detect the presence of blood. Optionally, the probe 210 could pull a vacuum to facilitate entry of blood into the probe 210. The probe 210 may also use ultrasonic detection to determine the location of a vessel. For example, ultrasound may be used to determine changes in composition of the tissue beyond the airway wall for determination of the location of a vessel. A probe 210 may, for example, use low frequency radio energy to induce heat at a point and determine the presence of a vessel by measuring a change in temperature due to the conduction away or removal of heat by the blood flowing within the vessel. Another variation is that the probe 210 could detect changes in impedance given a pre-arranged discharge of current through the bloodstream. If a probe 210 detects blood during its travel outside the airway, the user could select another spot for a collateral channel.
  • Another variation of the invention includes methods and devices for determining whether a blood vessel is in proximity to a potential site. Making this determination prior to creating the channel is advantageous as the risk of puncturing a blood vessel is minimized. As mentioned above, non-invasive imaging may be used to locate blood vessels or to confirm the absence of a vessel at a site. FIG. 2G illustrates an example of this variation of the device [0072] 226 having a single sensor 228. The device may be, but is not necessarily, steerable and rotatable such that the sensor 228 can be placed in contact with any portion of the airway 100 wall. In non-steerable variations, the device may be located to a site by the use of an endoscope. The device 226 may also be stiff so that the sensor 228 may be placed in firm contact with a wall of the airway 100. It is important that the device does not ‘wander’ causing the creation of a collateral channel at a distance from the area originally searched. Such an occurrence may compromise a blood vessel (e.g., puncture, rupture, or otherwise open the blood vessel) even though the step of detecting the location indicated the absence of a blood vessel. In those cases, a stiffer wall provides added benefits.
  • Another variation of the invention includes inserting a fluid into the airway to provide a medium for the sensor [0073] 228 couple to the wall of the airway 100 to detect blood vessels. In those cases where fluid is not inserted, the device may use mucus found within the airway to directly couple the sensor 228 to the wall of the airway 100.
  • FIG. 2H illustrates another variation of the inventive device [0074] 230 having a plurality of sensors 228 arranged in an array pattern. Although not shown, the array could extend around the circumference of the device 230. FIG. 2I illustrates yet another variation of the inventive device. In this example, the device 232 comprises a plurality of sensors 228 arranged in a linear pattern. Although not shown, the pattern may also wind helically or in other patterns around the perimeter of the device 232.
  • FIG. 2J illustrates another variation of the invention. In this example, the device [0075] 234 comprises a sensor 228 encapsulated by an expandable member 236 e.g., a balloon. The expandable member 236 may be filled with a fluid or other substance that couples the sensor 228 to an outer surface of the expandable member 236. The sensor 228 may be rotatable within the expandable member 236, or the entire device 234 may be rotatable within the airway 100. Another variation of the device 234 includes a mark 238 which provides a reference for orientation of the device 234 in the airway 100. The mark 238 is preferably remotely detectable and may be positioned on the expandable member 236.
  • Another variation of the invention includes a means for marking the site. This variation of the device allows marking of the site after it is located. Accordingly, once marked, a previously selected site can be located without the need to re-examine the surrounding area for collateral ventilation, or the presence or absence of a blood vessel. The marking may be accomplished by the deposit of a remotely detectable marker, dye, or ink. Or, the marking may comprise making a physical mark on the surface of the airway to designate the site. Preferably, the mark is detectable by such imaging methods as radiography, computer tomography (CT) imaging, ultrasound imaging, doppler imaging, acoustical detection, or thermal detection or locating. Also, the mark may be detectable by direct visualization such as the case when a fiber optic cable is used. FIG. 2K illustrates an example of the device [0076] 240 having a sensor 228 to locate a site and a marking lumen 242 which may deposit an ink, dye, or other marker (not shown) on the site once located.
  • Although not illustrated, the invention may include a user interface which provides feedback once an acceptable site is located. For example, once a site is located a visual or audible signal or image is transmitted to the user interface to alert the user of the location of a potential site. The signal could be triggered once a blood vessel is located so that the site is selected in another location. In another example, the signal may trigger so long as a blood vessel is not located. [0077]
  • FIGS. [0078] 3A-3I depict various ways of providing openings in the airway wall which may be used as collateral air passageways.
  • FIG. 3A illustrates an airway [0079] 100 having a piercing member 300 and a dilation member 302. In this example, the piercing member 300 makes an incision (not shown) in the airway 100 wall. Next, the piercing member 300 is advanced into the wall so that a dilation member 300 can expand the incision to thereby provide a collateral channel. In this example, the dilation member 300 is depicted as a balloon. One variation of the invention includes filling a balloon with a heated fluid as the balloon dilates the tissue to form the collateral channel. Use of a heated balloon allows the transfer of heat to the collateral channel for modifying the healing response. However, it is also contemplated that the dilation member may be an expanding wedge (not shown) or other similar device.
  • FIG. 3B shows a cutting device [0080] 304 and an airway 100 having an opening 306 cut from a wall. In this example, a flap 308 is cut from the wall and is attached to an outside or an inside wall of the airway 100. As will be mentioned below, the flap may be glued, using for instance, fibrin-based or cyano-acrylate-based glues or stapled to that wall.
  • FIG. 3C illustrates a cutter [0081] 304 making an incision 310 in a wall of the airway 100. FIG. 3D illustrates one example of placing the walls of the airway 100 in tension and inserting ablunt instrument 314 into the incision. In this example, the delivery device 312 is flexible and may be shaped to the contour of an airway 100 to provide support for the blunt instrument 314 so that the instrument 314 can advance into the incision. The delivery device 312 is also used to deliver a blunt instrument 314 which expands the original incision. The blunt instrument 314 may have a hooked configuration as needed.
  • FIG. 3E shows the use of a balloon [0082] 320 to dilate a previously formed collateral channel in the airway wall 100. This procedure may be used variously with other mechanical, chemical, cryo-energy or RF based penetration systems to expand the size of that previously-formed opening.
  • FIG. 3F illustrates a variation of the device [0083] 322 having an RF electrode 324. This variation of the invention uses RF energy to create a collateral channel. The device 322 may be mono-polar or bi-polar. The RF energy throughout this invention is similar to that of a typical RF cutting probe operating between the 300 KHz-600 KHz range.
  • FIG. 3G-[0084] 3I illustrates additional variations of devices of the present invention used to create collateral channels. The devices may use RF energy, either monopolar or bipolar, or the devices may use light, infrared heat, or any of the other methods describe herein. In the variation of FIG. 3G, the device 328 has an electrode 324 located on a side of the device. This variation of the device 328 automatically limits the depth of the collateral channel as the body of the device 328 remains against an airway 100 wall while the electrode 324 creates a channel.
  • FIGS. 3H and 3I illustrates another variation of a device [0085] 330 of the present invention having an electrode 324 located on a front face of the device. FIG. 3I illustrates a perspective view of the device 330 with an electrode on the front face 324. The device 330 may either have an electrode 324 disposed on a front surface of the device 330 or the device may comprise a conductive material with an insulating layer 332 covering the device 330 and leaving an electrode surface 324 exposed. In the variations illustrated in FIGS. 3G-3I, the size of the electrode may be selected based upon the size of the desired collateral channel.
  • The device of the present invention may also be configured to limit the depth of the collateral channel. In one example, the invention may include a shoulder or stop [0086] 326 to limit the depth of the collateral channel. Another example includes graduated index markings on a proximal end of the device or on the distal end so long as they are remotely detectable. Also contemplated is the use of RF impedance measuring. In this example, the use of RF impedance may be used to determine when the device leaves the wall of the airway and enters the air sac or less dense lung tissue.
  • The invention also includes creating a collateral channel by making a single or a series of incisions in an airway wall then folding back the cut tissue through the collateral channel. This procedure allows the surface epithelium which was previously on the inside of the airway wall to cover the walls of the newly formed collateral channel. As discussed herein, promoting growth of the epithelium over the walls of the collateral channel provides a beneficial healing response. The incision may be created by the use of heat or a mechanical surface. For example, FIG. 3J illustrates a section of an airway [0087] 100 having several incisions 356 forming a number of sections 358 of airway wall tissue the airway 100. FIG. 3K illustrates the sections or flaps 358 of the airway wall folded through the collateral channel 112. Any number of incisions 358 may be made to form any number of sections 358 of airway wall tissue as desired. For example, a plus-shaped incision would result in four sections of tissue that may be folded through a channel. The sections 358 may be affixed with a suture material, an adhesive, or the sections 358 may simply be inserted into surrounding tissue to remain folded through the collateral channel 112.
  • Another variation of the device includes safety features such as probes to determine the presence of blood. If a probe indicates that a blood vessel is contacted or penetrated, a signal is sent which prevents the channel making device from causing further harm to the vessel. Such a feature minimizes the risk of inadvertently puncturing a blood vessel within the lungs. [0088]
  • Although the examples depict mechanically forming a collateral opening, the invention is not limited to such. Alternative methods of forming the opening are contemplated in the use of RF energy, bi-polar, or single pole electrosurgical cutters, ultrasonic energy, laser, microwave, cryo-energy or chemicals. [0089]
  • The present invention includes the use of a device which is able to detect the presence or absence of a blood vessel by placing a front portion of the device in contact with tissue. One variation of the invention includes the use of Doppler ultrasound to detect the presence of blood vessels within tissue. It is known that sound waves at ultrasonic frequencies travel through tissue and reflect off of objects where density gradients exist. In which case the reflected signal and the transmitted signal will have the same frequency. Alternatively, in the case where the signal is reflected from the blood cells moving through a blood vessel, the reflected signal will have a shift in frequency from the transmitted signal. This shift is known as a Doppler shift. Furthermore, the frequency of the signals may be changed from ultrasonic to a frequency that is detectable within the range of human hearing. [0090]
  • The ultrasound Doppler operates at any frequency in the ultrasound range but preferably between 2 Mhz-30 Mhz. It is generally known that higher frequencies provide better the resolution while lower frequencies offer better penetration of tissue. In the present invention, because location of blood vessels does not require actual imaging, there may be a balance obtained between the need for resolution and for penetration of tissue. Accordingly, an intermediate frequency may be used (e.g., around 8 Mhz). [0091]
  • FIG. 6A illustrates a variation of a device [0092] 600 adapted to determine the presence of blood vessels as previously mentioned. The device 600 includes a flexible elongate member 604 having a transducer assembly 606, at least a portion of which is located adjacent to a distal end of the elongate member 604. Although the elongate member 604 is illustrated as having a lumen, the elongate member 604 may also be selected to be solid, or the elongate member 604 may have a support member (not shown) such as a braid to increase the strength and/or maneuverability of the device. The transducer assembly 606 is adapted to generate a source signal and receive a reflected signal. It may use a single transducer or multiple transducers. For example, at least a first transducer may be used to generate a signal and at least a second transducer may be used to receive the signal.
  • The transducer or transducers use may comprise a piezo-ceramic crystal. In the current invention, a single-crystal piezo (SCP) is preferred, but the invention does not exclude the use of other types of ferroelectric material such as poly-crystalline ceramic piezos, polymer piezos, or polymer composites. The substrate, typically made from piezoelectric single crystals (SCP) or ceramics such as PZT, PLZT, PMN, PMN-PT. Also, the crystal may be a multi layer composite of a ceramic piezoelectric material. Piezoelectric polymers such as PVDF may also be used. The transducer or transducers used may be ceramic pieces coated with a conductive coating, such as gold. Other conductive coatings include sputtered metal, metals, or alloys, such as a member of the Platinum Group of the Periodic Table (Ru, Rh, Pd, Re, Os, Ir, and Pt) or gold. Titanium (Ti) is also especially suitable. For example, the transducer may be further coated with a biocompatible layer such as Parylene or Parylene C. The transducer is then bonded on the lens. A coupling such as a biocompatible epoxy may be used to bond the transducer to the lens. The transducer assembly [0093] 606 communicates with an analyzing device 602 adapted to recognize the reflected signal or measure the Doppler shift between the signals. As mentioned above, the source signal may be reflected by changes in density between tissue. In such a case, the reflected signal will have the same frequency as the transmitted signal. When the source signal is reflected from blood moving within the vessel, the reflected signal has a different frequency than that of the source signal. This Doppler effect permits determination of the presence or absence of a blood vessel within tissue. Although depicted as being external to the device 600, it is contemplated that the analyzing device 602 may alternatively be incorporated into the device 600. The transducer assembly of the invention is intended to include any transducer assembly that allows for the observation of Doppler effect, e.g., ultrasound, light, sound etc. The device 600 illustrated in FIG. 6A includes a transducer assembly 606 comprising an ultrasound transducer 608 and an acoustic lens 610 that is adapted to refract and disperse a source signal over an outer surface of the lens 610. The lens 610 is designed such that it interferes and redirects the signals in a desired direction. The lens 610 may be comprised of materials such as dimethyl pentene (plastic-TPX), aluminum, carbon aerogel, polycarbonate (e.g., lexan), polystyrene, etc. It also may be desirable to place an epoxy between the lens 610 and the transducer 608. Preferably, the epoxy is thin and applied without air gaps or pockets. Also, the density/hardness of the epoxy should provide for transmission of the signal while minimizing any effect or change to the source signal. The configuration of the transducer assembly 606 permits the lens 610 to disperse a signal over a substantial portion of the outer surface of the lens 610. The lens 610 also is adapted to refract a reflected signal towards the transducer 608. Accordingly, given the above described configuration, the device 600 of FIG. 6A will be able to detect vessels with any part of the lens 610 that contacts tissue (as illustrated by the line 612-612.) Although the lens 610 is illustrated as being hemispherical, as described below, the lens 610 may have other shapes as well.
  • FIG. 6B illustrates another variation of the device [0094] 614 having a hemispherical shaped ultrasound transducer 618 affixed to an end of a flexible elongate member 616. The transducer 618 communicates with an analyzing device (not shown) to measure the Doppler effect to determine the location of a blood vessel.
  • FIG. 6C illustrates another variation of the device [0095] 620 including a transducer assembly 622, at least a portion of which is located adjacent to a distal end of the elongate member 628. The transducer assembly 622 includes a flat ultrasound transducer 626, and a cone or wedge-like acoustic mirror 624. The mirror 624 is adapted to reflect the signal over an area 360° around the device. The angle α of the mirror may be varied to optimally direct the signal as needed.
  • FIG. 6D illustrates a variation of a device [0096] 630 of the present invention further comprising a joint 632 to articulate an end of the device either to make sufficient contact with an area of tissue to be inspected for the presence of a blood vessel, or to navigate within the body to access the area to be inspected.
  • The variations of the invention described herein may also be adapted to use ultrasound energy, for example, high energy ultrasound, to produce openings in or marks on tissue. In such a case, the transducer assembly and acoustic lens also functions as a hole-making or site marking device. In this case, use of ultrasound in a low power operation permits the detection of a blood vessel and location of a site for a collateral channel. Using the same device and switching the operation of the device to a high power ultrasound permits the use of the ultrasound to create a collateral channel. [0097]
  • FIG. 6E illustrates a variation of a device [0098] 632 comprising a transducer assembly 634 connected to a flexible elongate member 636. In this example, the transducer assembly 634 comprises a first transducer 641, a second transducer 642, and an acoustic lens 640. As mentioned above, in variations using alternate transducers 641, 642, one transducer may transmit a signal while the other receives a signal. Also, both transducers 641, 642 may simultaneously transmit and receive signals. It is intended that any combination of using the transducers to send and receive signals is contemplated. The device 632 also includes a hole-making assembly 638 for creating a channel in tissue. FIG. 6E illustrates the hole-making assembly 638 as an RF wire-like member. As illustrated, the device 632 is connected an RF generator 644 as well as an analyzing device 646 which is adapted to measure the Doppler shift between the generated and reflected signals.
  • FIG. 6F illustrates the device [0099] 632 of FIG. 6E where the hole-making assembly 638 is retracted within the device 632, in this case within the elongated member 636.
  • FIG. 6G illustrates another variation of a device [0100] 648 where a hole-making assembly 650 is exterior to a transducer assembly 606. The hole-making assembly 650 may be either an RF device or a mechanical device that simply cuts the tissue. For example, the hole making assembly 650 can be a hypotube placed over the transducer assembly 606. In this variation of the device 648, the transducer assembly 606 may be moveable within the hole-making assembly 650, or the hole-making assembly 650 may be moveable over the transducer assembly 606. In either case, the transducer assembly 606 may be advanced out of the hole-making assembly 650 to determine the presence of a blood vessel. If no blood vessel is found, the transducer assembly 606 may be withdrawn into the hole-making assembly 650 allowing the hole-making assembly 650 to create a channel in the tissue either by mechanically cutting the tissue, or by using RF energy to create the channel. FIG. 6H illustrates a view taken along the line 6H in FIG. 6G.
  • FIG. 6I illustrates another version of a device [0101] 652 of the present invention wherein the device has a transducer assembly 654 with an opening 658 through which a hole-making assembly 656 may extend. FIG. 6J illustrates the hole-making assembly 656 extended through the transducer assembly 654. The hole-making assembly 656 may comprise RF electrodes or needle-like members which puncture the tissue to create the channels.
  • FIG. 6K illustrates a variation of a device [0102] 666 of the present invention where a tip 660 of the device has a conductive portion allowing the tip to serve as both an acoustic lens and an RF electrode. In such a case, the tip 660 is connected to an RF generator 644 for creating channels within tissue and a transducer 662 is placed in communication with an analyzing device 646 that is adapted to measure the Doppler shift between generated and reflected signals. In this variation, the tip 660 is separated from the transducer 662, but both the tip 660 and transducer 662 are in acoustic communication through the use of a separation medium 664. The separation medium 664 transmits signals between the tip 660 and the transducer 662. The spacing of the transducer 662 from the tip 660 serves to prevent heat or RF energy from damaging the transducer 662. It is intended that the spacing between the transducer 662 and tip 662 shown in the figures is for illustration purposes only. Accordingly, the spacing may vary as needed. The separation medium must have acceptable ultrasound transmission properties and may also serve to provide additional thermal insulation as well. For example, an epoxy may be used for the separation medium.
  • FIG. 6L illustrates a variation of a device [0103] 680 of the present invention wherein the transducer assembly 670 comprises a tip 672, an ultrasound coupling medium 674, a transducer 676, and an extension member 678. In this variation of the invention, the tip 672 of the device serves as an acoustic lens and also has conductive areas (not shown) which serve as RF electrodes. As shown in FIG. 6M, the tip 672 may extend from the device 680 and separate from the transducer 676. Separation of the tip 672 protects the transducer 676 from heat or RF energy as the tip 672 creates a channel in tissue. The extension member 678 may serve as a conductor to connect the tip 672 to an RF energy supply (not shown). When the tip 672 of the device 680 is being used in an ultrasound mode, the tip 672 may be coupled to the transducer 676 via the use of an ultrasound coupling medium 674. Any standard type of ultrasound gel material may be used, also highly formable silicone may be used. It is desirable to use a fluid boundary layer (such as the gel) which may be permanent or temporary. In those cases where the boundary layer is temporary, subsequent applications of the boundary layer may be necessary.
  • FIG. 6N illustrates another variation of a device [0104] 682 of the present invention having a tip 684 and transducer 686 that are separable from each other. Again, the tip 684 may include conductive areas and serve as both an RF electrode (not shown) as well as an acoustic lens. As shown in FIG. 6N, the tip 684 may be separable from the transducer 686 when creating a channel to protect the transducer 686 from heat or RF energy. The tip 684 may be placed in contact with the transducer 686 for operation in an ultrasound mode, or the device 682 may contain a separation medium 688 which permits acoustic coupling of the transducer 686 with the tip 684 when separated.
  • FIGS. [0105] 6P-6U illustrate variations of RF electrode tip 690 configurations for use with the present invention. As illustrated, the electrodes may be placed around a circumference of a tip, longitudinal along a tip, spirally along a tip, or a combination thereof. The electrodes 692, 694 may be used with a device having an acoustic lens or the electrodes may be employed solely as an RF hole-making device. While the variations illustrated in FIGS. 6P-6U show bipolar RF devices, the invention may also use a single electrode (monopolar.) The tip 690 may contain a first electrode 692 separated from a second electrode 694 by an electrical insulator 696 (e.g., ceramic, or plastic insulator). In variations of the device where electrodes are positioned on an acoustic lens, a sufficient amount of surface area of the lens must remain uncovered so that sufficient coupling remains for transmission of a signal between the lens and tissue. FIG. 6V illustrates a co-axial variation of a bi-polar RF tip having a first electrode 692, a second electrode 694, and an insulator 696.
  • FIGS. 6W and 6X illustrates additional variations of the lens of the present invention. FIG. 6W illustrates a device [0106] 724 with an acoustic lens 726 having an oblate spheroid shape. FIG. 6X illustrates a device 728 with an acoustic lens 730 having a prolate spheroid shape. FIG. 6Y illustrates a device 732 having a conical-shaped acoustic lens 734. These variations are only intended to illustrate variations of the lens. It is contemplated that the shape of a lens may not follow a mathematical description such as conical, prolate, oblate or hemispherical. The design of the shape relates to the distribution pattern of the signal over the lens. The shapes can affect the distribution pattern by making it wider or narrower as needed. In any case, the lens is of a shape that provides coverage over the front face of the device.
  • FIG. 7A illustrates a variation of the invention where a device [0107] 700 includes a heat-sink member 702. The heat-sink member 702 may preserve surround tissue during creation of the collateral channel. Or, the heat-sink member 702 may be a section of conductive material or a balloon. The heat-sink member 702 may be in fluid communication with a lumen 704 that provides a fluid, such as saline, that conducts heat away from the area surrounding the channel.
  • FIG. 7B illustrates another variation of a device [0108] 710 having a fluid delivery assembly 706 which assists in preserving surrounding tissue while a channel is being created. The fluid delivery assembly 706 may spray, mist, or otherwise apply fluid 708 to the area surrounding the channel. For example, cooled saline may be applied to the area to prevent excessive heating of the target area.
  • The invention includes the use of hole-making assembly on the side of the device with a transducer assembly on the tip of the device. For example, FIG. 7C illustrates a variation of an RF electrode [0109] 712 for use with the present invention. The electrode 712 may be a protrusion extending from a conductive member 716 that is covered with an insulating material 714. In this variation, the electrode 716 limits the depth of the channel due to the amount of material extending from the conductive member 716. The conductive member 716 may be connected to a source of RF energy (not shown) or may use another heating element (not shown). FIG. 7D illustrates another variation of an electrode configuration. In this variation, the electrode comprises a spherical member 718 extending from an elongate member 722. The electrode 718 is retractable through the elongate member 722 by use of an actuator 720. The actuator 720 may be conductive and connected to a source of RF energy to conduct energy through the electrode 718. Again, the design of the electrode 718 limits the depth of penetration of the electrode 718 while creating a channel in tissue. The electrodes described herein may also be used in conjunction with a device having a Doppler arrangement.
  • Also, a variation of the invention contemplates the delivery of drugs or medicines to the area of the collateral opening. Also contemplated is the use of a fibrin, cyano-acrylate, or any other bio-compatible adhesive to maintain the patency of the opening. For example, the adhesive could be deposited within the collateral channel to maintain patency of the channel or to create a cast implant of the channel. The adhesive could also coat the channel, or glue a flap to the wall of the airway. Also, the use of a bioabsorbable material may promote the growth of epithelium on the walls of the conduit. For example, covering the walls of a channel with small intestine submucosa, or other bioabsorbable material, may promote epithelium growth with the bioabsorbable material eventually being absorbed into the body. [0110]
  • FIG. 4 illustrates a variation of a device [0111] 400 having the ability to create multiple openings within the walls of the natural airway 100. The holes may be created by dilation, cutting, electrical energy, microwave energy, ultrasonic energy, laser, chemical, or any process as mentioned above. This device 400 may also be used to deploy multiple probes to determine the location of a blood vessel (not shown) using one of the procedures mentioned above.
  • FIG. 5A illustrates an implant or conduit [0112] 500 placed within a natural airway 100. As shown, the airway 100 has a portion of its wall removed, thereby providing a collateral opening 112 within the airway 100. The implant 500 typically has a porous structure which allows gasses to pass between the airway and the channels 112 and into the lung. Moreover, the structure of the insert 500 also maintains patency of the airway 100 and the channel 112.
  • Any variation of a conduit described herein may comprise a barrier layer which is impermeable to tissue. This aspect of the invention prevents tissue in-growth from occluding the channel. The barrier layer may extend between the ends of the body or the barrier layer may extend over a single portion or discrete portions of the body of the conduit. [0113]
  • FIG. 5B illustrates an conduit [0114] 500 having an expandable structure within an airway 100. Usually, the conduit 500 has a porous wall that allows the passage of gasses through the wall. The conduit 500 is delivered via a delivery device 502 which may also contain an expandable member (not shown) which expands the conduit 500. As shown in FIG. 5C, the conduit may have piercing members 504 attached on an outer surface which enable the conduit 500 to create an incision within the airway 100.
  • FIG. 5C illustrates the conduit [0115] 500 after being expanded by an expandable member 506, e.g. a balloon device, an expandable mechanical basket, or an expandable wedge. In this example, the conduit 500 expands through the walls of the airway 100 at sections 508. In this variation, the conduit 500 is lodged within the walls of the airway 100.
  • FIG. 5D illustrates a grommet-like insert [0116] 503 where the lumen of the insert 503 extends longitudinally through the collateral channel. In this example, an expanding member 501, e.g., a balloon, an expanding mechanical basket, or the like is used to secure the conduit 503 within the collateral channel.
  • Although not illustrated, the invention includes conduits having a length to diameter ratio approximately 1:1. However, this ratio may be varied as required. The cross-section of an implant may be circular, oval, rectangular, eliptical, or any other multi-faceted or curved shape as required. The cross-sectional area of an implant [0117] 500 may be between 0.196 mm2 to 254 mm2.
  • The conduit may also be any device capable of maintaining a patent opening, e.g., a plug, that is temporarily used as a conduit and then removed after the channel has healed in an open position. In another variation the plug may be a solid plug without an opening that is either bio-absorbable or removable. In such a case, the plug may be placed within an opening in tissue and allow the tissue to heal forming a collateral channel with the plug being ultimately absorbed into the body or removed from the body. [0118]
  • Another variation of the conduit is illustrated in FIG. 5E. In this example the conduit [0119] 510 comprises a cone 514 with a grommet 512 for attachment to a wall of the airway 100. The cone 514 may be porous or have other openings 516 to facilitate the passage of gas through the collateral channel. In the event that the distal opening of the cone become occluded, the porous cone permits the continued exchange of gasses between the collateral channel and the natural airway.
  • Another variation of the conduit is illustrated in FIG. 5F. For example, the conduit [0120] 518 may be configured in a ‘t-shape’ with a portion 520 of the conduit extending through the collateral channel. Again, the conduit 518 may be constructed to have a porous wall to allow gas exchange through the wall. The conduit may be configured in a variety of shapes so long as a portion of the conduit extends through the collateral channel. The portion may be formed into a particular shape, such as the ‘t-shape’ described above, or, the portion may be hinged so that it may be deployed within the channel. In such a case, a portion of a wall of the conduit may have a hinge allowing the wall of the conduit to swivel into a channel.
  • Yet another variation of the conduit is found in FIG. 5G. In this example, the conduit [0121] 522 is constructed with a geometry that reduces the chance that the conduit 522 will migrate within the airway 100.
  • FIG. 5H illustrates an example of a conduit [0122] 524 having an asymmetrical profile. The conduit 524 may have a flange 526 at either or both ends of the body 528. Although not shown, the flange 526 may have a cone-like profile to facilitate placement within an airway. As illustrated in FIG. 51, the asymmetrical profile of the conduit 524 assists in preventing obstruction of the airway.
  • FIG. 5J illustrate a variation of the conduit [0123] 530 having a self-cleaning mechanism. In this example, the self cleaning mechanism is a floating ball bearing 532. The ends of the conduit 530 have a reduced diameter 534 which prevents the bearing 532 from escaping. As gas passes through the conduit 530, the bearing 532 moves about the conduit 530 clearing it of debris. The shape of the bearing 532 and the size and shape of the reduced diameter 534 may be varied to optimize the self-cleaning effect of the device.
  • FIGS. 5K and 5L illustrate another variations of a self-expanding conduit [0124] 536. In this example, as shown in FIG. 5K, the conduit 536 may be constructed from a flat material 538 having a spring or springs 540. As shown in FIG. 5L, the conduit 536 is formed by rolling the assembly. The spring 540 provides an expanding force against the material 538. The conduit 536 may also be constructed so that the flat material 538 is resilient thus eliminating the need for springs 540.
  • FIG. 5M illustrates another variation of an expandable conduit [0125] 542 constructed from a braided material. The conduit 542 may be constructed so that the diameter is dependent upon the length of the device 542. For example, the diameter of the device 542 may decrease as the length is stretched, and the diameter may increase as the length of the device 542 is compressed. Such a construction being similar to a ‘finger cuff’ toy.
  • FIGS. [0126] 5N-5P illustrate another variation of a grommet-type conduit. FIG. 5N illustrates a conduit 544 having expandable ends 546. In one variation the ends 546 of the device 544 may flare outwards as illustrated in FIG. 5O. FIG. 5P illustrates another variation of the device 544 in which the ends 546 compress in length to expand in diameter.
  • FIGS. 5Q and 5R illustrate variations of a conduit having an anchor. In FIG. 5Q, the conduit [0127] 548 has an anchor 550 at a distal end of a hollow plug 540. The anchor 550 may be tapered to facilitate entry into the airway 100 wall or may have another design as required. The anchor 550 also contains ventilation openings 552 to facilitate gas exchange through the device. FIG. 5R illustrates another variation of the device.
  • FIG. 5S illustrates a variation of a conduit [0128] 561 having flanges 563 at either end to assist in placement of the conduit within an airway wall (not shown). The ends of the conduit 565 may be tapered to ease placement through a collateral channel. The conduit has an opening 565 to facilitate passage of air. To simplify construction, the conduit 561 may be constructed from a biocompatible material, such as stainless steel, or plastic.
  • FIG. 5T illustrates a variation of the invention having multiple openings for gas flow. The conduit [0129] 560 has a first hollow end 564 which can extend through a wall of the airway 100 and a second hollow end 566 which can remain parallel to the airway 100. This example also includes an opening 562 which allows gas to flow through the airway 100.
  • FIG. 5U illustrates a variation of the device having a one-way valve [0130] 570. The valve 570 allows the conduit 568 to permit exhaust of the air sac but prevents the conduit 568 from serving as another entrance of gas to the air-sac. The valve 570 may be placed at ends of the conduit or within a lumen of the conduit. The valve 570 may also be used as bacterial in-flow protection for the lungs.
  • FIG. 5V illustrates another variation of a conduit [0131] 572. In this variation, the conduit 572 may be a sponge material, or constructed of an open cell material 574, which allows air flow through the material. Or, the conduit 572 may have lumens 576 which allow flow through the conduit 572. To assist the conduit 572 in remaining within a channel, the conduit material may be selected such that it expands as it absorbs moisture. Also, the sponge material/open cell material may be bio-absorbable to allow for temporary placement of the conduit 572.
  • FIGS. [0132] 8A-8F illustrate another variation of a conduit 800 of the present invention. The conduit 800 has a center section 802 having extension members 804 located at either end of the center section 802. The center section 802 illustrated is tubular but may be of any other shape as needed for the particular application. The conduit of the invention has a passageway extending between the ends of the conduit suited for the passage of air. The variation of the conduit 800 illustrated in FIG. 8A has a center section 802 comprising a mesh formed from a plurality of ribs 806. FIGS. 8A and 8B illustrate the conduit 800 in a reduced profile while FIGS. 8C and 8D illustrate the conduit 800 in an expanded profile after expansion of the center section 802 of the conduit 800. As shown in FIGS. 8E and 8F, each free end 808 of each extension member 804 is unattached to the center section 802 and is bendable about the respective end of the center section 802 to which it is attached. Accordingly, once a conduit 800 is placed within a collateral channel (not shown), the extension members 804 are bent about the end of the center section 802 and form a cuff or grommet which assists in keeping the conduit 800 within a collateral channel. Accordingly, the cross section and number of extension members 804 located about either end of the conduit 800 may be selected as necessary to assist in placement and securing of the conduit 800 within a channel.
  • The conduits described herein may have a fluid-tight covering, as discussed below, about the center section, the extension members, or the entire conduit. Also, the conduit may be designed to limit a length of the center section to less than twice the square root of a cross sectional area of the center section when the center section is in the expanded profile. [0133]
  • FIGS. [0134] 8G-8I illustrates another variation of a conduit 812 for use with the invention. In this variation, the conduit 812 is formed from a rolled sheet of material 810. The rolled sheet 810 may be heat treated to preserve the shape of the conduit 812 or the sheet 810 may simply be rolled to form the conduit 812. In those cases where the sheet of material 810 comprises a shape-memory alloy, it is desirable to process the material 810 so that it exhibits super-elastic properties at or above body temperature.
  • FIG. 8G illustrates a variation of extension members [0135] 820 for use with a conduit (not shown) of the present invention. In this variation, the extension members 820 have an attachment 822 between adjacent extension members 820. FIG. 8H illustrates the extension members 820 as the conduit (not shown) is expanded and the extension members 820 are bent on the conduit. The attachment 822 assists in preventing the extension members 820 from deviating from a preferred position. As illustrated in FIG. 8I, the conduit 826 may have cut or weakened sections 824 to facilitate expansion of the conduit 826 and bending of the extension members in a desired manner (as shown by the section of 828).
  • FIGS. [0136] 8J-8K illustrate various additional cross sectional designs of conduits. FIG. 8J illustrates a possible conduit design 830 having extension members 834 attached to a center section 832. FIGS. 8K and 8L illustrate additional variations of conduit designs. As illustrated in FIGS. 8K and 8L, the extension members 840, 846 and center sections 838, 844 are designed to form a diamond pattern upon expansion of the conduit. FIG. 8K further illustrates a variation of an extension member 840 having an opening 841 to facilitate tissue in-growth and thereby secures placement of the conduit. FIG. 8M illustrates an expanded conduit 848 having the diamond pattern referred to above. The conduit 848 also contains a fluid-tight barrier 851 on the center section 850 of the conduit 848. Although not illustrated, fluid-tight barrier may be placed throughout a conduit. Another feature of the variation of FIG. 8M is that the extension members have a diamond pattern construction, this construction assists in maintaining alignment of the extension members allowing for a preferred aligned expansion of the extension members.
  • FIGS. [0137] 8N-8O illustrate another variation of a conduit 860 of the present invention. In this variation, the conduit design 854 may have extension members 856 at only one end of the conduit 860. In this variation, the center section of the conduit may comprise a body portion 858. The conduit 860 may have a covering about a portion of the conduit 860. The covering may extend throughout the length of the conduit 860 or it may be limited to a portion of the conduit 860. As illustrated in FIG. 8O, when expanded, the conduit 860 may form a reduced area 858 near the extension members 856. As mentioned above, the conduit cross section 854 may be designed such that the a diamond pattern is formed upon expansion of the conduit 860, as illustrated in FIG. 8O.
  • FIG. 8P illustrates a sheet of material [0138] 810 having extension members 814 extending from either end of the sheet 810. Although the sheet 810 is illustrated to be solid, a conduit may be formed from a sheet having openings within the center section of the sheet. FIG. 8Q illustrates the conduit 812 where the rolled sheet 810 comprises a center section 818 of the conduit 812 and the extension members 814 from either end of the center section 818. As illustrated in FIG. 8Q, the sheet 810 may be overlapped for a reduced profile and expanded into an expanded profile. FIG. 8R illustrates a free end 816 of each extension member 814 as having been bent away from a central axis of the conduit 812. As with any variation of a conduit of the present invention, the extension members 814 of the conduit 812 may be bent away from a central axis of the conduit 812 up to 180° with respect to the central axis. As mentioned above, the cross section and number of extension members 814 located about either end of the conduit 810 may be selected as necessary to assist in placement and securing of the conduit 810 within a channel.
  • In those cases where the conduit [0139] 812 of FIG. 8Q comprises a non-shape memory alloy the conduit 812 will be actively mechanically expanded. In those cases where the conduit 812 is comprised of a shape memory alloy, such as a super-elastic alloy, the conduit 812 may be pre-formed to assume a deployed shape which includes a grommet formed by extension members 814 and an expanded center section 818, such as the shape illustrated in FIG. 8R. Next, the super-elastic conduit 812 may be restrained or even rolled into the shape illustrated in FIG. 8Q. Because the conduit 812 is formed of a super-elastic material, no plastic deformation occurs. When the super-elastic conduit 812 is then placed within a collateral channel, the conduit 812 may naturally resume its pre-formed, deployed shape.
  • FIG. 8S illustrates another variation of a conduit [0140] 862 having a first portion 864 and a second portion 866 and a passageway 868 extending therethrough. The first portion 864 may be a conduit design as described herein. In particular, the first portion 864 is configured to secure the conduit 862 to the airway wall 100. Accordingly, the first portion 864 may or may not have a center that is expandable. The walls of the first portion 864 may be fluid-tight (either through design, or a fluid tight covering) to prevent tissue in-growth through the collateral channel. Alternatively, the first portion 864 may be partially fluid-tight to facilitate tissue in-growth to improve retention of the conduit 862 to the airway wall 100. However, in the latter case, the first portion 864 should be designed to minimize tissue in-growth within the channel to prevent substantial interference with airflow through the conduit 864. As with the first portion 864, the walls of the second portion 866 of the conduit may or may not be fluid-tight. If the second portion 866 is not fluid-tight, the larger area provides for improved airflow from lung tissue through the passageway 868 and into the airway. The second portion 866 may also be designed to be partially fluid-tight to encourage airflow through the conduit 862 but reduce the probability of blockage of the conduit 862.
  • FIGS. [0141] 8T-8U illustrate another variation of a conduit 870. For example, the conduit 870 may be formed from a tube that is slit to form extension members at a first portion 872 and second portion 876 with a center section 874 between the portions. The conduit 870 may be expanded as shown in FIG. 8U such that the first 872 and second 876 portions maintain the center portion 874 in a collateral channel in an airway wall. The center section 874 may or may not be expandable.
  • FIG. 8U illustrates the second portion [0142] 876 of the conduit 870 to expand in its center, however, the conduit 870 may be designed in other configuration as well (e.g., expanded to have a larger diameter at an end opposite to the center section 874.) However, a central aspect of this design is that the second portion 870 provides a large area in the lung tissue to permit a larger volume of air to pass from the lung tissue into the conduit 870. This design has an added benefit as the second portion 876 cannot be easily blocked by flaps of parenchyma tissue. A simple variation of the conduit 870 may be constructed from a metal tube, such as 316 stainless steel, titanium, titanium alloy, nitinol, etc. Alternatively, the conduit may be formed from a rigid or elastomeric material.
  • The conduits described herein may be comprised of a metallic material (e.g., stainless steel), a shape memory alloy, a super-elastic alloy (e.g., a NiTi alloy), a shape memory polymer, a polymeric material or a combination thereof. The conduit may be designed such that its natural state is an expanded state and it is restrained into a reduced profile, or, the conduit may be expanded into its expanded state by a variety of devices (e.g., a balloon catheter.) The conduit described herein may be manufactured by a variety of manufacturing processes including but not limited to laser cutting, chemical etching, punching, stamping, etc. [0143]
  • The conduits described herein may be coated with an elastomer, e.g., silicone, polyurethane, etc. The coatings may be applied, for example, by either dip coating, molding, or liquid injection molding (for silicone). Or, the coating may be a tube of a material and the tube is placed either over and/or within the conduit. The coating(s) may then be bonded, crimp, heated, melted, or shrink fit. The coatings may also placed on the conduit by either solvent swelling applications or by an extrusion process. Also, a coating of may be applied by either wrapping a sheet of PTFE about and/or within the conduit, or by placing a tube about and/or within the conduit and securing the tubes. [0144]
  • As mentioned above, the number of and cross sectional area of the extension members on a conduit may be selected as needed for the particular application. Also, the extension members may be bent such that they anchor into the tissue thereby securing placement of the conduit. Or, the extension members or the center section may contain barbs or other similar configurations to better adhere to the tissue. Moreover, the orientation of the extension members may vary as well. For example, the extension members may be configured to be radially expanding from the center section, or they may be angled with respect to a central axis of the conduit. Another variation of the invention includes a radioactive conduit which inhibits or prevents the growth of tissue within the conduit. [0145]
  • Although the conduits of the current invention have been described to contain expandable center sections, the invention is not necessarily limited as such. Instead, the design of the conduit may require extension members on the ends of a conduit with a non-expandable center section. [0146]
  • FIGS. [0147] 9A-9D illustrate a conduit 900 of the present invention. The deployment of the conduit 900 is intended to show an example of a possible means of deployment only. Accordingly, the inventive conduit may be delivered at an angle via an articulating or jointed device, the conduit may be delivered on a device that is adapted to locate and create the collateral channel, or the conduit may be delivered on a device having other features as needed for the particular application.
  • FIG. 9A illustrates the conduit [0148] 900 being delivered to a collateral channel in an airway wall 114 via a delivery device (e.g., a balloon catheter 902.) The conduit 900 may be attached to the delivery device 902 using the natural resiliency of the conduit 900. Or, in those cases where the conduit is spring loaded, the conduit 900 restrained in a reduced profile and may be removably affixed to the delivery device 902 using an adhesive, or a removable sleeve such as a heat shrink tube. In this example, the balloon catheter 902 has several balloons including a distal balloon 904, a proximal balloon 906, and a center balloon (not illustrated in FIG. 9A). FIG. 9B illustrates the inflation of the distal 904 and proximal 906 balloons to situate the extension members 908. Accordingly, the extension members 908 for a flange or collet about the airway wall 114. The balloons 904, 906 may be inflated simultaneously, or in a desired sequence. In any case, deployment of the balloons 904, 906 may serve to center the conduit 900 in the collateral channel.
  • FIG. 9C illustrates inflation of the center balloon [0149] 912 which causes expansion of the center section 910 of the conduit 900. If the conduit 900 is affixed to the delivery device 902, expansion of the center balloon 912 causes release of the conduit 900 by release of the adhesive or breaking of the heat shrink tubing (not shown). In any case, the means of attachment may be bioabsorbable and remain in the body, or may remain affixed to the delivery device 902 and is removed with removal of the delivery device 902. FIG. 9D illustrates the conduit 900 affixed to the airway wall 114 after the delivery device 902 is removed from the site. Another method of deploying a conduit includes restraining the conduit about a delivery device using a wire or string tied in a slip-knot or a series of slip-knots. When the conduit is delivered to a desired location, the proximal end of the wire or string may be pulled which releases the wire/string and deploys the conduit. FIGS. 9E and 9F illustrate possible ways to manipulate a conduit 914 for placement in an airway wall 114 using a delivery device 916. FIG. 9E illustrates deployment of a delivery device 916 to place a conduit 914 within an opening in an airway wall 114. The conduit 914 may be placed over a balloon 918 (or other expandable section) of the delivery device 916. FIG. 9F illustrates deployment of the balloon 918 to place and expand the conduit 914. In the variation illustrated in FIGS. 9E and 9F, a balloon 918 serves several functions. The balloon 918 first expands and starts bending the extension members 920. The balloon 918 continues to center the conduit 914 on the tissue and simultaneously begins to expand the conduit 914 and secures the conduit to the tissue.
  • FIGS. 9G and 9H illustrate additional variations of deployment devices. In these variations, the deployment devices [0150] 922, 926 contain hourglass-shaped balloons 924, 928. The hour glass-shaped balloons 924, 928 contain an interior profile 923. For deployment of a conduit (not shown) of the present invention, the conduit is placed on the balloon 924, 928. As the balloon 924, 928 expands, the conduit expansion matches the interior profile 923 of the balloon 924, 928. Accordingly, the hour glass-shaped balloon 924, 928 may be used to set the angle and orientation of the expandable members of a conduit as well as the expansion of a center section of the conduit.
  • FIG. 9I illustrates another variation of an hour glass shaped balloon delivery device [0151] 930. This variation of the hour glass shaped balloon 932 is designed to expand extension members (not shown) of a conduit (not shown) at a particular angle 934. The orientation of the balloon 932 may be designed as needed to impart the desired angle to the extension members of the conduit. The balloons described herein may be constructed polyethylene terephthalate (PET) or any other material which is used in the construction of balloon catheters.
  • The invention further includes methods of evaluating individuals having a diseased lung to assess inclusion of the individual for the procedure. [0152]
  • The method comprises the steps of performing pulmonary function tests on the individual. The pulmonary function tests may obtain such values as FEV (forced expiratory volume), FVC (forced vital capacity), FEF[0153] 25%-75% (forced expiratory flow rate), PEFR (peak expiratory flow rate), FRC (functional residual capacity), RV (residual volume), TLC (total lung capacity), and/or flow/volume loops.
  • FEV measures the volume of air exhaled over a pre-determined period of time by a forced expiration immediately after a full inspiration. FVC measures the total volume of air exhaled immediately after a full inspiration. FEF[0154] 25%-75% measures the rate of air flow during a forced expiration divided by the time in seconds for the middle half of expired volume. PEFR measures the maximum flow rate during a forced exhale starting from full inspiration. FRC is the volume of air remaining in the lungs after a full expiration. RV is the FRC minus the expiratory reserve volume. TLC is the total volume in the lungs at the end of a full inspiration. Flow/volume loops are graphical presentations of the percent of total volume expired (on the independent axis) versus the flow rate during a forced expiratory maneuver.
  • The invention further comprises methods to determine the completion of the procedure. This variation of the invention comprises the step of performing pulmonary function tests as described above, creating collateral channels in the lungs, performing a post-procedure pulmonary function test, obtaining clinical information, comparing the results of the tests, evaluating the clinical information with the results of the test to determine the effectiveness of the procedure. [0155]
  • Another method to determine the completion of the procedure includes checking the resistance of airflow upstream from a location of a collateral channel. The method includes making a collateral channel, checking airflow, measuring resistance to airflow, and repeating the procedure until acceptable resistance is obtained. Because the collateral channel allows for the release of trapped air, the resistance to airflow should decrease. A body plethysmograph or other suitable equipment used to measure in pulmonary medicine may be used to determine the resistance to airflow. [0156]
  • A measurement of total lung volume may be used to determine when the lung is suitably deflated and therefore when enough collateral channels are created. Or, non-invasive imaging may be used to determine pre and post procedure lung volume or diaphragm position. [0157]
  • An evaluation of the effectiveness of the procedure may also include creating a collateral channel then sealing the channel with a balloon catheter. The distal end of catheter is then opened for a measurement of the flow of trapped air through the catheter. [0158]
  • This variation of the invention includes obtaining clinical information regarding the quality of life of the individual before and after any procedures, physical testing of the pulmonary system of the individual, and a general screening for pulmonary condition. [0159]
  • The invention herein is described by examples and a desired way of practicing the invention is described. However, the invention as claimed herein is not limited to that specific description in any manner. Equivalence to the description as hereinafter claimed is considered to be within the scope of protection of this patent. [0160]

Claims (186)

    We claim as our invention:
  1. 1. A method of improving gaseous flow within a diseased lung comprising the step of altering the gaseous flow paths within the lung.
  2. 2. The method of claim 1 wherein the step of altering the gaseous flow comprises the steps of:
    selecting at least one site for collateral ventilation of the lung, and
    creating at least one collateral channel in at least one of the sites.
  3. 3. The method of claim 2 further comprising the step of locating the at least one site within a portion of a natural airway of the respiratory system prior to said selecting step.
  4. 4. The method of claim 3 wherein said locating step includes visually examining the airway for dynamic airway collapse.
  5. 5. The method of claim 4 wherein visual examination of the airway is performed via a fiber optic line.
  6. 6. The method of claim 1 wherein said locating step comprises transmitting a first signal into an area of tissue, receiving a second signal, comparing said first and second signal for Doppler shifting.
  7. 7. The method of claim 6 wherein said comparing step comprises determining whether a blood vessel is present near said area of tissue.
  8. 8. The method of claim 3 wherein said locating step includes
    (a) examining the lung using an imaging method selected from radiography, computer tomography, ultrasound, Doppler, MRI, PET and acoustic imaging to determine a location to alter the gaseous flow, and
    (b) examining the lung using the non-invasive imaging method selected from radiography, computer tomography, ultrasound, doppler, MRI, PET and acoustic imaging to determine a number of collateral channels to be created.
  9. 9. The method of claim 8 further including the step of inserting a fluid into the airway to assist in ultrasound or doppler imaging.
  10. 10. The method of claim 3 further comprising the step of inserting an additive to enhance the visibility of the airway during the examining step.
  11. 11. The method of claim 3 wherein said locating step includes determining the degree of collateral ventilation between a plurality of air sacs of the lung in a region adjacent to the airway.
  12. 12. The method of claim 11 wherein said step of determining the degree of collateral ventilation includes:
    (a) forcing a volume of a gas through the airway and into the air sacs;
    (b) reducing pressure in the airway after the forcing step;
    (c) determining the reduction in a diameter of the airway as a result of the reduced pressure.
  13. 13. The method of claim 12 further including the step of occluding a segment of the airway and wherein said steps of reducing pressure and determining the reduction in diameter are performed distally of the occluded segment.
  14. 14. The method of claim 11 wherein said step of determining the degree of collateral ventilation includes:
    (a) occluding a segment of the airway;
    (b) adding or removing gas distally of the occluded segment; and
    (c) monitoring flow or pressure distally of the occluded segment.
  15. 15. The method of claim 11 wherein said step of determining the degree of collateral ventilation includes:
    (a) forcing a volume of a gas within the lung near to the airway; and
    (b) measuring pressure, flow, or return volume of the gas within the airway, wherein said measuring step is performed after said forcing step.
  16. 16. The method of claim 15 further including the step of occluding a segment of the airway and wherein said measuring step is performed distally of the occluded segment.
  17. 17. The method of claim 15 wherein said forcing step comprises forcing the gas through a wall of the airway directly into the air sacs.
  18. 18. The method of claim 17 further comprising the step of measuring the difference between the forced volume and the return volume to determine the degree of collateral ventilation.
  19. 19. The method of claim 3 wherein the step of selecting each of the sites comprises locating blood vessels in the region of said at least one site and selecting a site non-adjacent to any blood vessels.
  20. 20. The method of claim 19 wherein said step of locating blood vessels includes providing a remote signal to indicate the presence of any blood vessel.
  21. 21. The method of claim 19 wherein the step of locating blood vessels is performed using ultrasound.
  22. 22. The method of claim 19 further including the step of marking a location of said at least one site.
  23. 23. The method of claim 19 where said locating is conducted using an imaging method selected from radiography, computer tomography, ultrasound, doppler, acoustic, pulse oxymetry and thermal.
  24. 24. The method of claim 3 wherein the step of selecting each of the sites comprises detecting the absence of blood vessels at a particular site and selecting the site where the blood vessel is not detected.
  25. 25. The method of claim 24 wherein said step of detecting the absence of any blood vessel includes providing a remote signal to indicate the absence of any blood vessel.
  26. 26. The method of claim 24 wherein the step of detecting the absence of any blood vessels is performed using ultrasound.
  27. 27. The method of claim 3 wherein the portion of the natural airway is selected from a group consisting of bronchi, upper lobe, middle lobe, lower lobe, segmental bronchi, and bronchioles.
  28. 28. The method of claim 27 wherein the step of selecting each of the sites comprises introducing a probe into a wall of the natural airway, and detecting the presence of a blood vessel.
  29. 29. The method of claim 28 wherein said step of detecting the blood vessel includes providing a remote signal to indicate the presence or absence of any blood vessel.
  30. 30. The method of claim 27 further comprising de-laminating a blood vessel from a wall of the natural airway.
  31. 31. The method of claim 30 wherein the step of de-laminating comprises inflating a balloon within the natural airway until delamination occurs.
  32. 32. The method of claim 30 wherein the step of de-laminating comprises generating a vacuum within the natural airway to separate the wall of the natural airway from the vessel.
  33. 33. The method of claim 27 further comprising the step of pushing a blood vessel away from a wall of the natural airway prior to creating the collateral channel.
  34. 34. The method of claim 27 wherein the step of creating at least one collateral airway comprises mechanically forming the collateral channel.
  35. 35. The method of claim 34 wherein the at least one collateral channel is mechanically formed using a process selected from dilation, cutting, piercing, and bursting.
  36. 36. The method of claim 27 wherein the step of creating at least one collateral channel comprises electrically forming the collateral channel.
  37. 37. The method of claim 36 wherein the at least one collateral channel is electrically formed using RF energy.
  38. 38. The method of claim 27 wherein the step of creating at least one collateral channel comprises ultrasonically forming the collateral channel.
  39. 39. The method of claim 27 wherein the step of creating at least one collateral channel comprises forming the collateral channel using a laser.
  40. 40. The method of claim 27 wherein the step of creating at least one collateral channel comprises forming the collateral channel using microwave energy.
  41. 41. The method of claim 27 wherein the step of creating at least one collateral channel comprises chemically forming the collateral channel.
  42. 42. The method of claim 27 wherein the channel comprises an opening in the wall of the airway.
  43. 43. The method of claim 27 wherein the channel has an approximate area between 0.196 mm2 to 254 mm2.
  44. 44. The method of claim 27 wherein the channel extends immediately beyond an epithelial layer.
  45. 45. The method of claim 27 wherein the channel extends up to 12 cm beyond an epithelial layer.
  46. 46. The method of claim 27 wherein the channel has a shape selected from a hole, slit, skive, tear, and partially removed flap.
  47. 47. The method of claim 27 wherein the channel comprises a periphery of the wall of the airway wall that is removed.
  48. 48. The method of claim 27 further comprising the step of applying a glue in proximity to the at least one site for collateral ventilation.
  49. 49. The method of claim 27 further comprising the step of delivering steroids to the lung.
  50. 50. The method of claim 27 wherein the step of creating the at least one collateral channel comprises making an incision in a wall of the natural airway, placing the wall of the natural airway in tension, advancing a blunt instrument into the incision.
  51. 51. The method of claim 27 wherein the step of altering includes the step of inserting conduits having various cross-sectional areas in discrete areas of the lung to improve gaseous flow.
  52. 52. The method of claim 27 wherein the step of creating at least one collateral channel comprises inserting a conduit within a wall of the natural airway.
  53. 53. The method of claim 27 further comprising the step of inserting at least one conduit within each of the collateral channels.
  54. 54. The method of claim 53 wherein each of said conduit has a length to a diameter ratio of 1:1.
  55. 55. The method of claim 53 wherein the conduit is comprised of a material selected from the group consisting of elastomers, polymers, metals, metal alloys, shape memory alloys, and shape memory polymers.
  56. 56. The method of claim 53 wherein the conduit has a wall extending between a proximal end and a distal end, the wall forming a lumen, and where the conduit is inserted so the lumen extends longitudinally with the collateral channel.
  57. 57. The method of claim 56 wherein the conduit has at least one opening within a wall of the conduit.
  58. 58. The method of claim 53 wherein the conduit is removable from the body.
  59. 59. The method of claim 1 where the altering step comprises collaterally ventilating the lung by forming at least one opening in a natural airway wall within said lung that is in fluid communication with lung tissue.
  60. 60. The method of claim 59 further comprising the step of folding tissue through the opening in the airway wall.
  61. 61. The method of claim 59 further comprising the step of placing a bioabsorbable material in the opening to maintain patency of the opening.
  62. 62. The method of claim 61 wherein the bioabsorbable material comprises small intestine submucosa.
  63. 63. The method of claim 65 wherein said preserving step comprises cooling the tissue adjacent to the opening.
  64. 64. The method of claim 59 wherein said step of forming at least one opening comprises creating at least one section of airway wall tissue and folding the flap through the opening.
  65. 65. The method of claim 1 where the altering step comprises promoting flow through parenchymal inter-conduits.
  66. 66. The method of claim 1 where the altering step comprises bypassing restricted airways.
  67. 67. The method of claim 1 where the altering step comprises making an inspiratory path different from an expiratory path within the lung.
  68. 68. The method of claim 1 where the altering step comprises promoting patency and gaseous flow within at least one natural airway by relieving pressure external to a wall of at least that area.
  69. 69. The method of claim 1 where the altering step comprises creating at least one secondary artificial airflow path parallel to at least one natural airflow path.
  70. 70. The method of claim 1 where the altering step comprises increasing a cross-sectional area of an airflow at a treatment site.
  71. 71. A device for altering gaseous flow in a diseased lung comprising a locator for locating at least one site for creating a collateral channel in the lung.
  72. 72. The device of claim 71 further comprising a means for creating at least one collateral channel in the at least one site.
  73. 73. The device of claim 72 further comprising a means for coagulating blood upon entry into a blood vessel.
  74. 74. The device of claim 72 wherein said means for locating comprises a probe configured to puncture a wall of an airway within the lung and detect the presence of blood.
  75. 75. The device of claim 72 wherein the means for creating the at least one collateral channel uses a forming device selected from a group consisting of mechanical, electrical, laser, ultrasonic, microwave energy, and chemical.
  76. 76. The device of claim 75 wherein the forming device is electrical and uses RF energy.
  77. 77. The device of claim 75 further including a means for stopping the forming device upon contact with a blood vessel.
  78. 78. The device of claim 72 wherein the means for creating the at least one collateral channel uses a forming device comprises means capable of performing steps selected from dilation, cutting, piercing, and bursting.
  79. 79. The device of claim 72 wherein the device comprises a means for simultaneously creating a plurality of collateral channels.
  80. 80. The device of claim 72 wherein said locator includes a gas delivery member terminating at a distal end of the device, said delivery member being configured to transfer a volume of a gas to an air sac of the diseased lung.
  81. 81. The device of claim 80 further comprising a probe located at the distal end of the device configured to collect or transfer data within the lung.
  82. 82. The device of claim 80 where said probe collects data on pressure, volume, or flow rate of the gas within the airway.
  83. 83. The device of claim 80 wherein said device further comprises an expandable member at said distal end, said expandable member being proximal to said probe, said expandable member configured to sealingly occlude the airway while permitting said probe to extend proximally through said expandable member.
  84. 84. The device of claim 80 wherein said delivery member is configured to pass through a wall of the airway to force the gas directly into air sacs.
  85. 85. The device of claim 72 wherein said locator includes an expandable member located at a distal end of the device, said expandable member configured to sealingly occlude the airway, and a passageway extending from a proximal end of the device through said expandable member to a distal end of the device, said passageway being in fluid communication with said airway.
  86. 86. The device of claim 72 wherein locator includes a visualizing means for viewing an airway in the lung.
  87. 87. The device of claim 86 wherein said visualizing means comprises a fiber optic cable.
  88. 88. The device of claim 72 further comprising a means for marking the at least one site.
  89. 89. A medical device for detecting motion within tissue by observing a Doppler shift and for creating channels in tissue, the medical device comprising:
    a flexible elongate member having a proximal end and a distal end;
    a transducer assembly adapted to generate a source signal and receive a reflected signal, a portion of said assembly located adjacent to said distal end of said elongate member, said transducer assembly comprising a tip located at said distal end of said medical device, said tip being distal to said elongate member; and
    a hole-making assembly located adjacent to said transducer assembly.
  90. 90. The medical device of claim 89 wherein said transducer assembly is adapted to generate said source signal and receive said reflected signal over a substantial portion of said tip.
  91. 91. The medical device of claim 90 wherein said transducer assembly comprises an ultrasound transducer and wherein said tip of said transducer assembly comprises a signal interfering medium, said transducer and said signal interfering medium being in acoustical communication, and wherein said source and said reflected signals are ultrasound signals.
  92. 92. The medical device of claim 91 wherein said signal interfering medium comprises an acoustic lens having an inner surface and an outer surface, said lens inner surface being in at least acoustical communication with said ultrasound transducer, wherein when said transducer generates said source signal said lens refracts and disperses said source signal substantially about said outer surface of said lens, and when said outer surface receives said reflected signal, said lens refracts said reflected signal towards said transducer.
  93. 93. The medical device of claim 91 wherein said signal interfering medium comprises a hemispherical outer surface.
  94. 94. The medical device of claim 91 wherein said signal interfering medium comprises a oblate spheroid shaped outer surface.
  95. 95. The medical device of claim 91 wherein said signal interfering medium comprises a prolate spheroid shaped outer surface.
  96. 96. The medical device of claim 91 wherein said signal interfering medium comprises a cone shaped outer surface.
  97. 97. The medical device of claim 89 wherein said tip comprises a hemispherical shaped ultrasound transducer.
  98. 98. The medical device of claim 89 wherein said elongate member has a joint between said proximal and distal ends, said joint adapted to permit a first portion of said device defined from said joint to said tip to form an angle with a second portion of said elongate member defined from said joint to said proximal end of said elongate member.
  99. 99. The medical device of claim 89 wherein at least a portion of said elongate member further comprises a reinforcing member.
  100. 100. The medical device of claim 89 wherein said reinforcing member comprises a braid.
  101. 101. The medical device of claim 89 wherein said hole-making assembly is adapted to mechanically create an opening in tissue.
  102. 102. The medical device of claim 89 further comprising a source of RF energy in electrical communication with said hole-making assembly, and wherein said hole-making assembly is configured to make holes using RF energy.
  103. 103. The medical device of claim 102 further comprising a heat sink adjacent to said hole-making assembly.
  104. 104. The medical device of claim 102 wherein said elongate member further comprises a fluid dispensing assembly adjacent to said hole-making assembly.
  105. 105. The medical device of claim 102 wherein said hole-making assembly comprises a first conductive portion on said tip, wherein said first conductive portion functioning as a first RF electrode.
  106. 106. The medical device of claim 105 further comprising a second conductive portion on said tip, said second conductive portion functioning as a second RF electrode, said second conductive portion being insulated from said first conductive portion.
  107. 107. The medical device of claim 106 wherein said first conductive portion and said second conductive portion extend spirally along said tip.
  108. 108. The medical device of claim 105 wherein said transducer assembly comprises an ultrasound transducer and said tip comprises an acoustic lens, wherein said transducer assembly and said lens are in acoustic communication, said transducer assembly adapted to generate said source signal and receive said reflected signal, wherein said lens is separated from said transducer by a separation medium, said separation medium being adapted to transmit ultrasound energy.
  109. 109. The medical device of claim 105 wherein said transducer assembly further comprises a transducer adapted to generate said source signal and receive said reflected signal wherein said conductive distal surface of said transducer assembly and said transducer are moveable relative to each other.
  110. 110. The medical device of claim 102 wherein said hole-making assembly further comprises a conductive wire-like member extending away from said elongate member.
  111. 111. The medical device of claim 110 wherein said wire-like member is retractable into said elongate member.
  112. 112. The medical device of claim 102 wherein said hole-making assembly further comprises a conductive member located on a surface of said elongate member.
  113. 113. The medical device of claim 102 wherein said hole-making assembly further comprises a conductive member located coaxially about said transducer assembly, and wherein said transducer assembly is axially moveable within said conductive member.
  114. 114. The medical device of claim 102 wherein said hole-making assembly further comprises an electrode extending from a side of said elongate member adjacent to said distal end.
  115. 115. The medical device of claim 114 wherein said elongate member is conductive and said electrode is a protrusion integral with said elongate member, wherein said elongate member is covered with an insulative covering.
  116. 116. The medical device of claim 114 wherein said electrode is a spherical member which is retractable into said elongate member.
  117. 117. The medical device of claim 102 further comprising an RF energy source.
  118. 118. The medical device of claim 89 further comprising an ultrasound device capable of triggering said source signal and detecting said reflected signal.
  119. 119. The medical device of claim 118 wherein said ultrasound device is further capable of detecting a Doppler shift between said source and said reflected signal.
  120. 120. The medical device of claim 89 wherein said device is configured to fit within a working channel of an endoscope.
  121. 121. A medical device for detecting blood vessels within tissue by observing a Doppler shift, the medical device comprising:
    a flexible elongate member having a proximal end and a distal end;
    a transducer assembly adapted to generate a source signal and receive a reflected signal, a portion of said transducer assembly located adjacent to said distal end of said elongate member, said transducer assembly comprising at least one an ultrasound transducer and an acoustic lens, said transducer located adjacent to said elongate member and adapted to generate said source signal and to receive said reflected signal, said acoustic lens located distally of said elongate member and comprising a tip of said device, said lens having an inner surface and an outer surface, said lens inner surface being in at least acoustic communication with said transducer, wherein when said transducer generates said source signal said lens refracts and disperses said source signal substantially about said outer surface of said lens, and when said outer surface receives said reflected signal, said lens refracts said reflected signal towards said transducer.
  122. 122. The medical device of claim 121 wherein at least said outer surface of acoustic lens is hemispherical.
  123. 123. The medical device of claim 121 wherein at least said outer surface of acoustic lens is oblate spheroid shaped.
  124. 124. The medical device of claim 121 wherein at least said outer surface of acoustic lens is prolate spheroid shaped.
  125. 125. The medical device of claim 121 wherein at least said outer surface of acoustic lens is cone shaped.
  126. 126. The medical device of claim 121 wherein said transducer assembly is further adapted to produce therapeutic ultrasound to create openings in or mark tissue.
  127. 127. The medical device of claim 126 wherein said transducer assembly is adapted to produce a high energy ultrasound to create openings in tissue.
  128. 128. The medical device of claim 121 wherein said elongate member has a joint between said proximal and distal ends, said joint adapted to permit a first portion of said device defined from said joint to said tip to form an angle with a second portion of said elongate member defined from said joint to said proximal end of said elongate member.
  129. 129. The medical device of claim 121 wherein at least a portion of said elongate member comprises a support member.
  130. 130. The medical device of claim 129 wherein said support member is a braid.
  131. 131. A medical device for creating an opening in tissue within the lungs and applying heat to the opening, said medical device comprising:
    an elongate member having a proximal end and a distal end and at least one lumen extending therebetween, said elongate member including a reinforcing member extending through at least a portion of said elongate member, said reinforcing member adapted to increase an axial compressive strength of said elongate member;
    a dilating member having a body extending from a distal end of said elongate member and a tapered end opposite to said elongate member;
    a heating element affixed to said dilating member, said heating element adapted to heat said dilating member.
  132. 132. The medical device of claim 131 wherein said body of said dilating member has at least two regions of varying diameter.
  133. 133. The medical device of claim 131 wherein said heating element comprises a plurality of conductive windings about a surface of said dilating member.
  134. 134. The medical device of claim 131 wherein said heating element comprises a resistive wire wrapped about a surface of said dilating member.
  135. 135. The medical device of claim 131 further comprising a heat sink adjacent to said body of said dilating member, said heat sink having a first profile extending radially farther from said elongate member than said dilating member.
  136. 136. The medical device of claim 135 wherein said heat sink comprises an expandable balloon.
  137. 137. The medical device of claim 136 wherein said expandable balloon contains saline.
  138. 138. The medical device of claim 131 wherein said elongate member further comprises a fluid dispensing assembly adjacent to said body of said dilating member.
  139. 139. The medical device of claim 138 wherein said fluid dispensing assembly is adapted to spray a fluid about and away from said dilating member.
  140. 140. A conduit for maintaining the patency of an opening in tissue comprising:
    a center section having a first end and a second end and a central axis extending between said ends, a passageway within said center section extending between said ends; and
    at least one extension member extending from each end of said center section, each said extension member having a free end extending away from said center section, each of said extension members being parallel to said central axis of said center section, each of said free ends of said extension members being moveable such that said extension member may bend about said respective end of said center section.
  141. 141. The conduit of claim 140 wherein said center section is radially expandable away from said central axis to allow said center section to assume an expanded profile from a reduced profile.
  142. 142. The conduit of claim 141 wherein a length of said center section is less than twice the square root of a cross sectional area of said center section when said center section is in said expanded profile.
  143. 143. The conduit of claim 141 wherein a length of said center section measured along said central axis decreases as said center section expands from said reduced profile to said expanded profile.
  144. 144. The conduit of claim 141 wherein said center section is spring biased to assume said expanded profile.
  145. 145. The conduit of claim 140 where said extension members extending from said first end of said conduit are longer than said extension members extending from a second end of said conduit.
  146. 146. The conduit of claim 140 wherein said at least one extension member comprises a plurality of extension members extending from each end of said center section, said extension members arranged around a circumference of said center section.
  147. 147. The conduit of claim 140 wherein said center section comprises a mesh formed from a plurality of ribs.
  148. 148. The conduit of claim 147 further comprising a coating about said center section adapted to preventing tissue from extending through said mesh.
  149. 149. The conduit of claim 140 wherein said conduit is fully coated.
  150. 150. The conduit of claim 140 further comprising a fluid-tight cover about said center section of said conduit.
  151. 151. The conduit of claim 140 further comprising a fluid-tight cover about a portion of said conduit containing said extension members.
  152. 152. The conduit of claim 140 further comprising a fluid-tight cover about an entirety of said conduit.
  153. 153. The conduit of claim 140 wherein said center section comprises a rolled sheet of material, wherein said extension members are extend from a first and a second end of said sheet.
  154. 154. The conduit of claim 140 wherein said passageway has a cross sectional area between 0.196 mm2 to 254 mm2.
  155. 155. The conduit of claim 140 wherein said passageway has a cross sectional area between 3 mm2 to 20 mm2
  156. 156. The conduit of claim 140 wherein said conduit has an asymmetrical profile.
  157. 157. The conduit of claim 140 wherein said conduit has a ratio of a length to a diameter of approximately 1:1.
  158. 158. The conduit of claim 140 wherein said conduit comprises a material selected from a group consisting of elastomers, metals, metal alloys, polymers, shape memory alloys, and shape memory plastics.
  159. 159. The conduit of claim 140 further comprising a self-cleaning mechanism within said passageway.
  160. 160. The conduit of claim 159 wherein said self-cleaning mechanism is a ball bearing shaker valve.
  161. 161. The conduit of claim 140 further comprising a one-way valve located within said passageway.
  162. 162. The conduit of claim 140 further comprising a gas-permeable bacterial-resistant barrier located within said passageway.
  163. 163. An implantable device comprising a conduit for placement in a collateral channel within a diseased lung comprising a means for maintaining a gas passageway between parenchymal tissue and a natural airway within the lung.
  164. 164. The implant of claim 163 wherein said conduit is sized to fit an airway selected from the group consisting of a trachea, a bronchus, and a bronchiole.
  165. 165. The implant of claim 163 wherein said conduit has a lumen having a substantial cross-sectional area between 0.196 mm2 to 254 mm2.
  166. 166. The implant of claim 163 wherein said conduit has an asymmetrical profile.
  167. 167. The implant of claim 163 wherein said conduit has a ratio of a length to a diameter of approximately 1:1.
  168. 168. The implant of claim 163 wherein said conduit is removable.
  169. 169. The implant of claim 163 comprising a material selected from a group consisting of elastomers, metals, metal alloys, polymers, shape memory alloys, and shape memory plastics.
  170. 170. The implant of claim 163 wherein said conduit further comprises a wall extending from a distal end and a proximal end, where the wall is gas permeable.
  171. 171. The implant of claim 163 further comprising a barrier layer extending from a distal end to a proximal end to define a lumen, said barrier layer being sufficiently non-porous to prevent the tissue from entering the lumen.
  172. 172. The implant of claim 163 further comprising an anchor located at an end of said conduit, said anchor having a diameter decreasing in a direction away from said conduit to prevent dislodging of said conduit from the airway wall, and said anchor having at least one ventilation opening.
  173. 173. The implant of claim 172 wherein said anchor has an internal thread to receive an external thread of said conduit.
  174. 174. The implant of claim 163 wherein said conduit has an opening in a wall of said conduit.
  175. 175. A catheter for deploying a conduit within an airway in a lung comprising:
    a flexible elongate portion having a distal end and a proximal end;
    at least one lumen extending between said distal and proximal ends; and
    an hour-glass shaped balloon located adjacent to said distal end, said balloon having a first portion, a second portion, and a third portion, wherein said first and second portions are capable of expanding to a greater diameter than said second portion.
  176. 176. A kit for maintaining the patency of an opening in tissue comprising:
    a conduit comprising a tubular center section having a first end and a second end and a central axis extending between said ends, said center section comprising a mesh formed from a plurality of ribs, a plurality of extension members having a free end extending from each end of said center section, said extension members arranged around a circumference of said center section, each of said free ends of said extension members being independently moveable in a direction orthogonal to said central axis to form an angle with said central axis; and
    a delivery catheter.
  177. 177. The kit of claim 176 wherein said delivery catheter further comprises an an ultrasound transducer assembly for transmitting and receiving an ultrasound signal, and a hole-making assembly for creating a collateral channel.
  178. 178. The kit of claim 177 wherein said hole-making assembly uses RF energy and further comprising a RF energy supply.
  179. 179. The kit of claim 177 further comprising an ultrasound device capable of detecting an ultrasound signal and determining a Doppler shift between a transmitted signal and a reflected signal.
  180. 180. A method of evaluating an individual having a diseased lung as a candidate for a procedure to create collateral channels within an airway of the individual, said method comprising the steps of:
    (a) performing pulmonary function tests on the individual to obtain at least one pulmonary function value;
    (b) comparing the at least one pulmonary function to a corresponding predetermined pulmonary function value;
    (c) assigning a rating to the individual based upon said comparing step; and
    (d) evaluating the individual based upon the rating.
  181. 181. The method of claim 180 wherein the pulmonary function value is selected from a group consisting of FEV (forced expiratory volume), FVC (forced vital capacity), FEF (forced expiratory flow), Vmax (maximum flow), PFER (peak expiratory flow rate), FRC (functional residual capacity), RV (residual volume), TLC (total lung capacity), or a combination thereof.
  182. 182. The method of claim 180 further comprising the step of obtaining clinical information from the individual, and wherein said assigning step further includes accounting for the clinical information to assign the rating.
  183. 183. The method of claim 182 further comprising the step of using imaging to identify an amount of the lung that is hyper-inflated, and wherein said assigning step further includes accounting for the amount of the lung that is hyper-inflated to assign the rating.
  184. 184. A method of determining the effectiveness of a procedure to improve gaseous flow within a diseased lung, said method comprising the steps of:
    (a) performing pulmonary function tests on the individual to obtain at least one pulmonary function value;
    (b) creating collateral channels within the lung;
    (c) performing post procedure pulmonary function tests on the individual to obtain at least one post-procedure pulmonary function value; and
    (d) obtaining clinical information from the individual;
    (e) comparing the pulmonary function value with the post-procedure pulmonary function value to determine the effect of creating collateral ventilation; and
    (f) evaluating the comparing step with the clinical information to assess the effectiveness of the procedure to improve gaseous flow within the diseased lung.
  185. 185. The method of claim 184 wherein the pulmonary function value is selected from a group consisting of FEV (forced expiratory volume), FVC (forced vital capacity), FEF (forced expiratory flow), Vmax (maximum flow), PFER (peak expiratory flow rate), FRC (functional residual capacity), RV (residual volume), TLC (total lung capacity), or a combination thereof.
  186. 186. A modified respiratory airway having an artificially created channel allowing gaseous communication between an exterior of the airway and an interior of the airway.
US09908087 1999-08-05 2001-07-18 Devices for creating collateral channels in the lungs Abandoned US20020042564A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US14752899 true 1999-08-05 1999-08-05
US17614100 true 2000-01-14 2000-01-14
US09633651 US6692494B1 (en) 1999-08-05 2000-08-07 Methods and devices for creating collateral channels in the lungs
US09908087 US20020042564A1 (en) 1999-08-05 2001-07-18 Devices for creating collateral channels in the lungs

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09908087 US20020042564A1 (en) 1999-08-05 2001-07-18 Devices for creating collateral channels in the lungs
US09946706 US6749606B2 (en) 1999-08-05 2001-09-04 Devices for creating collateral channels
US10080344 US7422563B2 (en) 1999-08-05 2002-02-21 Multifunctional tip catheter for applying energy to tissue and detecting the presence of blood flow
US10079605 US7022088B2 (en) 1999-08-05 2002-02-21 Devices for applying energy to tissue
US11357244 US7393330B2 (en) 1999-08-05 2006-02-16 Electrosurgical device having hollow tissue cutting member and transducer assembly

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09633651 Continuation US6692494B1 (en) 1999-08-05 2000-08-07 Methods and devices for creating collateral channels in the lungs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09946706 Continuation-In-Part US6749606B2 (en) 1999-08-05 2001-09-04 Devices for creating collateral channels

Publications (1)

Publication Number Publication Date
US20020042564A1 true true US20020042564A1 (en) 2002-04-11

Family

ID=26845007

Family Applications (10)

Application Number Title Priority Date Filing Date
US09633651 Active 2021-04-16 US6692494B1 (en) 1999-08-05 2000-08-07 Methods and devices for creating collateral channels in the lungs
US09908177 Abandoned US20020042565A1 (en) 1999-08-05 2001-07-18 Conduits for maintaining openings in tissue
US09908008 Active 2020-08-15 US6629951B2 (en) 1999-08-05 2001-07-18 Devices for creating collateral in the lungs
US09908087 Abandoned US20020042564A1 (en) 1999-08-05 2001-07-18 Devices for creating collateral channels in the lungs
US10633902 Abandoned US20040073201A1 (en) 1999-08-05 2003-08-04 Methods for treating chronic obstructive pulmonary disease
US10966644 Abandoned US20050049615A1 (en) 1999-08-05 2004-10-15 Methods for treating chronic obstructive pulmonary disease
US10966765 Abandoned US20050085801A1 (en) 1999-08-05 2004-10-15 Methods of treating chronic obstructive pulmonary disease
US10978905 Abandoned US20050096529A1 (en) 1999-08-05 2004-11-01 Methods for treating chronic obstructive pulmonary disease
US11357639 Abandoned US20060276807A1 (en) 1999-08-05 2006-02-16 Methods for treating chronic obstructive pulmonary disease
US12939956 Abandoned US20110146673A1 (en) 1999-08-05 2010-11-04 Methods for treating chronic obstructive pulmonary disease

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09633651 Active 2021-04-16 US6692494B1 (en) 1999-08-05 2000-08-07 Methods and devices for creating collateral channels in the lungs
US09908177 Abandoned US20020042565A1 (en) 1999-08-05 2001-07-18 Conduits for maintaining openings in tissue
US09908008 Active 2020-08-15 US6629951B2 (en) 1999-08-05 2001-07-18 Devices for creating collateral in the lungs

Family Applications After (6)

Application Number Title Priority Date Filing Date
US10633902 Abandoned US20040073201A1 (en) 1999-08-05 2003-08-04 Methods for treating chronic obstructive pulmonary disease
US10966644 Abandoned US20050049615A1 (en) 1999-08-05 2004-10-15 Methods for treating chronic obstructive pulmonary disease
US10966765 Abandoned US20050085801A1 (en) 1999-08-05 2004-10-15 Methods of treating chronic obstructive pulmonary disease
US10978905 Abandoned US20050096529A1 (en) 1999-08-05 2004-11-01 Methods for treating chronic obstructive pulmonary disease
US11357639 Abandoned US20060276807A1 (en) 1999-08-05 2006-02-16 Methods for treating chronic obstructive pulmonary disease
US12939956 Abandoned US20110146673A1 (en) 1999-08-05 2010-11-04 Methods for treating chronic obstructive pulmonary disease

Country Status (6)

Country Link
US (10) US6692494B1 (en)
EP (3) EP1151729A1 (en)
JP (1) JP2003506132A (en)
CA (1) CA2393898A1 (en)
DE (1) DE60008072T2 (en)
WO (1) WO2001010314A2 (en)

Cited By (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020138074A1 (en) * 1999-08-05 2002-09-26 Thomas Keast Devices for applying energy to tissue
US20030070676A1 (en) * 1999-08-05 2003-04-17 Cooper Joel D. Conduits having distal cage structure for maintaining collateral channels in tissue and related methods
US6743259B2 (en) * 2001-08-03 2004-06-01 Core Medical, Inc. Lung assist apparatus and methods for use
US6749606B2 (en) 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
US20040211434A1 (en) * 2002-07-05 2004-10-28 Broncus Technologies, Inc. Extrapleural airway device and method
US20040243122A1 (en) * 2003-02-13 2004-12-02 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
US20040244803A1 (en) * 2003-06-05 2004-12-09 Don Tanaka Intra-thoracic collateral ventilation bypass system
US20050016530A1 (en) * 2003-07-09 2005-01-27 Mccutcheon John Treatment planning with implantable bronchial isolation devices
US20050025816A1 (en) * 2003-07-15 2005-02-03 Don Tanaka Methods and devices to accelerate wound healing in thoracic anastomosis applications
US20050049615A1 (en) * 1999-08-05 2005-03-03 Broncus Technologies, Inc. Methods for treating chronic obstructive pulmonary disease
US20050288549A1 (en) * 2004-06-14 2005-12-29 Pneumrx, Inc. Guided access to lung tissues
US20050288684A1 (en) * 2004-06-16 2005-12-29 Aronson Nathan A Method of reducing collateral flow in a portion of a lung
US20060009801A1 (en) * 2004-07-08 2006-01-12 Mcgurk Erin Pleural effusion treatment device, method and material
US20060025815A1 (en) * 2004-07-08 2006-02-02 Mcgurk Erin Lung device with sealing features
US20060079870A1 (en) * 2004-10-07 2006-04-13 Barry Robert L Systems and methods for shrinking and/or securing cardiovascular tissue
US20060122680A1 (en) * 2003-02-13 2006-06-08 Auth David C Systems and methods for securing cardiovascular tissue
US20060118125A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Pulmonary drug delivery
US20060118126A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Methods and devices for controlling collateral ventilation
US20060124126A1 (en) * 2004-12-10 2006-06-15 Don Tanaka Collateral ventilation device with chest tube/evacuation features
US20060167416A1 (en) * 2004-11-23 2006-07-27 Mark Mathis Steerable device for accessing a target site and methods
US20070093805A1 (en) * 2005-10-17 2007-04-26 Coaptus Medical Corporation Systems and methods for securing cardiovascular tissue, including via asymmetric electrodes
US20070163598A1 (en) * 2006-01-17 2007-07-19 Asia Chang Variable resistance pulmonary ventilation bypass valve
US20070221230A1 (en) * 2006-03-13 2007-09-27 David Thompson Minimally invasive lung volume reduction device and method
US20070265600A1 (en) * 2006-01-13 2007-11-15 Olympus Medical Systems Corporation Retainer for medical use and the method using the same
US20080072914A1 (en) * 2006-08-25 2008-03-27 Hendricksen Michael J Bronchial Isolation Devices for Placement in Short Lumens
US20080119840A1 (en) * 2006-11-21 2008-05-22 Vancelette David W Ridged Cryoprobe Tip
US20080188809A1 (en) * 2003-05-07 2008-08-07 Portaero, Inc. Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US20080208083A1 (en) * 2006-04-28 2008-08-28 Bryant Lin System and method to counter material deposition on devices in the urinary tract
US20080281433A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080287878A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Pulmonary visceral pleura anastomosis reinforcement
US20080283065A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung
US20080295829A1 (en) * 2007-05-30 2008-12-04 Portaero, Inc. Bridge element for lung implant
US20090093802A1 (en) * 2007-10-05 2009-04-09 Coaptus Medical Corporation Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Penetrating Members and Associted Methods
US20090209971A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US7704248B2 (en) 2005-12-21 2010-04-27 Boston Scientific Scimed, Inc. Ablation device with compression balloon
US7708712B2 (en) 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20100170507A1 (en) * 2009-01-08 2010-07-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US7789083B2 (en) 2003-05-20 2010-09-07 Portaero, Inc. Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US7896008B2 (en) 2003-06-03 2011-03-01 Portaero, Inc. Lung reduction system
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US8062315B2 (en) * 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8104474B2 (en) 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
US8172827B2 (en) 2003-05-13 2012-05-08 Innovative Pulmonary Solutions, Inc. Apparatus for treating asthma using neurotoxin
WO2012038495A3 (en) * 2010-09-24 2012-05-18 St Jude Medical Systems Ab A valve unit and a device for sealing a puncture hole in a vessel wall
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20130253641A1 (en) * 2001-12-08 2013-09-26 Trans Cardiac Therapeutics, Inc. Methods for accessing a left ventricle
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US8721734B2 (en) 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US8740921B2 (en) 2006-03-13 2014-06-03 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8844526B2 (en) 2012-03-30 2014-09-30 Covidien Lp Methods and systems for triggering with unknown base flow
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
CN104519940A (en) * 2012-08-07 2015-04-15 柯惠有限合伙公司 Microwave ablation catheter and method of utilizing same
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US20160066990A1 (en) * 2004-11-05 2016-03-10 Asthmatx, Inc. Energy delivery devices and methods
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
US9364624B2 (en) 2011-12-07 2016-06-14 Covidien Lp Methods and systems for adaptive base flow
US9393133B2 (en) 2011-02-18 2016-07-19 Piolax Medical Devices, Inc. Abdominal cavity-vein shunt stent
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US9498589B2 (en) 2011-12-31 2016-11-22 Covidien Lp Methods and systems for adaptive base flow and leak compensation
US20160354193A1 (en) * 2015-06-05 2016-12-08 Bruce Gordon McNAB, SR. Prostatic urethral stent
US9533128B2 (en) 2003-07-18 2017-01-03 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US9649458B2 (en) 2008-09-30 2017-05-16 Covidien Lp Breathing assistance system with multiple pressure sensors
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US9925346B2 (en) 2015-01-20 2018-03-27 Covidien Lp Systems and methods for ventilation with unknown exhalation flow
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
US9981096B2 (en) 2013-03-13 2018-05-29 Covidien Lp Methods and systems for triggering with unknown inspiratory flow

Families Citing this family (258)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6997189B2 (en) * 1998-06-05 2006-02-14 Broncus Technologies, Inc. Method for lung volume reduction
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US8016823B2 (en) 2003-01-18 2011-09-13 Tsunami Medtech, Llc Medical instrument and method of use
US20030130657A1 (en) * 1999-08-05 2003-07-10 Tom Curtis P. Devices for applying energy to tissue
US20040073155A1 (en) * 2000-01-14 2004-04-15 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in tissue
US20110306997A9 (en) * 2002-02-21 2011-12-15 Roschak Edmund J Devices for creating passages and sensing for blood vessels
US20050137715A1 (en) * 1999-08-05 2005-06-23 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20050060044A1 (en) * 1999-08-05 2005-03-17 Ed Roschak Methods and devices for maintaining patency of surgically created channels in a body organ
WO2006014732A3 (en) * 2004-07-19 2006-03-30 Broncus Tech Inc Methods and devices for maintaining patency of surgically created channels in a body organ
US20050137611A1 (en) * 2001-09-04 2005-06-23 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US7815590B2 (en) * 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US20050060041A1 (en) * 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US7422563B2 (en) * 1999-08-05 2008-09-09 Broncus Technologies, Inc. Multifunctional tip catheter for applying energy to tissue and detecting the presence of blood flow
US8002740B2 (en) * 2003-07-18 2011-08-23 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US20050060042A1 (en) * 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
WO2001035844A3 (en) 1999-11-10 2001-12-13 Novacept System and method for detecting perforations in a body cavity
US6679264B1 (en) 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US8474460B2 (en) 2000-03-04 2013-07-02 Pulmonx Corporation Implanted bronchial isolation devices and methods
US7549987B2 (en) 2000-12-09 2009-06-23 Tsunami Medtech, Llc Thermotherapy device
US9433457B2 (en) 2000-12-09 2016-09-06 Tsunami Medtech, Llc Medical instruments and techniques for thermally-mediated therapies
US8444636B2 (en) 2001-12-07 2013-05-21 Tsunami Medtech, Llc Medical instrument and method of use
US6527761B1 (en) 2000-10-27 2003-03-04 Pulmonx, Inc. Methods and devices for obstructing and aspirating lung tissue segments
EP1436022A4 (en) * 2001-09-04 2008-06-11 Broncus Tech Inc Conduits having distal cage structure for maintaining collateral channels in tissue and related methods
US7175644B2 (en) * 2001-02-14 2007-02-13 Broncus Technologies, Inc. Devices and methods for maintaining collateral channels in tissue
US20030036746A1 (en) 2001-08-16 2003-02-20 Avi Penner Devices for intrabody delivery of molecules and systems and methods utilizing same
EP1420702B1 (en) * 2001-08-31 2005-04-20 Boston Scientific Limited Percutaneous pringle occlusion device
US20070142742A1 (en) * 2005-07-13 2007-06-21 Pulmonx Methods and systems for segmental lung diagnostics
US8523782B2 (en) 2005-12-07 2013-09-03 Pulmonx Corporation Minimally invasive determination of collateral ventilation in lungs
US20140142455A1 (en) * 2005-12-07 2014-05-22 Pulmonx Corporation Minimally invasive determination of collateral ventilation in lungs
US7883471B2 (en) * 2001-09-10 2011-02-08 Pulmonx Corporation Minimally invasive determination of collateral ventilation in lungs
JP4301945B2 (en) * 2001-09-10 2009-07-22 パルモンクス Method and apparatus for intrabronchial diagnosis
US8496006B2 (en) 2005-01-20 2013-07-30 Pulmonx Corporation Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US20030050648A1 (en) 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
JP4446739B2 (en) * 2001-10-11 2010-04-07 パルモンクス・コーポレイションPulmonx Corporation Using bronchial flow control device and the device
US20040089306A1 (en) * 2002-05-28 2004-05-13 Ronald Hundertmark Devices and methods for removing bronchial isolation devices implanted in the lung
US6592594B2 (en) 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US7192436B2 (en) * 2001-11-08 2007-03-20 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
CA2468835A1 (en) * 2001-12-03 2003-06-12 Ekos Corporation Small vessel ultrasound catheter
US6929637B2 (en) * 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20030181922A1 (en) * 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7197363B2 (en) 2002-04-16 2007-03-27 Vivant Medical, Inc. Microwave antenna having a curved configuration
US20030195385A1 (en) * 2002-04-16 2003-10-16 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20030212412A1 (en) * 2002-05-09 2003-11-13 Spiration, Inc. Intra-bronchial obstructing device that permits mucus transport
US20030216769A1 (en) * 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
WO2003103479A3 (en) * 2002-06-07 2004-03-18 Broncus Tech Inc Method and devices for maintaining patency of surgically created channels in tissue
US7819908B2 (en) * 2002-06-17 2010-10-26 Aeris Therapeutics, Inc. Compositions and methods for reducing lung volume
US20040010209A1 (en) * 2002-07-15 2004-01-15 Spiration, Inc. Device and method for measuring the diameter of an air passageway
US20040059263A1 (en) * 2002-09-24 2004-03-25 Spiration, Inc. Device and method for measuring the diameter of an air passageway
US8303511B2 (en) 2002-09-26 2012-11-06 Pacesetter, Inc. Implantable pressure transducer system optimized for reduced thrombosis effect
WO2004028348A3 (en) * 2002-09-26 2004-06-17 Neal L Eigler Cardiovascular anchoring device and method of deploying same
JP4648704B2 (en) * 2002-09-30 2011-03-09 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム The stent delivery system and how to use them.
US7611482B2 (en) * 2002-11-21 2009-11-03 Boston Scientific Scimed, Inc. Minimally-invasive smart devices
US7814912B2 (en) 2002-11-27 2010-10-19 Pulmonx Corporation Delivery methods and devices for implantable bronchial isolation devices
EP1583569A4 (en) * 2003-01-03 2009-05-06 Ekos Corp Ultrasonic catheter with axial energy field
US8092450B2 (en) * 2003-01-21 2012-01-10 Baylis Medical Company Inc. Magnetically guidable energy delivery apparatus and method of using same
US20040210248A1 (en) * 2003-03-12 2004-10-21 Spiration, Inc. Apparatus, method and assembly for delivery of intra-bronchial devices
US20040181214A1 (en) * 2003-03-13 2004-09-16 Garabedian Robert J. Passively cooled array
US7100616B2 (en) * 2003-04-08 2006-09-05 Spiration, Inc. Bronchoscopic lung volume reduction method
WO2004093656A3 (en) * 2003-04-22 2006-06-01 Ekos Corp Ultrasound enhanced central venous catheter
US7533667B2 (en) * 2003-05-29 2009-05-19 Portaero, Inc. Methods and devices to assist pulmonary decompression
US6943881B2 (en) * 2003-06-04 2005-09-13 Tomophase Corporation Measurements of optical inhomogeneity and other properties in substances using propagation modes of light
US7970458B2 (en) * 2004-10-12 2011-06-28 Tomophase Corporation Integrated disease diagnosis and treatment system
US8498681B2 (en) * 2004-10-05 2013-07-30 Tomophase Corporation Cross-sectional mapping of spectral absorbance features
EP1648283A4 (en) * 2003-07-18 2011-12-21 Broncus Tech Inc Devices for maintaining patency of surgically created channels in tissue
US7533671B2 (en) 2003-08-08 2009-05-19 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
JP2007504910A (en) 2003-09-12 2007-03-08 ミノウ・メディカル・エルエルシイ Selectable biasing of atherosclerotic material remodeling and / or ablation
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US20070287956A1 (en) * 2003-09-24 2007-12-13 Tal Michael G Method and apparatus for treatment of thrombosed hemodialysis access grafts and arterio venous fistulas
US20070060882A1 (en) * 2003-09-24 2007-03-15 Tal Michael G Method and apparatus for treatment of thrombosed hemodialysis access grafts
US8206684B2 (en) 2004-02-27 2012-06-26 Pulmonx Corporation Methods and devices for blocking flow through collateral pathways in the lung
US8876791B2 (en) 2005-02-25 2014-11-04 Pulmonx Corporation Collateral pathway treatment using agent entrained by aspiration flow current
US20120035540A1 (en) 2006-04-12 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Event-based control of a lumen traveling device
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US9801527B2 (en) 2004-04-19 2017-10-31 Gearbox, Llc Lumen-traveling biological interface device
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
EP2545874B1 (en) 2004-11-16 2017-09-20 Uptake Medical Technology Inc. Device for lung treatment
US7771472B2 (en) 2004-11-19 2010-08-10 Pulmonx Corporation Bronchial flow control devices and methods of use
EP2289392B1 (en) 2004-11-24 2012-05-09 Remon Medical Technologies Ltd. Implantable medical device with integrated acoustic transducer
EP1827527B1 (en) * 2004-12-06 2016-08-24 Cook Incorporated Inflatable occlusion devices, methods, and systems
WO2006078451A3 (en) * 2005-01-20 2007-10-18 Pulmonx Minimally invasive determination of collateral ventilation in lungs
US8080030B2 (en) * 2005-01-21 2011-12-20 University Of South Florida Endoscopic sheath having a biomimetic retractor
US7803142B2 (en) 2005-02-02 2010-09-28 Summit Access Llc Microtaper needle and method of use
US7517346B2 (en) * 2005-02-08 2009-04-14 Boston Scientific Scimed, Inc. Radio frequency ablation system with integrated ultrasound imaging
US7879050B2 (en) * 2005-03-23 2011-02-01 Wilk Peter J Trans-vascular surgical method and associated device
US9204819B2 (en) 2005-05-06 2015-12-08 Vasonova, Inc. Endovenous access and guidance system utilizing non-image based ultrasound
US7736320B2 (en) * 2005-05-25 2010-06-15 Sierra Medical Technology, Inc. Self-condensing pH sensor and catheter apparatus
US20070032785A1 (en) * 2005-08-03 2007-02-08 Jennifer Diederich Tissue evacuation device
US20070038115A1 (en) * 2005-08-12 2007-02-15 Quigley David P High intensity ultrasound apparatus methods and systems
US7628789B2 (en) 2005-08-17 2009-12-08 Pulmonx Corporation Selective lung tissue ablation
US9265605B2 (en) * 2005-10-14 2016-02-23 Boston Scientific Scimed, Inc. Bronchoscopic lung volume reduction valve
US9037247B2 (en) 2005-11-10 2015-05-19 ElectroCore, LLC Non-invasive treatment of bronchial constriction
EP1948301B8 (en) 2005-11-10 2014-03-12 ElectroCore LLC Electrical stimulation treatment of bronchial constriction
US8812112B2 (en) 2005-11-10 2014-08-19 ElectroCore, LLC Electrical treatment of bronchial constriction
US8002695B2 (en) 2006-01-13 2011-08-23 Olympus Medical Systems Corp. Medical procedure via natural opening
US8041428B2 (en) 2006-02-10 2011-10-18 Electrocore Llc Electrical stimulation treatment of hypotension
JP2009525806A (en) 2006-02-10 2009-07-16 エレクトロコア、インコーポレイテッド Low blood pressure electrical stimulation therapy
CN101400402A (en) 2006-02-10 2009-04-01 电子核心公司 Electrical stimulation treatment of hypotension
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US20070244529A1 (en) * 2006-04-18 2007-10-18 Zoom Therapeutics, Inc. Apparatus and methods for treatment of nasal tissue
US7744542B2 (en) * 2006-04-20 2010-06-29 Cardiac Pacemakers, Inc. Implanted air passage sensors
WO2007124038A3 (en) 2006-04-20 2008-07-03 Joshua Adams Apparatus and methods for treating root canals of teeth
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
EP2032059A4 (en) * 2006-06-05 2009-09-16 Broncus Tech Inc Devices for creating passages and sensing blood vessels
US7517320B2 (en) * 2006-06-30 2009-04-14 Broncus Technologies, Inc. Airway bypass site selection and treatment planning
US7949396B2 (en) 2006-07-21 2011-05-24 Cardiac Pacemakers, Inc. Ultrasonic transducer for a metallic cavity implated medical device
US7912548B2 (en) * 2006-07-21 2011-03-22 Cardiac Pacemakers, Inc. Resonant structures for implantable devices
US20080027520A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Laser treatment of tissue
EP1891902A1 (en) * 2006-08-22 2008-02-27 Carag AG Occluding device
US7860567B2 (en) * 2006-08-31 2010-12-28 Cardiac Pacemakers, Inc. Sensor for edema
EP2076198A4 (en) 2006-10-18 2009-12-09 Minnow Medical Inc Inducing desirable temperature effects on body tissue
JP5559539B2 (en) 2006-10-18 2014-07-23 べシックス・バスキュラー・インコーポレイテッド System to induce the temperature desired effect on the body tissue
JP5312337B2 (en) 2006-10-18 2013-10-09 べシックス・バスキュラー・インコーポレイテッド Adjusted characterization of rf energy and electrical organization for selective treatment of target tissues
US8585645B2 (en) * 2006-11-13 2013-11-19 Uptake Medical Corp. Treatment with high temperature vapor
US7993323B2 (en) 2006-11-13 2011-08-09 Uptake Medical Corp. High pressure and high temperature vapor catheters and systems
EP2091439B1 (en) * 2006-11-22 2012-10-24 Broncus Technologies, Inc. Devices for creating passages and sensing for blood vessels
US9254162B2 (en) * 2006-12-21 2016-02-09 Myoscience, Inc. Dermal and transdermal cryogenic microprobe systems
WO2008089429A3 (en) * 2007-01-19 2008-11-20 David T Raphael Acoustic back-scattering sensing screw for preventing spine surgery complications
US20080228231A1 (en) * 2007-01-19 2008-09-18 University Of Southern California Acoustic Back-Scattering Sensing Screw for Preventing Spine Surgery Complications
EP2821027A3 (en) * 2007-01-25 2015-04-01 Sonendo, Inc. Apparatus for removing organic material from a root canal of a tooth
US8409185B2 (en) 2007-02-16 2013-04-02 Myoscience, Inc. Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling
JP4896763B2 (en) * 2007-02-19 2012-03-14 東芝メディカルシステムズ株式会社 Respiratory depression member and magnetic resonance imaging apparatus
WO2008109760A3 (en) * 2007-03-06 2008-10-23 Broncus Tech Inc Blood vessel sensing catheter having working lumen for medical appliances
US20080228137A1 (en) 2007-03-12 2008-09-18 Pulmonx Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US7706646B2 (en) * 2007-04-24 2010-04-27 Tomophase Corporation Delivering light via optical waveguide and multi-view optical probe head
US20080281151A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Pulmonary pleural stabilizer
US8825161B1 (en) 2007-05-17 2014-09-02 Cardiac Pacemakers, Inc. Acoustic transducer for an implantable medical device
JP2010528814A (en) 2007-06-14 2010-08-26 カーディアック ペースメイカーズ, インコーポレイテッド Multi-element acoustic re-charging system
WO2009009398A1 (en) 2007-07-06 2009-01-15 Tsunami Medtech, Llc Medical system and method of use
US8842739B2 (en) * 2007-07-20 2014-09-23 Samsung Electronics Co., Ltd. Method and system for communication of uncompressed video information in wireless systems
WO2009013755A3 (en) * 2007-07-26 2010-03-04 Pulmone Advanced Medical Devices, Ltd. System and methods for the measurement of lung volumes
US8657757B2 (en) * 2007-07-26 2014-02-25 Pulmone Advanced Medical Devices, Ltd. System and methods for the measurement of lung volumes
US8702609B2 (en) * 2007-07-27 2014-04-22 Meridian Cardiovascular Systems, Inc. Image-guided intravascular therapy catheters
US9125552B2 (en) * 2007-07-31 2015-09-08 Ethicon Endo-Surgery, Inc. Optical scanning module and means for attaching the module to medical instruments for introducing the module into the anatomy
FR2919486B1 (en) * 2007-07-31 2009-10-02 Captomed Entpr Unipersonnelle self-calibrating pressure sensor.
US8858576B2 (en) * 2007-09-10 2014-10-14 Olympus Medical Systems Corp. Tissue fastening tool, stent, applicator for placing the same, and tissue fastening method through natural orifice
US20090076491A1 (en) * 2007-09-19 2009-03-19 Broncus Technologies, Inc. Methods for maintaining the patency of collateral channels in the lungs using cryo-energy
US8430920B2 (en) * 2007-09-28 2013-04-30 Kasey K. LI Device and methods for treatment of tissue
WO2009049296A3 (en) * 2007-10-12 2009-06-11 Brett Eugene Bouma Systems and processes for optical imaging of luminal anatomic structures
US8043301B2 (en) 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
CN101868199B (en) 2007-10-12 2016-04-06 斯波瑞申有限公司 Valve loader methods, systems, and devices
US8322335B2 (en) * 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US8147532B2 (en) * 2007-10-22 2012-04-03 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US9017248B2 (en) * 2007-11-08 2015-04-28 Olympus Medical Systems Corp. Capsule blood detection system and method
US20100329520A2 (en) * 2007-11-08 2010-12-30 Olympus Medical Systems Corp. Method and System for Correlating Image and Tissue Characteristic Data
US9131847B2 (en) * 2007-11-08 2015-09-15 Olympus Corporation Method and apparatus for detecting abnormal living tissue
US9924992B2 (en) * 2008-02-20 2018-03-27 Tsunami Medtech, Llc Medical system and method of use
US8452383B2 (en) * 2008-02-29 2013-05-28 Tomophase Corporation Temperature profile mapping and guided thermotherapy
US20100152600A1 (en) * 2008-04-03 2010-06-17 Kai Sensors, Inc. Non-contact physiologic motion sensors and methods for use
CA2720871A1 (en) * 2008-04-03 2009-10-08 Kai Medical, Inc. Non-contact physiologic motion sensors and methods for use
WO2009134876A1 (en) 2008-04-29 2009-11-05 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
WO2009137815A1 (en) * 2008-05-09 2009-11-12 Dentatek Corporation Apparatus and methods for root canal treatments
US8579888B2 (en) 2008-06-17 2013-11-12 Tsunami Medtech, Llc Medical probes for the treatment of blood vessels
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US20100016810A1 (en) * 2008-07-21 2010-01-21 Arstasis. Inc., Devices and methods for forming tracts in tissue
US8721632B2 (en) * 2008-09-09 2014-05-13 Tsunami Medtech, Llc Methods for delivering energy into a target tissue of a body
US8761877B2 (en) * 2008-10-03 2014-06-24 Cardiac Pacemakers, Inc. Biosorbable battery and related methods
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9700365B2 (en) * 2008-10-06 2017-07-11 Santa Anna Tech Llc Method and apparatus for the ablation of gastrointestinal tissue
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
EP2355737A4 (en) 2008-11-17 2013-01-16 Vessix Vascular Inc Selective accumulation of energy with or without knowledge of tissue topography
EP2352559B1 (en) * 2008-11-17 2013-12-25 Vytronus, Inc. System for ablating body tissue
US8444635B2 (en) * 2008-11-19 2013-05-21 Samuel Victor Lichtenstein Methods for selectively heating tissue
US20100262133A1 (en) * 2009-02-03 2010-10-14 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
US9369759B2 (en) * 2009-04-15 2016-06-14 Samsung Electronics Co., Ltd. Method and system for progressive rate adaptation for uncompressed video communication in wireless systems
US8467858B2 (en) * 2009-04-29 2013-06-18 Tomophase Corporation Image-guided thermotherapy based on selective tissue thermal treatment
EP2470886A4 (en) 2009-08-26 2016-11-02 Tomophase Inc Optical tissue imaging based on optical frequency domain imaging
DE102009048433A1 (en) * 2009-10-07 2011-04-28 Technische Universität München Anastomosierungsvorrichtung
WO2011051787A3 (en) * 2009-10-27 2011-07-14 Ayelet Kanter Transthoracic pulmonary doppler ultrasound
US8900223B2 (en) * 2009-11-06 2014-12-02 Tsunami Medtech, Llc Tissue ablation systems and methods of use
CN107115154A (en) 2010-10-21 2017-09-01 索南多股份有限公司 Apparatus, methods, and compositions for endodontic treatments
US8469953B2 (en) 2009-11-16 2013-06-25 Covidien Lp Twin sealing chamber hub
US9161801B2 (en) * 2009-12-30 2015-10-20 Tsunami Medtech, Llc Medical system and method of use
US9107606B2 (en) 2010-01-08 2015-08-18 Pulmonx Corporation Measuring lung function and lung disease progression at a lobar/segmental level
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
KR20130108067A (en) 2010-04-09 2013-10-02 베식스 바스큘라 인코포레이티드 Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9592008B2 (en) 2010-07-01 2017-03-14 Pulmonx Corporation Devices and systems for lung treatment
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
EP2694150A1 (en) 2011-04-08 2014-02-12 Covidien LP Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
EP2734259B1 (en) 2011-07-20 2016-11-23 Boston Scientific Scimed, Inc. Percutaneous device to visualize, target and ablate nerves
US9186209B2 (en) 2011-07-22 2015-11-17 Boston Scientific Scimed, Inc. Nerve modulation system having helical guide
WO2013044267A1 (en) 2011-09-23 2013-03-28 Pulmonx, Inc. Implant loading device and system
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
EP2765942B1 (en) 2011-10-10 2016-02-24 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US10085799B2 (en) 2011-10-11 2018-10-02 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
EP2768563B1 (en) 2011-10-18 2016-11-09 Boston Scientific Scimed, Inc. Deflectable medical devices
WO2013059202A1 (en) 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
WO2013070724A1 (en) 2011-11-08 2013-05-16 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
WO2013096913A3 (en) 2011-12-23 2013-10-10 Vessix Vascular, Inc. Tissue remodeling systems and a method for delivering energy to maintain predetermined target temperature
CN104135958B (en) 2011-12-28 2017-05-03 波士顿科学西美德公司 There are new methods and apparatus with an ablation catheter ablation element becomes transferred polymer nerve
JP2013138666A (en) * 2011-12-28 2013-07-18 Terumo Corp Pleurolysis model lung of non-human animal and making method of the same, and making method of pleurolysis model non-human animal
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
CN104159534B (en) 2012-01-13 2017-02-22 肌肉科技股份有限公司 For skin protection and other beauty subcutaneous low-temperature processing of remodeling
US20140099597A1 (en) 2012-04-13 2014-04-10 Sonendo Inc. Apparatus and methods for cleaning teeth and gingival pockets
WO2013157208A1 (en) * 2012-04-20 2013-10-24 テルモ株式会社 Vascular insertion type treatment device
US9314239B2 (en) 2012-05-23 2016-04-19 Depuy Mitek, Llc Methods and devices for securing suture to tissue
US10058332B2 (en) * 2012-08-01 2018-08-28 Terumo Kabushiki Kaisha Method for treatment of chronic obstructive pulmonary disease
US9173696B2 (en) 2012-09-17 2015-11-03 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
EP2945556A4 (en) 2013-01-17 2016-08-31 Virender K Sharma Method and apparatus for tissue ablation
US9504536B2 (en) 2013-02-04 2016-11-29 Sonendo, Inc. Dental treatment system
US9956033B2 (en) 2013-03-11 2018-05-01 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US20140276764A1 (en) * 2013-03-14 2014-09-18 Gyrus ACM, Inc. (d.b.a Olympus Surgical Technologies America) Flexible RF Ablation Needle
US9295512B2 (en) 2013-03-15 2016-03-29 Myoscience, Inc. Methods and devices for pain management
EP2967734A1 (en) 2013-03-15 2016-01-20 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US9610112B2 (en) 2013-03-15 2017-04-04 Myoscience, Inc. Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis
US9943353B2 (en) 2013-03-15 2018-04-17 Tsunami Medtech, Llc Medical system and method of use
US9668800B2 (en) 2013-03-15 2017-06-06 Myoscience, Inc. Methods and systems for treatment of spasticity
US10022182B2 (en) 2013-06-21 2018-07-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
CN105473091A (en) 2013-06-21 2016-04-06 波士顿科学国际有限公司 Renal denervation balloon catheter with ride along electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
EP3013277A2 (en) 2013-06-26 2016-05-04 Sonendo, Inc. Apparatus and methods for filling teeth and root canals
CN105358084B (en) 2013-07-01 2018-11-09 波士顿科学国际有限公司 For renal nerve ablation medical devices
EP3049007A1 (en) 2013-07-19 2016-08-03 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
EP3041425A1 (en) 2013-09-04 2016-07-13 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
US9782211B2 (en) 2013-10-01 2017-10-10 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
CN105592778A (en) 2013-10-14 2016-05-18 波士顿科学医学有限公司 High resolution cardiac mapping electrode array catheter
CN105636537B (en) 2013-10-15 2018-08-17 波士顿科学国际有限公司 Medical Devices balloon
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
WO2015069792A1 (en) 2013-11-05 2015-05-14 Myoscience, Inc. Secure cryosurgical treatment system
WO2015119890A1 (en) 2014-02-04 2015-08-13 Boston Scientific Scimed, Inc. Alternative placement of thermal sensors on bipolar electrode
US9554801B2 (en) 2014-03-14 2017-01-31 Cook Medical Technologies Llc Extravascular implant for facilitating sutured side-to-side arteriovenous fistula creation and maintaining patency
US9693854B2 (en) * 2014-03-31 2017-07-04 Boston Scientific Scimed, Inc. Devices for forming collateral channels and related methods of use
CN106413601A (en) * 2014-04-30 2017-02-15 索菲亚医疗器械公司 Methods and devices for treating a hyper-inflated lung
US9592138B1 (en) 2015-09-13 2017-03-14 Martin Mayse Pulmonary airflow
JP2016025958A (en) * 2015-10-07 2016-02-12 パルティ、ヨーラム Transthoracic lung doppler ultrasonic wave
WO2017087578A1 (en) * 2015-11-16 2017-05-26 The Board Of Trustees Of The Leland Stanford Jr. University Lung isolation devices, systems, and methods for use

Citations (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127903A (en) * 1936-05-05 1938-08-23 Davis & Geck Inc Tube for surgical purposes and method of preparing and using the same
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4534761A (en) * 1981-08-14 1985-08-13 Bentley Laboratories, Inc. Implant device
US4582067A (en) * 1983-02-14 1986-04-15 Washington Research Foundation Method for endoscopic blood flow detection by the use of ultrasonic energy
US4583969A (en) * 1984-06-26 1986-04-22 Mortensen J D Apparatus and method for in vivo extrapulmonary blood gas exchange
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US4753236A (en) * 1986-04-08 1988-06-28 Healey Maureen A Temporary anastomotic device
US4769031A (en) * 1986-06-25 1988-09-06 Mcgough Edwin C Ventricular access device and method
US4773413A (en) * 1983-06-13 1988-09-27 Trimedyne Laser Systems, Inc. Localized heat applying medical device
US4795465A (en) * 1987-05-14 1989-01-03 Hood Laboratories Tracheobronchial stent
US4887606A (en) * 1986-09-18 1989-12-19 Yock Paul G Apparatus for use in cannulation of blood vessels
US4899757A (en) * 1988-02-22 1990-02-13 Intertherapy, Inc. Ultrasound imaging probe with zero dead space
US4957508A (en) * 1986-10-31 1990-09-18 Ube Industries, Ltd. Medical tubes
US5030201A (en) * 1989-11-24 1991-07-09 Aubrey Palestrant Expandable atherectomy catheter device
US5054483A (en) * 1989-03-06 1991-10-08 Hood Laboratories Tracheal cannulas and stents
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5064435A (en) * 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5127917A (en) * 1989-06-01 1992-07-07 Schneider (Europe) A.G. Probe, especially for the recanalization of occlusions, and catheter arrangement with such a probe
US5174295A (en) * 1987-04-10 1992-12-29 Cardiometrics, Inc. Apparatus, system and method for measuring spatial average velocity and/or volumetric flow of blood in a vessel and screw joint for use therewith
US5238027A (en) * 1990-06-06 1993-08-24 Asten Group, Inc. Papermakers fabric with orthogonal machine direction yarn seaming loops
US5257990A (en) * 1992-02-24 1993-11-02 Kensey Nash Corporation Electrosurgical catheter instrument with impacting working head and method of use
US5261409A (en) * 1991-05-27 1993-11-16 Sulzer Brothers Limited Puncturing device for blood vessels
US5295484A (en) * 1992-05-19 1994-03-22 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Apparatus and method for intra-cardiac ablation of arrhythmias
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5344420A (en) * 1991-02-13 1994-09-06 Applied Medical Resources Corporation Surgical trocar
US5351693A (en) * 1991-11-08 1994-10-04 Baxter International Inc. Ultrasound probe for use with transport catheter and method of making same
US5381795A (en) * 1993-11-19 1995-01-17 Advanced Technology Laboratories, Inc. Intraoperative ultrasound probe
US5413601A (en) * 1990-03-26 1995-05-09 Keshelava; Viktor V. Tubular organ prosthesis
US5425739A (en) * 1989-03-09 1995-06-20 Avatar Design And Development, Inc. Anastomosis stent and stent selection system
US5454373A (en) * 1994-07-20 1995-10-03 Boston Scientific Corporation Medical acoustic imaging
US5466242A (en) * 1994-02-02 1995-11-14 Mori; Katsushi Stent for biliary, urinary or vascular system
US5520684A (en) * 1993-06-10 1996-05-28 Imran; Mir A. Transurethral radio frequency apparatus for ablation of the prostate gland and method
US5527324A (en) * 1994-09-07 1996-06-18 Krantz; Kermit E. Surgical stent
US5540713A (en) * 1991-10-11 1996-07-30 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5545195A (en) * 1994-08-01 1996-08-13 Boston Scientific Corporation Interstitial heating of tissue
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5571180A (en) * 1992-01-10 1996-11-05 Hansa Medical Products, Inc. Tool for loading flexible flange into retainer
US5607444A (en) * 1993-12-02 1997-03-04 Advanced Cardiovascular Systems, Inc. Ostial stent for bifurcations
US5618301A (en) * 1993-10-07 1997-04-08 Angiomed Ag Reducing stent, device with reducing stent and use of a reducing stent
US5647871A (en) * 1995-03-10 1997-07-15 Microsurge, Inc. Electrosurgery with cooled electrodes
US5653746A (en) * 1994-03-08 1997-08-05 Meadox Medicals, Inc. Radially expandable tubular prosthesis
US5658280A (en) * 1995-05-22 1997-08-19 Issa; Muta M. Resectoscope electrode assembly with simultaneous cutting and coagulation
US5672172A (en) * 1994-06-23 1997-09-30 Vros Corporation Surgical instrument with ultrasound pulse generator
US5674298A (en) * 1994-10-21 1997-10-07 The Board Of Regents Of The University Of Michigan Calcification-resistant bioprosthetic tissue and methods of making same
US5713949A (en) * 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5716393A (en) * 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5741333A (en) * 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5755769A (en) * 1992-03-12 1998-05-26 Laboratoire Perouse Implant Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof
US5759769A (en) * 1993-06-09 1998-06-02 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides
US5795325A (en) * 1991-07-16 1998-08-18 Heartport, Inc. Methods and apparatus for anchoring an occluding member
US5797920A (en) * 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US5810836A (en) * 1996-03-04 1998-09-22 Myocardial Stents, Inc. Device and method for trans myocardial revascularization (TMR)
US5840431A (en) * 1994-04-14 1998-11-24 Fritz Borsi Kg Method for preferably region-by-region coating of a transparent carrier plate
US5849037A (en) * 1995-04-12 1998-12-15 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body, and method for its preparation
US5876448A (en) * 1992-05-08 1999-03-02 Schneider (Usa) Inc. Esophageal stent
US5876434A (en) * 1997-07-13 1999-03-02 Litana Ltd. Implantable medical devices of shape memory alloy
US5922019A (en) * 1995-11-27 1999-07-13 Schneider (Europe) A.G. Conical stent
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US5951567A (en) * 1997-07-24 1999-09-14 Cardiogenesis Corporation Introducer for channel forming device
US5957849A (en) * 1997-06-30 1999-09-28 The Regents Of The University Of California Endoluminal ultrasound-guided resectoscope
US5968053A (en) * 1997-01-31 1999-10-19 Cardiac Assist Technologies, Inc. Method and apparatus for implanting a graft in a vessel of a patient
US5968070A (en) * 1995-02-22 1999-10-19 Cordis Corporation Covered expanding mesh stent
US5993484A (en) * 1996-10-23 1999-11-30 United States Surgical Apparatus and method for dilatation of a body lumen and delivery of a prosthesis therein
US6004319A (en) * 1995-06-23 1999-12-21 Gyrus Medical Limited Electrosurgical instrument
US6007574A (en) * 1993-12-28 1999-12-28 Pulnev; Sergei Appolonovich Stent
US6007544A (en) * 1996-06-14 1999-12-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US6011995A (en) * 1997-12-29 2000-01-04 The Regents Of The University Of California Endovascular device for hyperthermia and angioplasty and method for using the same
US6015405A (en) * 1998-01-20 2000-01-18 Tricardia, L.L.C. Device for forming holes in tissue
US6024703A (en) * 1997-05-07 2000-02-15 Eclipse Surgical Technologies, Inc. Ultrasound device for axial ranging
US6096053A (en) * 1996-05-03 2000-08-01 Scimed Life Systems, Inc. Medical retrieval basket
US6112123A (en) * 1998-07-28 2000-08-29 Endonetics, Inc. Device and method for ablation of tissue
US6143019A (en) * 1995-08-22 2000-11-07 Board Of Regents, The University Of Texas System Method for emitting therapeutic energy within tissue
US6183444B1 (en) * 1998-05-16 2001-02-06 Microheart, Inc. Drug delivery module
US6258100B1 (en) * 1999-08-24 2001-07-10 Spiration, Inc. Method of reducing lung size
US6287290B1 (en) * 1999-07-02 2001-09-11 Pulmonx Methods, systems, and kits for lung volume reduction
US6328689B1 (en) * 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method
US6572553B2 (en) * 1988-03-21 2003-06-03 Scimed Life Systems, Inc. Medical imaging device

Family Cites Families (211)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174851A (en) * 1961-12-01 1965-03-23 William J Buehler Nickel-base alloys
US3433226A (en) * 1965-07-21 1969-03-18 Aeroprojects Inc Vibratory catheterization apparatus and method of using
US3617060A (en) * 1967-04-10 1971-11-02 Warren Iezzi Pneumothorox-inducing hunting arrow
US3556079A (en) * 1967-05-16 1971-01-19 Haruo Omizo Method of puncturing a medical instrument under guidance of ultrasound
US3565062A (en) * 1968-06-13 1971-02-23 Ultrasonic Systems Ultrasonic method and apparatus for removing cholesterol and other deposits from blood vessels and the like
US3707151A (en) * 1971-02-16 1972-12-26 Richard Robert Jackson Self-inflating endotracheal tube
US3779234A (en) 1971-06-30 1973-12-18 Intersc Res Inst Ultrasonic catheter with rotating transducers
DK131541C (en) 1973-09-03 1975-12-29 Akad Tekn Videnskaber
US4249539A (en) * 1979-02-09 1981-02-10 Technicare Corporation Ultrasound needle tip localization system
US4249541A (en) * 1979-04-26 1981-02-10 David S. Pratt Biopsy device
US4319580A (en) * 1979-08-28 1982-03-16 The Board Of Regents Of The University Of Washington Method for detecting air emboli in the blood in an intracorporeal blood vessel
US4324235A (en) * 1980-03-24 1982-04-13 Beran Anthony V Endotracheal tube
US4431006A (en) * 1982-01-07 1984-02-14 Technicare Corporation Passive ultrasound needle probe locator
US4493320A (en) * 1982-04-02 1985-01-15 Treat Michael R Bipolar electrocautery surgical snare
US4538606A (en) * 1982-12-10 1985-09-03 Whited Robert E Endotracheal tube
US4770185A (en) 1983-02-14 1988-09-13 The Board Of Regents Of The University Of Washington Method and apparatus for endoscopic blood flow detection by the use of ultrasonic energy
EP0148250A1 (en) 1983-07-06 1985-07-17 STASZ, Peter Electro cautery surgical blade
US4687482A (en) 1984-04-27 1987-08-18 Scripps Clinic And Research Foundation Vascular prosthesis
US4682596A (en) 1984-05-22 1987-07-28 Cordis Corporation Electrosurgical catheter and method for vascular applications
EP0177124A3 (en) * 1984-07-18 1987-01-21 Sumitomo Electric Industries Limited Catheter
CA1245931A (en) * 1984-09-21 1988-12-06 Sophia Pesotchinsky Positionable tissue interfacing device for the management of percutaneous conduits
US4658817A (en) * 1985-04-01 1987-04-21 Children's Hospital Medical Center Method and apparatus for transmyocardial revascularization using a laser
US4892098A (en) * 1985-06-26 1990-01-09 Sauer Jude S Tubular tissue welding device without moving parts
US4750902A (en) 1985-08-28 1988-06-14 Sonomed Technology, Inc. Endoscopic ultrasonic aspirators
JPH0824678B2 (en) 1985-11-02 1996-03-13 株式会社東芝 The ultrasonic diagnostic apparatus
JPS62108175A (en) * 1985-11-06 1987-05-19 Mitsubishi Electric Corp Radar equipment
US4807634A (en) 1986-02-04 1989-02-28 Kabushiki Kaisha Toshiba Mechanical type ultrasonic scanner
US5002058A (en) 1986-04-25 1991-03-26 Intra-Sonix, Inc. Ultrasonic transducer
US4771788A (en) 1986-07-18 1988-09-20 Pfizer Hospital Products Group, Inc. Doppler tip wire guide
US4757821A (en) 1986-11-12 1988-07-19 Corazonix Corporation Omnidirectional ultrasonic probe
US4808153A (en) * 1986-11-17 1989-02-28 Ultramed Corporation Device for removing plaque from arteries
US4967753A (en) 1987-04-10 1990-11-06 Cardiometrics, Inc. Apparatus, system and method for measuring spatial average velocity and/or volumetric flow of blood in a vessel
EP0286359A3 (en) * 1987-04-10 1991-12-11 Cardiometrics, Inc. Apparatus, system and method for measuring volumetric flow of blood in a vessel
US4802476A (en) 1987-06-01 1989-02-07 Everest Medical Corporation Electro-surgical instrument
US4917097A (en) 1987-10-27 1990-04-17 Endosonics Corporation Apparatus and method for imaging small cavities
GB2212267B (en) 1987-11-11 1992-07-29 Circulation Res Ltd Methods and apparatus for the examination and treatment of internal organs
US4870953A (en) 1987-11-13 1989-10-03 Donmicheal T Anthony Intravascular ultrasonic catheter/probe and method for treating intravascular blockage
US4977898A (en) 1988-02-25 1990-12-18 Hoffrel Instruments, Inc. Miniaturized encapsulated ultrasonic transducer
US4834102A (en) 1988-02-25 1989-05-30 Jack Schwarzchild Endoscope for transesophageal echocardiography
US5368035A (en) 1988-03-21 1994-11-29 Boston Scientific Corporation Ultrasound imaging guidewire
JPH01310648A (en) 1988-06-08 1989-12-14 Toshiba Corp Ultrasonic blood circulation imaging device
US4966162A (en) * 1989-01-25 1990-10-30 Wang Ko P Flexible encoscope assembly
JP2754493B2 (en) 1989-05-20 1998-05-20 富士通株式会社 Blood flow visualization system
US4991602A (en) * 1989-06-27 1991-02-12 Flexmedics Corporation Flexible guide wire with safety tip
US6344053B1 (en) * 1993-12-22 2002-02-05 Medtronic Ave, Inc. Endovascular support device and method
US5240003A (en) 1989-10-16 1993-08-31 Du-Med B.V. Ultrasonic instrument with a micro motor having stator coils on a flexible circuit board
GB8928533D0 (en) * 1989-12-18 1990-02-21 Aindow Joseph Ultrasonic instrument
JP2791165B2 (en) 1990-02-07 1998-08-27 株式会社東芝 Intravascular ultrasound probe
US5148809A (en) 1990-02-28 1992-09-22 Asgard Medical Systems, Inc. Method and apparatus for detecting blood vessels and displaying an enhanced video image from an ultrasound scan
NL9001755A (en) 1990-08-02 1992-03-02 Optische Ind De Oude Delft Nv Endoscopic scanning device.
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5282799A (en) * 1990-08-24 1994-02-01 Everest Medical Corporation Bipolar electrosurgical scalpel with paired loop electrodes
DE69118083T2 (en) * 1990-10-09 1996-08-22 Cook Inc Percutaneous stent assembly
US5190528A (en) * 1990-10-19 1993-03-02 Boston University Percutaneous transseptal left atrial cannulation system
US5389096A (en) * 1990-12-18 1995-02-14 Advanced Cardiovascular Systems System and method for percutaneous myocardial revascularization
US5380316A (en) * 1990-12-18 1995-01-10 Advanced Cardiovascular Systems, Inc. Method for intra-operative myocardial device revascularization
US5201316A (en) 1991-03-18 1993-04-13 Cardiovascular Imaging Systems, Inc. Guide wire receptacle for catheters having rigid housings
US5377682A (en) * 1991-09-05 1995-01-03 Matsushita Electric Industrial Co., Ltd. Ultrasonic probe for transmission and reception of ultrasonic wave and ultrasonic diagnostic apparatus including ultrasonic probe
US5683366A (en) * 1992-01-07 1997-11-04 Arthrocare Corporation System and method for electrosurgical tissue canalization
US5704361A (en) * 1991-11-08 1998-01-06 Mayo Foundation For Medical Education And Research Volumetric image ultrasound transducer underfluid catheter system
GB2263974B (en) 1992-01-30 1995-11-08 Intravascular Res Ltd Ultrasound imaging and catheters for use therein
JP2727536B2 (en) 1992-02-20 1998-03-11 富士写真光機株式会社 Body-cavity diagnostic equipment
US5313950A (en) 1992-02-25 1994-05-24 Fujitsu Limited Ultrasonic probe
US5226421A (en) * 1992-03-06 1993-07-13 Cardiometrics, Inc. Doppler elongate flexible member having an inflatable balloon mounted thereon
US5178635A (en) * 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5339289A (en) 1992-06-08 1994-08-16 Erickson Jon W Acoustic and ultrasound sensor with optical amplification
WO1994002077A3 (en) * 1992-07-15 1994-04-14 Angelase Inc Ablation catheter system
US5370675A (en) 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US5383460A (en) 1992-10-05 1995-01-24 Cardiovascular Imaging Systems, Inc. Method and apparatus for ultrasound imaging and atherectomy
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
DE4236210C1 (en) * 1992-10-27 1994-04-14 Olympus Optical Europ A tubular implant for use in percutaneous food intake
US5287861A (en) * 1992-10-30 1994-02-22 Wilk Peter J Coronary artery by-pass method and associated catheter
US5409019A (en) * 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5275166A (en) 1992-11-16 1994-01-04 Ethicon, Inc. Method and apparatus for performing ultrasonic assisted surgical procedures
FR2699809B1 (en) * 1992-12-28 1995-02-17 Celsa Lg Device which can selectively form a temporary blood filter.
JPH06285106A (en) 1993-03-30 1994-10-11 Shimadzu Corp Ultrasonic therapeutic device
US5334210A (en) * 1993-04-09 1994-08-02 Cook Incorporated Vascular occlusion assembly
WO1994027501A1 (en) 1993-05-24 1994-12-08 Boston Scientific Corporation Medical acoustic imaging catheter and guidewire
US5309915A (en) 1993-06-07 1994-05-10 Mte, Inc. Apparatus for locating veins and arteries
US5385148A (en) 1993-07-30 1995-01-31 The Regents Of The University Of California Cardiac imaging and ablation catheter
US5484416A (en) * 1993-08-05 1996-01-16 Advanced Cardiovascular Systems, Inc. Coaxial cable vascular access system for use in various needles
WO1995005212A3 (en) * 1993-08-11 1995-03-30 Electro Catheter Corp Improved ablation electrode
US5505088A (en) 1993-08-27 1996-04-09 Stellartech Research Corp. Ultrasound microscope for imaging living tissues
US5855598A (en) * 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
US5474075A (en) 1993-11-24 1995-12-12 Thomas Jefferson University Brush-tipped catheter for ultrasound imaging
US5427107A (en) 1993-12-07 1995-06-27 Devices For Vascular Intervention, Inc. Optical encoder for catheter device
US5458120A (en) 1993-12-08 1995-10-17 General Electric Company Ultrasonic transducer with magnetostrictive lens for dynamically focussing and steering a beam of ultrasound energy
JPH07171150A (en) 1993-12-20 1995-07-11 Fuji Photo Optical Co Ltd Internally inserting type ultrasonic inspecting device
JPH07184898A (en) 1993-12-28 1995-07-25 Olympus Optical Co Ltd Ultrasound probe
US5409012A (en) * 1993-12-30 1995-04-25 Boston Scientific Corporation Sample collection using catheter with expandable member
US5582167A (en) * 1994-03-02 1996-12-10 Thomas Jefferson University Methods and apparatus for reducing tracheal infection using subglottic irrigation, drainage and servoregulation of endotracheal tube cuff pressure
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5435314A (en) 1994-03-25 1995-07-25 Hewlett Packard Company Intravascular imaging catheter tip having a dynamic radius
JPH07265329A (en) * 1994-03-31 1995-10-17 Fuji Photo Optical Co Ltd Puncture high frequency treatment device
EP0688545B1 (en) * 1994-06-17 2002-09-18 Terumo Kabushiki Kaisha Method for manufacturing an indwelling stent
US6694163B1 (en) * 1994-10-27 2004-02-17 Wake Forest University Health Sciences Method and system for producing interactive, three-dimensional renderings of selected body organs having hollow lumens to enable simulated movement through the lumen
US5782762A (en) * 1994-10-27 1998-07-21 Wake Forest University Method and system for producing interactive, three-dimensional renderings of selected body organs having hollow lumens to enable simulated movement through the lumen
US6013093A (en) * 1995-11-28 2000-01-11 Boston Scientific Corporation Blood clot filtering
EP0794732A4 (en) 1994-11-30 1999-11-24 Boston Scient Corp Acoustic imaging and doppler catheters and guidewires
US6030392A (en) * 1995-01-18 2000-02-29 Motorola, Inc. Connector for hollow anatomical structures and methods of use
FR2729845B1 (en) 1995-02-01 1997-07-25 Centre Nat Rech Scient Imaging Catheter echographic endocardial
JP3406106B2 (en) 1995-02-06 2003-05-12 ジーイー横河メディカルシステム株式会社 Ultrasonic image display method and ultrasonic diagnostic apparatus
US5485841A (en) 1995-02-14 1996-01-23 Univ Mcgill Ultrasonic lung tissue assessment
DE19506484C2 (en) 1995-02-24 1999-09-16 Stiftung Fuer Lasertechnologie Method and apparatus for the selective non-invasive Lasermyographie (LMG)
WO1996032907A1 (en) * 1995-04-19 1996-10-24 Schneider (Usa) Inc. Drug release coated stent
US5593442A (en) * 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5673695A (en) * 1995-08-02 1997-10-07 Ep Technologies, Inc. Methods for locating and ablating accessory pathways in the heart
US6176872B1 (en) * 1995-08-15 2001-01-23 Ethicon, Inc. Radial strength stent
US5555886A (en) 1995-09-28 1996-09-17 Siemens Medical Systems, Inc. Apparatus and method for detecting blood vessel size and direction for doppler flow measurement system
US5935135A (en) * 1995-09-29 1999-08-10 United States Surgical Corporation Balloon delivery system for deploying stents
WO1998016161A1 (en) * 1996-10-11 1998-04-23 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
EP0954248B1 (en) 1995-10-13 2004-09-15 Transvascular, Inc. Apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6283983B1 (en) 1995-10-13 2001-09-04 Transvascular, Inc. Percutaneous in-situ coronary bypass method and apparatus
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US5591195A (en) * 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
US5979453A (en) * 1995-11-09 1999-11-09 Femrx, Inc. Needle myolysis system for uterine fibriods
US5593417A (en) * 1995-11-27 1997-01-14 Rhodes; Valentine J. Intravascular stent with secure mounting means
US5725547A (en) * 1996-01-04 1998-03-10 Chuter; Timothy A. M. Corrugated stent
US5779642A (en) * 1996-01-16 1998-07-14 Nightengale; Christopher Interrogation device and method
US6139527A (en) 1996-03-05 2000-10-31 Vnus Medical Technologies, Inc. Method and apparatus for treating hemorrhoids
US5853422A (en) * 1996-03-22 1998-12-29 Scimed Life Systems, Inc. Apparatus and method for closing a septal defect
US5678555A (en) 1996-04-08 1997-10-21 O'connell; Peter Method of locating and marking veins
US5741234A (en) * 1996-07-16 1998-04-21 Aboul-Hosn; Walid Nagib Anatomical cavity access sealing condit
US6045532A (en) * 1998-02-20 2000-04-04 Arthrocare Corporation Systems and methods for electrosurgical treatment of tissue in the brain and spinal cord
US5682880A (en) * 1996-07-26 1997-11-04 Brain; Archibald Ian Jeremy Laryngeal-mask airway with guide element, stiffener, and fiberoptic access
US6343936B1 (en) * 1996-09-16 2002-02-05 The Research Foundation Of State University Of New York System and method for performing a three-dimensional virtual examination, navigation and visualization
US5868763A (en) * 1996-09-16 1999-02-09 Guidant Corporation Means and methods for performing an anastomosis
US5868781A (en) * 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US5752518A (en) 1996-10-28 1998-05-19 Ep Technologies, Inc. Systems and methods for visualizing interior regions of the body
US6091995A (en) * 1996-11-08 2000-07-18 Surx, Inc. Devices, methods, and systems for shrinking tissues
US6495579B1 (en) * 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US5810008A (en) 1996-12-03 1998-09-22 Isg Technologies Inc. Apparatus and method for visualizing ultrasonic images
US5736642A (en) * 1997-01-08 1998-04-07 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Nonlinear ultrasonic scanning to detect material defects
US5846205A (en) 1997-01-31 1998-12-08 Acuson Corporation Catheter-mounted, phased-array ultrasound transducer with improved imaging
US5720735A (en) * 1997-02-12 1998-02-24 Dorros; Gerald Bifurcated endovascular catheter
US5876345A (en) 1997-02-27 1999-03-02 Acuson Corporation Ultrasonic catheter, system and method for two dimensional imaging or three-dimensional reconstruction
US6346940B1 (en) * 1997-02-27 2002-02-12 Kabushiki Kaisha Toshiba Virtualized endoscope system
US6013954A (en) * 1997-03-31 2000-01-11 Nec Corporation Semiconductor wafer having distortion-free alignment regions
US6488673B1 (en) * 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US6283988B1 (en) * 1997-04-07 2001-09-04 Broncus Technologies, Inc. Bronchial stenter having expandable electrodes
US6634363B1 (en) * 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US6273907B1 (en) * 1997-04-07 2001-08-14 Broncus Technologies, Inc. Bronchial stenter
WO1998046258A3 (en) * 1997-04-11 1999-03-11 Beth Israel Hospital Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
US6120432A (en) * 1997-04-23 2000-09-19 Vascular Science Inc. Medical grafting methods and apparatus
EP1011532B1 (en) * 1997-04-23 2014-05-07 Ethicon Endo-Surgery, Inc. Bifurcated stent and distal protection system
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5957919A (en) * 1997-07-02 1999-09-28 Laufer; Michael D. Bleb reducer
US6514249B1 (en) * 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US5984871A (en) 1997-08-12 1999-11-16 Boston Scientific Technologies, Inc. Ultrasound transducer with extended focus
JPH1189843A (en) 1997-09-22 1999-04-06 Fuji Photo Optical Co Ltd Ultrasonograph to be inserted in manner of via-endoscope
US6181348B1 (en) * 1997-09-22 2001-01-30 Siemens Corporate Research, Inc. Method for selective volume visualization via texture mapping
US6074416A (en) * 1997-10-09 2000-06-13 St. Jude Medical Cardiovascular Group, Inc. Wire connector structures for tubular grafts
US5935108A (en) * 1997-11-14 1999-08-10 Reflow, Inc. Recanalization apparatus and devices for use therein and method
US5876344A (en) 1997-12-09 1999-03-02 Endosonics Corporation Modular imaging/treatment catheter assembly and method
US6342591B1 (en) * 1998-09-22 2002-01-29 Biosurface Engineering Technologies, Inc. Amphipathic coating for modulating cellular adhesion composition and methods
US6048362A (en) * 1998-01-12 2000-04-11 St. Jude Medical Cardiovascular Group, Inc. Fluoroscopically-visible flexible graft structures
US6994713B2 (en) * 1998-01-30 2006-02-07 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
EP1054952A1 (en) * 1998-02-20 2000-11-29 PHARMACIA & UPJOHN S.p.A. Paclitaxel production by actinomycetes
CA2265136C (en) * 1998-03-13 2008-09-09 Juan Carlos Parodi Endovascular device for application of prostheses with sutures
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6019789A (en) * 1998-04-01 2000-02-01 Quanam Medical Corporation Expandable unit cell and intraluminal stent
US6003517A (en) 1998-04-30 1999-12-21 Ethicon Endo-Surgery, Inc. Method for using an electrosurgical device on lung tissue
US6168621B1 (en) * 1998-05-29 2001-01-02 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6174323B1 (en) * 1998-06-05 2001-01-16 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6599311B1 (en) * 1998-06-05 2003-07-29 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6997189B2 (en) * 1998-06-05 2006-02-14 Broncus Technologies, Inc. Method for lung volume reduction
US5967990A (en) 1998-08-13 1999-10-19 President And Fellows Of Harvard College Surgical probe comprising visible markings on an elastic membrane
US6059731A (en) 1998-08-19 2000-05-09 Mayo Foundation For Medical Education And Research Simultaneous side-and-end viewing underfluid catheter
US6335029B1 (en) * 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6516213B1 (en) * 1999-09-03 2003-02-04 Robin Medical, Inc. Method and apparatus to estimate location and orientation of objects during magnetic resonance imaging
JP2000107178A (en) 1998-09-30 2000-04-18 Olympus Optical Co Ltd Ultrasonic-guided paracentesis system
US6113612A (en) * 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6152937A (en) * 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
US6206831B1 (en) * 1999-01-06 2001-03-27 Scimed Life Systems, Inc. Ultrasound-guided ablation catheter and methods of use
WO2000053104A8 (en) * 1999-03-09 2001-01-25 St Jude Medical Cardiovascular Medical grafting methods and apparatus
US6015415A (en) * 1999-03-09 2000-01-18 General Science And Technology Polypectomy snare instrument
US6695859B1 (en) * 1999-04-05 2004-02-24 Coalescent Surgical, Inc. Apparatus and methods for anastomosis
US6394093B1 (en) * 1999-05-13 2002-05-28 Scott Lethi Nasopharyngeal airway with inflatable cuff
US6428550B1 (en) * 1999-05-18 2002-08-06 Cardica, Inc. Sutureless closure and deployment system for connecting blood vessels
US20050060044A1 (en) * 1999-08-05 2005-03-17 Ed Roschak Methods and devices for maintaining patency of surgically created channels in a body organ
US7022088B2 (en) * 1999-08-05 2006-04-04 Broncus Technologies, Inc. Devices for applying energy to tissue
US6712812B2 (en) * 1999-08-05 2004-03-30 Broncus Technologies, Inc. Devices for creating collateral channels
US20050060042A1 (en) * 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US7815590B2 (en) * 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US7708712B2 (en) * 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20050060041A1 (en) * 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
JP2003506132A (en) * 1999-08-05 2003-02-18 ブロンカス テクノロジーズ, インコーポレイテッド Method and device for producing a collateral channel in the lungs
US7462162B2 (en) * 2001-09-04 2008-12-09 Broncus Technologies, Inc. Antiproliferative devices for maintaining patency of surgically created channels in a body organ
US6749606B2 (en) * 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
US6996430B1 (en) * 1999-08-16 2006-02-07 Super Dimension Ltd Method and system for displaying cross-sectional images of a body
US6231561B1 (en) * 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
JP4363719B2 (en) 1999-10-08 2009-11-11 オリンパス株式会社 Ultrasonically guided puncturing system unit
EP1095628A3 (en) * 1999-10-29 2001-05-16 Marconi Medical Systems, Inc. Planning minimally invasive procedures for in - vivo placement of objects
US7798147B2 (en) * 2001-03-02 2010-09-21 Pulmonx Corporation Bronchial flow control devices with membrane seal
US6514290B1 (en) * 2000-03-31 2003-02-04 Broncus Technologies, Inc. Lung elastic recoil restoring or tissue compressing device and method
WO2001087169A9 (en) * 2000-05-16 2010-12-02 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6506408B1 (en) * 2000-07-13 2003-01-14 Scimed Life Systems, Inc. Implantable or insertable therapeutic agent delivery device
EP1318766A2 (en) * 2000-09-21 2003-06-18 Atritech, Inc. Apparatus for implanting devices in atrial appendages
US7175644B2 (en) * 2001-02-14 2007-02-13 Broncus Technologies, Inc. Devices and methods for maintaining collateral channels in tissue
JP2004528031A (en) * 2001-03-14 2004-09-16 セントカー・インコーポレーテツド Chronic obstructive pulmonary disease-associated immunoglobulin derived protein, compositions, methods and uses
US6712845B2 (en) * 2001-04-24 2004-03-30 Advanced Cardiovascular Systems, Inc. Coating for a stent and a method of forming the same
US6852111B1 (en) * 2002-04-11 2005-02-08 David Lieber Laparoscopic electrotome
US20050016530A1 (en) * 2003-07-09 2005-01-27 Mccutcheon John Treatment planning with implantable bronchial isolation devices
US20060200041A1 (en) * 2005-03-04 2006-09-07 Ethicon Endo-Surgery, Inc. Biopsy device incorporating an adjustable probe sleeve
US9204819B2 (en) * 2005-05-06 2015-12-08 Vasonova, Inc. Endovenous access and guidance system utilizing non-image based ultrasound
US20070010438A1 (en) * 2005-07-08 2007-01-11 Mayo Kevin H Tumor treatment using beta-sheet peptides and radiotherapy
US7517320B2 (en) * 2006-06-30 2009-04-14 Broncus Technologies, Inc. Airway bypass site selection and treatment planning

Patent Citations (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127903A (en) * 1936-05-05 1938-08-23 Davis & Geck Inc Tube for surgical purposes and method of preparing and using the same
US4534761A (en) * 1981-08-14 1985-08-13 Bentley Laboratories, Inc. Implant device
US4582067A (en) * 1983-02-14 1986-04-15 Washington Research Foundation Method for endoscopic blood flow detection by the use of ultrasonic energy
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4773413A (en) * 1983-06-13 1988-09-27 Trimedyne Laser Systems, Inc. Localized heat applying medical device
US4583969A (en) * 1984-06-26 1986-04-22 Mortensen J D Apparatus and method for in vivo extrapulmonary blood gas exchange
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US4753236A (en) * 1986-04-08 1988-06-28 Healey Maureen A Temporary anastomotic device
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US4769031A (en) * 1986-06-25 1988-09-06 Mcgough Edwin C Ventricular access device and method
US4887606A (en) * 1986-09-18 1989-12-19 Yock Paul G Apparatus for use in cannulation of blood vessels
US4957508A (en) * 1986-10-31 1990-09-18 Ube Industries, Ltd. Medical tubes
US5174295A (en) * 1987-04-10 1992-12-29 Cardiometrics, Inc. Apparatus, system and method for measuring spatial average velocity and/or volumetric flow of blood in a vessel and screw joint for use therewith
US4795465A (en) * 1987-05-14 1989-01-03 Hood Laboratories Tracheobronchial stent
US4899757A (en) * 1988-02-22 1990-02-13 Intertherapy, Inc. Ultrasound imaging probe with zero dead space
US6572553B2 (en) * 1988-03-21 2003-06-03 Scimed Life Systems, Inc. Medical imaging device
US5054483A (en) * 1989-03-06 1991-10-08 Hood Laboratories Tracheal cannulas and stents
US5425739A (en) * 1989-03-09 1995-06-20 Avatar Design And Development, Inc. Anastomosis stent and stent selection system
US5127917A (en) * 1989-06-01 1992-07-07 Schneider (Europe) A.G. Probe, especially for the recanalization of occlusions, and catheter arrangement with such a probe
US5030201A (en) * 1989-11-24 1991-07-09 Aubrey Palestrant Expandable atherectomy catheter device
US5413601A (en) * 1990-03-26 1995-05-09 Keshelava; Viktor V. Tubular organ prosthesis
US5238027A (en) * 1990-06-06 1993-08-24 Asten Group, Inc. Papermakers fabric with orthogonal machine direction yarn seaming loops
US5064435A (en) * 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5344420A (en) * 1991-02-13 1994-09-06 Applied Medical Resources Corporation Surgical trocar
US5261409A (en) * 1991-05-27 1993-11-16 Sulzer Brothers Limited Puncturing device for blood vessels
US5795325A (en) * 1991-07-16 1998-08-18 Heartport, Inc. Methods and apparatus for anchoring an occluding member
US5540713A (en) * 1991-10-11 1996-07-30 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5351693A (en) * 1991-11-08 1994-10-04 Baxter International Inc. Ultrasound probe for use with transport catheter and method of making same
US5571180A (en) * 1992-01-10 1996-11-05 Hansa Medical Products, Inc. Tool for loading flexible flange into retainer
US5257990A (en) * 1992-02-24 1993-11-02 Kensey Nash Corporation Electrosurgical catheter instrument with impacting working head and method of use
US6019787A (en) * 1992-03-12 2000-02-01 Laboratoire Perouse Implant Fitting tool for use of an expansible endoprosthesis for a human or animal tubular organ
US5755769A (en) * 1992-03-12 1998-05-26 Laboratoire Perouse Implant Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof
US5876448A (en) * 1992-05-08 1999-03-02 Schneider (Usa) Inc. Esophageal stent
US5295484A (en) * 1992-05-19 1994-03-22 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Apparatus and method for intra-cardiac ablation of arrhythmias
US5759769A (en) * 1993-06-09 1998-06-02 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides
US5520684A (en) * 1993-06-10 1996-05-28 Imran; Mir A. Transurethral radio frequency apparatus for ablation of the prostate gland and method
US5618301A (en) * 1993-10-07 1997-04-08 Angiomed Ag Reducing stent, device with reducing stent and use of a reducing stent
US5381795A (en) * 1993-11-19 1995-01-17 Advanced Technology Laboratories, Inc. Intraoperative ultrasound probe
US5607444A (en) * 1993-12-02 1997-03-04 Advanced Cardiovascular Systems, Inc. Ostial stent for bifurcations
US6007574A (en) * 1993-12-28 1999-12-28 Pulnev; Sergei Appolonovich Stent
US5466242A (en) * 1994-02-02 1995-11-14 Mori; Katsushi Stent for biliary, urinary or vascular system
US5653746A (en) * 1994-03-08 1997-08-05 Meadox Medicals, Inc. Radially expandable tubular prosthesis
US5840431A (en) * 1994-04-14 1998-11-24 Fritz Borsi Kg Method for preferably region-by-region coating of a transparent carrier plate
US5716393A (en) * 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5672172A (en) * 1994-06-23 1997-09-30 Vros Corporation Surgical instrument with ultrasound pulse generator
US5454373A (en) * 1994-07-20 1995-10-03 Boston Scientific Corporation Medical acoustic imaging
US5545195A (en) * 1994-08-01 1996-08-13 Boston Scientific Corporation Interstitial heating of tissue
US5527324A (en) * 1994-09-07 1996-06-18 Krantz; Kermit E. Surgical stent
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5674298A (en) * 1994-10-21 1997-10-07 The Board Of Regents Of The University Of Michigan Calcification-resistant bioprosthetic tissue and methods of making same
US5968070A (en) * 1995-02-22 1999-10-19 Cordis Corporation Covered expanding mesh stent
US5647871A (en) * 1995-03-10 1997-07-15 Microsurge, Inc. Electrosurgery with cooled electrodes
US5849037A (en) * 1995-04-12 1998-12-15 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body, and method for its preparation
US5741333A (en) * 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5658280A (en) * 1995-05-22 1997-08-19 Issa; Muta M. Resectoscope electrode assembly with simultaneous cutting and coagulation
US6004319A (en) * 1995-06-23 1999-12-21 Gyrus Medical Limited Electrosurgical instrument
US6143019A (en) * 1995-08-22 2000-11-07 Board Of Regents, The University Of Texas System Method for emitting therapeutic energy within tissue
US5922019A (en) * 1995-11-27 1999-07-13 Schneider (Europe) A.G. Conical stent
US5810836A (en) * 1996-03-04 1998-09-22 Myocardial Stents, Inc. Device and method for trans myocardial revascularization (TMR)
US6096053A (en) * 1996-05-03 2000-08-01 Scimed Life Systems, Inc. Medical retrieval basket
US5797920A (en) * 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US6007544A (en) * 1996-06-14 1999-12-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US5713949A (en) * 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5993484A (en) * 1996-10-23 1999-11-30 United States Surgical Apparatus and method for dilatation of a body lumen and delivery of a prosthesis therein
US5968053A (en) * 1997-01-31 1999-10-19 Cardiac Assist Technologies, Inc. Method and apparatus for implanting a graft in a vessel of a patient
US6024703A (en) * 1997-05-07 2000-02-15 Eclipse Surgical Technologies, Inc. Ultrasound device for axial ranging
US5957849A (en) * 1997-06-30 1999-09-28 The Regents Of The University Of California Endoluminal ultrasound-guided resectoscope
US5876434A (en) * 1997-07-13 1999-03-02 Litana Ltd. Implantable medical devices of shape memory alloy
US5951567A (en) * 1997-07-24 1999-09-14 Cardiogenesis Corporation Introducer for channel forming device
US6011995A (en) * 1997-12-29 2000-01-04 The Regents Of The University Of California Endovascular device for hyperthermia and angioplasty and method for using the same
US6015405A (en) * 1998-01-20 2000-01-18 Tricardia, L.L.C. Device for forming holes in tissue
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6309375B1 (en) * 1998-05-16 2001-10-30 Microheart, Inc. Drug delivery module
US6183444B1 (en) * 1998-05-16 2001-02-06 Microheart, Inc. Drug delivery module
US6112123A (en) * 1998-07-28 2000-08-29 Endonetics, Inc. Device and method for ablation of tissue
US6287290B1 (en) * 1999-07-02 2001-09-11 Pulmonx Methods, systems, and kits for lung volume reduction
US6258100B1 (en) * 1999-08-24 2001-07-10 Spiration, Inc. Method of reducing lung size
US6293951B1 (en) * 1999-08-24 2001-09-25 Spiration, Inc. Lung reduction device, system, and method
US6328689B1 (en) * 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method

Cited By (189)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020138074A1 (en) * 1999-08-05 2002-09-26 Thomas Keast Devices for applying energy to tissue
US20030070676A1 (en) * 1999-08-05 2003-04-17 Cooper Joel D. Conduits having distal cage structure for maintaining collateral channels in tissue and related methods
US20060142672A1 (en) * 1999-08-05 2006-06-29 Broncus Technologies, Inc. Devices for applying energy to tissue
US6749606B2 (en) 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
US20050096529A1 (en) * 1999-08-05 2005-05-05 Broncus Technologies, Inc. Methods for treating chronic obstructive pulmonary disease
US20050049615A1 (en) * 1999-08-05 2005-03-03 Broncus Technologies, Inc. Methods for treating chronic obstructive pulmonary disease
US8506648B2 (en) 1999-08-05 2013-08-13 Broncus Medical Inc. Extrapleural airway device and method
US20080302359A1 (en) * 1999-08-05 2008-12-11 Broncus Technologies, Inc. Extrapleural airway device and method
US6743259B2 (en) * 2001-08-03 2004-06-01 Core Medical, Inc. Lung assist apparatus and methods for use
US7708712B2 (en) 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US9999442B2 (en) * 2001-12-08 2018-06-19 Trans Cardiac Therapeutics, Inc. Methods for accessing a left ventricle
US20130253641A1 (en) * 2001-12-08 2013-09-26 Trans Cardiac Therapeutics, Inc. Methods for accessing a left ventricle
US7422584B2 (en) 2002-07-05 2008-09-09 Broncus Technologies, Inc. Extrapleural airway device and method
US20040211434A1 (en) * 2002-07-05 2004-10-28 Broncus Technologies, Inc. Extrapleural airway device and method
US20040243122A1 (en) * 2003-02-13 2004-12-02 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
US20080312646A9 (en) * 2003-02-13 2008-12-18 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
US8021359B2 (en) 2003-02-13 2011-09-20 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
US20080009859A1 (en) * 2003-02-13 2008-01-10 Coaptus Medical Corporation Transseptal left atrial access and septal closure
US20060122680A1 (en) * 2003-02-13 2006-06-08 Auth David C Systems and methods for securing cardiovascular tissue
US8052677B2 (en) * 2003-02-13 2011-11-08 Coaptus Medical Corporation Transseptal left atrial access and septal closure
US20070203479A1 (en) * 2003-02-13 2007-08-30 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
US8029492B2 (en) 2003-05-07 2011-10-04 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US7828789B2 (en) 2003-05-07 2010-11-09 Portaero, Inc. Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US20080188809A1 (en) * 2003-05-07 2008-08-07 Portaero, Inc. Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US8172827B2 (en) 2003-05-13 2012-05-08 Innovative Pulmonary Solutions, Inc. Apparatus for treating asthma using neurotoxin
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US7789083B2 (en) 2003-05-20 2010-09-07 Portaero, Inc. Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US7896008B2 (en) 2003-06-03 2011-03-01 Portaero, Inc. Lung reduction system
US7377278B2 (en) * 2003-06-05 2008-05-27 Portaero, Inc. Intra-thoracic collateral ventilation bypass system and method
US20040244803A1 (en) * 2003-06-05 2004-12-09 Don Tanaka Intra-thoracic collateral ventilation bypass system
US7753052B2 (en) 2003-06-05 2010-07-13 Portaero, Inc. Intra-thoracic collateral ventilation bypass system
US20050016530A1 (en) * 2003-07-09 2005-01-27 Mccutcheon John Treatment planning with implantable bronchial isolation devices
US8323230B2 (en) 2003-07-15 2012-12-04 Portaero, Inc. Methods and devices to accelerate wound healing in thoracic anastomosis applications
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
US20100129420A1 (en) * 2003-07-15 2010-05-27 Portaero, Inc. Methods and devices to accelerate wound healing in thoracic anastomosis applications
US20050025816A1 (en) * 2003-07-15 2005-02-03 Don Tanaka Methods and devices to accelerate wound healing in thoracic anastomosis applications
US9533128B2 (en) 2003-07-18 2017-01-03 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
US7775968B2 (en) 2004-06-14 2010-08-17 Pneumrx, Inc. Guided access to lung tissues
US20050288549A1 (en) * 2004-06-14 2005-12-29 Pneumrx, Inc. Guided access to lung tissues
US20050288684A1 (en) * 2004-06-16 2005-12-29 Aronson Nathan A Method of reducing collateral flow in a portion of a lung
US20060009748A1 (en) * 2004-06-16 2006-01-12 Mathis Mark L Method of compressing a portion of a lung
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US7766938B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Pleural effusion treatment device, method and material
US20060025815A1 (en) * 2004-07-08 2006-02-02 Mcgurk Erin Lung device with sealing features
US20060009801A1 (en) * 2004-07-08 2006-01-12 Mcgurk Erin Pleural effusion treatment device, method and material
US20140323951A1 (en) * 2004-07-19 2014-10-30 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
US8784400B2 (en) 2004-07-19 2014-07-22 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
US8608724B2 (en) 2004-07-19 2013-12-17 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
US20060079870A1 (en) * 2004-10-07 2006-04-13 Barry Robert L Systems and methods for shrinking and/or securing cardiovascular tissue
US20160066990A1 (en) * 2004-11-05 2016-03-10 Asthmatx, Inc. Energy delivery devices and methods
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US20060118126A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Methods and devices for controlling collateral ventilation
US20060118125A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Pulmonary drug delivery
US9125639B2 (en) 2004-11-23 2015-09-08 Pneumrx, Inc. Steerable device for accessing a target site and methods
US20060167416A1 (en) * 2004-11-23 2006-07-27 Mark Mathis Steerable device for accessing a target site and methods
US10034999B2 (en) 2004-11-23 2018-07-31 Pneumrx, Inc. Steerable device for accessing a target site and methods
US20060124126A1 (en) * 2004-12-10 2006-06-15 Don Tanaka Collateral ventilation device with chest tube/evacuation features
US7824366B2 (en) 2004-12-10 2010-11-02 Portaero, Inc. Collateral ventilation device with chest tube/evacuation features and method
US8104474B2 (en) 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
US20070100324A1 (en) * 2005-10-17 2007-05-03 Coaptus Medical Corporation Systems and methods for applying vacuum to a patient, including via a disposable liquid collection unit
US20070106214A1 (en) * 2005-10-17 2007-05-10 Coaptus Medical Corporation Systems and methods for securing cardiovascular tissue, including via asymmetric inflatable members
US20070123824A1 (en) * 2005-10-17 2007-05-31 Coaptus Medical Corporation Systems and methods for directing valves that control a vacuum applied to a patient
US20070093804A1 (en) * 2005-10-17 2007-04-26 Coaptus Medical Corporation Control systems for patient devices, including devices for securing cardiovascular tissue, and associated methods
US20070093805A1 (en) * 2005-10-17 2007-04-26 Coaptus Medical Corporation Systems and methods for securing cardiovascular tissue, including via asymmetric electrodes
US7704248B2 (en) 2005-12-21 2010-04-27 Boston Scientific Scimed, Inc. Ablation device with compression balloon
US7959631B2 (en) 2005-12-21 2011-06-14 Boston Scientific Scimed, Inc. Ablation device with compression balloon
US20070265600A1 (en) * 2006-01-13 2007-11-15 Olympus Medical Systems Corporation Retainer for medical use and the method using the same
US8540621B2 (en) 2006-01-13 2013-09-24 Olympus Medical Systems Corp. Medical retainer and medical operation using the same
US7726305B2 (en) 2006-01-17 2010-06-01 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve
US7406963B2 (en) * 2006-01-17 2008-08-05 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve and method
US20070163598A1 (en) * 2006-01-17 2007-07-19 Asia Chang Variable resistance pulmonary ventilation bypass valve
US7686013B2 (en) 2006-01-17 2010-03-30 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8282660B2 (en) 2006-03-13 2012-10-09 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9402971B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US8932310B2 (en) 2006-03-13 2015-01-13 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9782558B2 (en) 2006-03-13 2017-10-10 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8668707B2 (en) 2006-03-13 2014-03-11 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US20090076622A1 (en) * 2006-03-13 2009-03-19 Pneumrx, Inc. Delivery of Minimally Invasive Lung Volume Reduction Devices
US20070221230A1 (en) * 2006-03-13 2007-09-27 David Thompson Minimally invasive lung volume reduction device and method
US9402632B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8740921B2 (en) 2006-03-13 2014-06-03 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8142455B2 (en) 2006-03-13 2012-03-27 Pneumrx, Inc. Delivery of minimally invasive lung volume reduction devices
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US8157823B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9474533B2 (en) 2006-03-13 2016-10-25 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US20080208083A1 (en) * 2006-04-28 2008-08-28 Bryant Lin System and method to counter material deposition on devices in the urinary tract
US20080072914A1 (en) * 2006-08-25 2008-03-27 Hendricksen Michael J Bronchial Isolation Devices for Placement in Short Lumens
US9913969B2 (en) 2006-10-05 2018-03-13 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
US20080119840A1 (en) * 2006-11-21 2008-05-22 Vancelette David W Ridged Cryoprobe Tip
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080281433A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080283065A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung
US20100147295A1 (en) * 2007-05-15 2010-06-17 Portaero, Inc. Devices and methods to create and maintain the patency of an opening relative to parenchymal tissue of the lung
US20080287878A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Pulmonary visceral pleura anastomosis reinforcement
US8062315B2 (en) * 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US20080295829A1 (en) * 2007-05-30 2008-12-04 Portaero, Inc. Bridge element for lung implant
US8308763B2 (en) 2007-10-05 2012-11-13 Coaptus Medical Corporation Systems and methods for transeptal cardiac procedures, including separable guidewires
US20090093802A1 (en) * 2007-10-05 2009-04-09 Coaptus Medical Corporation Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Penetrating Members and Associted Methods
US20090118726A1 (en) * 2007-10-05 2009-05-07 Coaptus Medical Corporation Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Sealing Members Associated Methods
US8235986B2 (en) 2007-10-05 2012-08-07 Coaptus Medical Corporation Systems and methods for transeptal cardiac procedures, including tissue penetrating members and associated methods
US8489192B1 (en) 2008-02-15 2013-07-16 Holaira, Inc. System and method for bronchial dilation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US9125643B2 (en) 2008-02-15 2015-09-08 Holaira, Inc. System and method for bronchial dilation
US8731672B2 (en) 2008-02-15 2014-05-20 Holaira, Inc. System and method for bronchial dilation
US8430094B2 (en) 2008-02-19 2013-04-30 Portaero, Inc. Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8474449B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US20090209936A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Aspirator and method for pneumostoma management
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US8491602B2 (en) 2008-02-19 2013-07-23 Portaero, Inc. Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090205650A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8506577B2 (en) 2008-02-19 2013-08-13 Portaero, Inc. Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090205665A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Methods and devices for follow-up care and treatment of a pneumostoma
US20090205651A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205649A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090209856A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090209971A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8365722B2 (en) 2008-02-19 2013-02-05 Portaero, Inc. Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8348906B2 (en) 2008-02-19 2013-01-08 Portaero, Inc. Aspirator for pneumostoma management
US8347880B2 (en) 2008-02-19 2013-01-08 Potaero, Inc. Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US8464708B2 (en) 2008-02-19 2013-06-18 Portaero, Inc. Pneumostoma management system having a cosmetic and/or protective cover
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US7909803B2 (en) 2008-02-19 2011-03-22 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US7927324B2 (en) 2008-02-19 2011-04-19 Portaero, Inc. Aspirator and method for pneumostoma management
US8252003B2 (en) 2008-02-19 2012-08-28 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8021320B2 (en) 2008-02-19 2011-09-20 Portaero, Inc. Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
US8453637B2 (en) 2008-02-19 2013-06-04 Portaero, Inc. Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US20090205648A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US8453638B2 (en) 2008-02-19 2013-06-04 Portaero, Inc. One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8231581B2 (en) 2008-02-19 2012-07-31 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8808280B2 (en) 2008-05-09 2014-08-19 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8226638B2 (en) 2008-05-09 2012-07-24 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US9668809B2 (en) 2008-05-09 2017-06-06 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961507B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961508B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8821489B2 (en) 2008-05-09 2014-09-02 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US9173669B2 (en) 2008-09-12 2015-11-03 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US10058331B2 (en) 2008-09-12 2018-08-28 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US9192403B2 (en) 2008-09-12 2015-11-24 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US9649458B2 (en) 2008-09-30 2017-05-16 Covidien Lp Breathing assistance system with multiple pressure sensors
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US20100170507A1 (en) * 2009-01-08 2010-07-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8721734B2 (en) 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US9005195B2 (en) 2009-10-27 2015-04-14 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9931162B2 (en) 2009-10-27 2018-04-03 Nuvaira, Inc. Delivery devices with coolable energy emitting assemblies
US9017324B2 (en) 2009-10-27 2015-04-28 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8932289B2 (en) 2009-10-27 2015-01-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9675412B2 (en) 2009-10-27 2017-06-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8777943B2 (en) 2009-10-27 2014-07-15 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9649153B2 (en) 2009-10-27 2017-05-16 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9649154B2 (en) 2009-11-11 2017-05-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
WO2012038495A3 (en) * 2010-09-24 2012-05-18 St Jude Medical Systems Ab A valve unit and a device for sealing a puncture hole in a vessel wall
US9393133B2 (en) 2011-02-18 2016-07-19 Piolax Medical Devices, Inc. Abdominal cavity-vein shunt stent
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9421070B2 (en) 2011-05-13 2016-08-23 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
US9486229B2 (en) 2011-05-13 2016-11-08 Broncus Medical Inc. Methods and devices for excision of tissue
US8932316B2 (en) 2011-05-13 2015-01-13 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9993306B2 (en) 2011-05-13 2018-06-12 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9364624B2 (en) 2011-12-07 2016-06-14 Covidien Lp Methods and systems for adaptive base flow
US9498589B2 (en) 2011-12-31 2016-11-22 Covidien Lp Methods and systems for adaptive base flow and leak compensation
US8844526B2 (en) 2012-03-30 2014-09-30 Covidien Lp Methods and systems for triggering with unknown base flow
US10029057B2 (en) 2012-03-30 2018-07-24 Covidien Lp Methods and systems for triggering with unknown base flow
US9993296B2 (en) 2012-08-07 2018-06-12 Covidien Lp Microwave ablation catheter and method of utilizing the same
US9370398B2 (en) 2012-08-07 2016-06-21 Covidien Lp Microwave ablation catheter and method of utilizing the same
US9247993B2 (en) 2012-08-07 2016-02-02 Covidien, LP Microwave ablation catheter and method of utilizing the same
US9993295B2 (en) 2012-08-07 2018-06-12 Covidien Lp Microwave ablation catheter and method of utilizing the same
US9247992B2 (en) 2012-08-07 2016-02-02 Covidien, LP Microwave ablation catheter and method of utilizing the same
US9259269B2 (en) 2012-08-07 2016-02-16 Covidien Lp Microwave ablation catheter and method of utilizing the same
CN104519940A (en) * 2012-08-07 2015-04-15 柯惠有限合伙公司 Microwave ablation catheter and method of utilizing same
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US9414752B2 (en) 2012-11-09 2016-08-16 Elwha Llc Embolism deflector
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9981096B2 (en) 2013-03-13 2018-05-29 Covidien Lp Methods and systems for triggering with unknown inspiratory flow
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
US9925346B2 (en) 2015-01-20 2018-03-27 Covidien Lp Systems and methods for ventilation with unknown exhalation flow
US20160354193A1 (en) * 2015-06-05 2016-12-08 Bruce Gordon McNAB, SR. Prostatic urethral stent

Also Published As

Publication number Publication date Type
US20050049615A1 (en) 2005-03-03 application
EP1143864A2 (en) 2001-10-17 application
WO2001010314A2 (en) 2001-02-15 application
US20050085801A1 (en) 2005-04-21 application
EP1400204A1 (en) 2004-03-24 application
EP1143864B1 (en) 2004-02-04 grant
US20020049370A1 (en) 2002-04-25 application
US6629951B2 (en) 2003-10-07 grant
US20020042565A1 (en) 2002-04-11 application
US20050096529A1 (en) 2005-05-05 application
US20060276807A1 (en) 2006-12-07 application
US20040073201A1 (en) 2004-04-15 application
EP1151729A1 (en) 2001-11-07 application
CA2393898A1 (en) 2001-02-15 application
JP2003506132A (en) 2003-02-18 application
DE60008072T2 (en) 2004-08-05 grant
US6692494B1 (en) 2004-02-17 grant
US20110146673A1 (en) 2011-06-23 application
DE60008072D1 (en) 2004-03-11 grant

Similar Documents

Publication Publication Date Title
US5810810A (en) Apparatus and method for sealing vascular punctures
US7959627B2 (en) Precision ablating device
US6726677B1 (en) Stabilized tissue penetrating catheters
US7134438B2 (en) Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6872205B2 (en) Circumferential ablation device assembly
USRE40863E1 (en) Apparatus and method for sealing vascular punctures
US6245064B1 (en) Circumferential ablation device assembly
US6508824B1 (en) Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
US20070043350A1 (en) Selective lung tissue ablation
US20030233099A1 (en) Modification of airways by application of energy
US7422563B2 (en) Multifunctional tip catheter for applying energy to tissue and detecting the presence of blood flow
US20050137518A1 (en) Devices for maintaining surgically created openings
US20070213583A1 (en) Percutaneous access and visualization of the spine
US20070213584A1 (en) Percutaneous access and visualization of the spine
US20120310233A1 (en) Systems, apparatuses, and methods for treating tissue and controlling stenosis
US6520974B2 (en) Surgical fastener
US20070203517A1 (en) Transgastric surgical devices and procedures
US6520975B2 (en) Kit for endovascular venous surgery
US6063085A (en) Apparatus and method for sealing vascular punctures
US8740895B2 (en) Delivery devices with coolable energy emitting assemblies
US20050148818A1 (en) Method and apparatus for performing transgastric procedures
US20120259263A1 (en) Apparatus and methods to create and maintain an intra-atrial pressure relief opening
US20090143808A1 (en) Guided Tissue Cutting Device, Method of Use and Kits Therefor
US20060249164A1 (en) Bronchoscopic lung volume reduction method
EP2320821B1 (en) Systems for treating a bronchial tree

Legal Events

Date Code Title Description
AS Assignment

Owner name: BRONCUS TECHNOLOGIES, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:COOPER, JOEL D.;LOOMAS, BRYAN;TANAKA, DON;AND OTHERS;REEL/FRAME:012115/0616;SIGNING DATES FROM 20010810 TO 20010820

AS Assignment

Owner name: VENTURE LENDING & LEASING III, INC., CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:BRONCUS TECHNOLOGIES, INC.;REEL/FRAME:015311/0009

Effective date: 20040408

AS Assignment

Owner name: VENTURE LENDING & LEASING III, LLC, SUCCESSOR IN I

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BRONCUS TECHNOLOGIES, INC.;REEL/FRAME:020016/0847

Effective date: 20071015